,aeid,acid,assay_component_endpoint_name,export_ready,internal_ready,assay_component_endpoint_desc,assay_function_type,normalized_data_type,burst_assay,key_positive_control,signal_direction,intended_target_type,intended_target_type_sub,intended_target_family,intended_target_family_sub,fit_all,cell_viability_assay,data_usability,n_chemicals,n_chemicals_no_chid
0,2,1,ACEA_ER_80hr,1,1,"Data from the assay component ACEA_ER_80hr was analyzed into 1 assay endpoint. 
This assay endpoint, ACEA_ER_80hr_Positive, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, measures of the cells for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",signaling,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,3184,15499
1,4,2,APR_HepG2_CellCycleArrest_1hr,1,1,"Data from the assay component APR_HepG2_CellCycleArrest_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,310,0
2,6,3,APR_HepG2_CellLoss_1hr,1,1,"Data from the assay component APR_HepG2_CellLoss_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,310,0
3,8,4,APR_HepG2_MicrotubuleCSK_1hr,1,1,"Data from the assay component APR_HepG2_MicrotubuleCSK_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,310,0
4,10,5,APR_HepG2_MitoMass_1hr,1,1,"Data from the assay component APR_HepG2_MitoMass_1hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,310,0
5,12,6,APR_HepG2_MitoMembPot_1hr,1,1,"Data from the assay component APR_HepG2_MitoMembPot_1hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,310,0
6,14,7,APR_HepG2_MitoticArrest_1hr,1,1,"Data from the assay component APR_HepG2_MitoticArrest_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,310,0
7,16,8,APR_HepG2_NuclearSize_1hr,1,1,"Data from the assay component APR_HepG2_NuclearSize_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_NuclearSize_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,nucleus,cell morphology,organelle conformation,0,0,1,310,0
8,18,9,APR_HepG2_P-H2AX_1hr,1,1,"Data from the assay component APR_HepG2_P-H2AX_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,cellular response to DNA damage stimulus,0,0,1,310,0
9,20,10,APR_HepG2_p53Act_1hr,1,1,"Data from the assay component APR_HepG2_p53Act_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,310,0
10,22,11,APR_HepG2_StressKinase_1hr,1,1,"Data from the assay component APR_HepG2_StressKinase_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,stress response,0,0,1,310,0
11,24,12,APR_HepG2_CellCycleArrest_24hr,1,1,"Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1067,40
12,26,13,APR_HepG2_CellLoss_24hr,1,1,"Data from the assay component APR_HepG2_CellLoss_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1067,40
13,28,14,APR_HepG2_MicrotubuleCSK_24hr,1,1,"Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,1067,20
14,30,15,APR_HepG2_MitoMass_24hr,1,1,"Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1067,20
15,32,16,APR_HepG2_MitoMembPot_24hr,1,1,"Data from the assay component APR_HepG2_MitoMembPot_24hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1067,20
16,34,17,APR_HepG2_MitoticArrest_24hr,1,1,"Data from the assay component APR_HepG2_MitoticArrest_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1067,20
17,36,18,APR_HepG2_NuclearSize_24hr,1,1,"Data from the assay component APR_HepG2_NuclearSize_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_NuclearSize_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,nucleus,cell morphology,organelle conformation,0,0,1,1067,40
18,38,19,APR_HepG2_P-H2AX_24hr,1,1,"Data from the assay component APR_HepG2_P-H2AX_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,cellular response to DNA damage stimulus,0,0,1,1067,20
19,40,20,APR_HepG2_p53Act_24hr,1,1,"Data from the assay component APR_HepG2_p53Act_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,1067,20
20,42,21,APR_HepG2_StressKinase_24hr,1,1,"Data from the assay component APR_HepG2_StressKinase_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,stress response,0,0,1,1067,20
21,44,22,APR_HepG2_CellCycleArrest_72hr,1,1,"Data from the assay component APR_HepG2_CellCycleArrest_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1067,40
22,46,23,APR_HepG2_CellLoss_72hr,1,1,"Data from the assay component APR_HepG2_CellLoss_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1067,40
23,48,24,APR_HepG2_MicrotubuleCSK_72hr,1,1,"Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,1052,20
24,50,25,APR_HepG2_MitoMass_72hr,1,1,"Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1052,20
25,52,26,APR_HepG2_MitoMembPot_72hr,1,1,"Data from the assay component APR_HepG2_MitoMembPot_72hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1052,20
26,54,27,APR_HepG2_MitoticArrest_72hr,1,1,"Data from the assay component APR_HepG2_MitoticArrest_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1052,20
27,56,28,APR_HepG2_NuclearSize_72hr,1,1,"Data from the assay component APR_HepG2_NuclearSize_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_NuclearSize_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,nucleus,cell morphology,organelle conformation,0,0,1,1067,40
28,58,29,APR_HepG2_P-H2AX_72hr,1,1,"Data from the assay component APR_HepG2_P-H2AX_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,cellular response to DNA damage stimulus,0,0,1,1067,20
29,60,30,APR_HepG2_p53Act_72hr,1,1,"Data from the assay component APR_HepG2_p53Act_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,1067,20
30,62,31,APR_HepG2_StressKinase_72hr,1,1,"Data from the assay component APR_HepG2_StressKinase_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,stress response,0,0,1,1067,20
31,63,32,ATG_Ahr_CIS,1,1,"Data from the assay component ATG_Ahr_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Ahr_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain or loss-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AHR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,6-formylindolo carbazole,bidirectional,protein,transcription factor,dna binding,basic helix-loop-helix protein,0,0,1,4040,2703
32,64,33,ATG_AP_1_CIS,1,1,"Data from the assay component ATG_AP_1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AP_1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOS and JUN. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703
33,65,34,ATG_AP_2_CIS,1,1,"Data from the assay component ATG_AP_2_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AP_2_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TFAP2A and TFAP2B and TFAP2D. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-turn-helix leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic helix-turn-helix leucine zipper,0,0,1,4040,2702
34,66,35,ATG_BRE_CIS,1,1,"Data from the assay component ATG_BRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_BRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SMAD1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is Smad protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,Smad protein,0,0,1,4040,2703
35,67,36,ATG_C_EBP_CIS,1,1,"Data from the assay component ATG_C_EBP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_C_EBP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CEBPB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703
36,68,37,ATG_CMV_CIS,1,1,"Data from the assay component ATG_CMV_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CMV_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2702
37,69,38,ATG_CRE_CIS,1,1,"Data from the assay component ATG_CRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CREB3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,Forskolin,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703
38,70,39,ATG_DR4_LXR_CIS,1,1,"Data from the assay component ATG_DR4_LXR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_DR4_LXR_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2 and NR1H3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703
39,71,40,ATG_DR5_RAR_CIS,1,1,"Data from the assay component ATG_DR5_RAR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_DR5_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA and RARB and RARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,9-cis-Retinoic acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703
40,72,41,ATG_E_Box_CIS,1,1,"Data from the assay component ATG_E_Box_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_E_Box_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene USF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic helix-loop-helix protein,0,0,1,4040,2703
41,73,42,ATG_E2F_CIS,1,1,"Data from the assay component ATG_E2F_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_E2F_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene E2F1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is E2F transcription factor.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,E2F transcription factor,0,0,1,4040,2703
42,74,43,ATG_EGR_CIS,1,1,"Data from the assay component ATG_EGR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_EGR_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene EGR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2703
43,75,44,ATG_ERE_CIS,1,1,"Data from the assay component ATG_ERE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,17b-Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2703
44,76,45,ATG_Ets_CIS,1,1,"Data from the assay component ATG_Ets_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Ets_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ETS1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is winged helix-turn-helix.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,winged helix-turn-helix,0,0,1,4040,2703
45,77,46,ATG_FoxA2_CIS,1,1,"Data from the assay component ATG_FoxA2_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FoxA2_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXA2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,forkhead box protein,0,0,1,4040,2703
46,78,47,ATG_FoxO_CIS,1,1,"Data from the assay component ATG_FoxO_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FoxO_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXO1 and FOXO3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,forkhead box protein,0,0,1,4040,2702
47,79,48,ATG_GATA_CIS,1,1,"Data from the assay component ATG_GATA_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GATA_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GATA1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is GATA proteins.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,GATA proteins,0,0,1,4040,2703
48,80,49,ATG_GLI_CIS,1,1,"Data from the assay component ATG_GLI_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GLI_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GLI1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2703
49,81,50,ATG_GRE_CIS,1,1,"Data from the assay component ATG_GRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2703
50,82,51,ATG_HIF1a_CIS,1,1,"Data from the assay component ATG_HIF1a_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HIF1a_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HIF1A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic helix-loop-helix protein,0,0,1,4040,2703
51,83,52,ATG_HNF6_CIS,1,1,"Data from the assay component ATG_HNF6_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HNF6_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ONECUT1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is homeobox protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,homeobox protein,0,0,1,4040,2703
52,84,53,ATG_HSE_CIS,1,1,"Data from the assay component ATG_HSE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HSE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HSF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein.",reporter gene,log2_fold_induction,0,Geldanamycin,gain,protein,transcription factor,dna binding,heat shock protein,0,0,1,4040,2703
53,85,54,ATG_IR1_CIS,1,1,"Data from the assay component ATG_IR1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_IR1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2702
54,86,55,ATG_ISRE_CIS,1,1,"Data from the assay component ATG_ISRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ISRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene IRF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is interferon regulatory factors.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,interferon regulatory factors,0,0,1,4040,2703
55,87,56,ATG_M_06_CIS,1,1,"Data from the assay component ATG_M_06_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_06_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703
56,88,57,ATG_M_19_CIS,1,1,"Data from the assay component ATG_M_19_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_19_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703
57,89,58,ATG_M_32_CIS,1,1,"Data from the assay component ATG_M_32_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_32_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703
58,90,59,ATG_M_61_CIS,1,1,"Data from the assay component ATG_M_61_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_61_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703
59,91,60,ATG_MRE_CIS,1,1,"Data from the assay component ATG_MRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_MRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MTF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2703
60,92,61,ATG_Myb_CIS,1,1,"Data from the assay component ATG_Myb_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Myb_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is MYB proteins.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,MYB proteins,0,0,1,4040,2703
61,93,62,ATG_Myc_CIS,1,1,"Data from the assay component ATG_Myc_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Myc_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic helix-loop-helix leucine zipper,0,0,1,4040,2686
62,94,63,ATG_NF_kB_CIS,1,1,"Data from the assay component ATG_NF_kB_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NF_kB_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFKB1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,NF-kappa B,0,0,1,4040,2703
63,95,64,ATG_NFI_CIS,1,1,"Data from the assay component ATG_NFI_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NFI_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFIA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear factor I.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,nuclear factor I,0,0,1,4040,2703
64,96,65,ATG_NRF1_CIS,1,1,"Data from the assay component ATG_NRF1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NRF1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NRF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear respiratory factors.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,nuclear respiratory factors,0,0,1,4040,2703
65,97,66,ATG_NRF2_ARE_CIS,1,1,"Data from the assay component ATG_NRF2_ARE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NRF2_ARE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFE2L2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703
66,98,67,ATG_Oct_MLP_CIS,1,1,"Data from the assay component ATG_Oct_MLP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Oct_MLP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene POU2F1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is POU domain protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,POU domain protein,0,0,1,4040,2703
67,99,68,ATG_p53_CIS,1,1,"Data from the assay component ATG_p53_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_p53_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TP53. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,tumor suppressor,0,0,1,4040,2703
68,100,69,ATG_Pax6_CIS,1,1,"Data from the assay component ATG_Pax6_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Pax6_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PAX6. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is paired box protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,paired box protein,0,0,1,4040,2703
69,101,70,ATG_PBREM_CIS,1,1,"Data from the assay component ATG_PBREM_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PBREM_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2702
70,102,71,ATG_PPRE_CIS,1,1,"Data from the assay component ATG_PPRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA and PPARD and PPARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rosiglitazone,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703
71,103,72,ATG_PXRE_CIS,1,1,"Data from the assay component ATG_PXRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PXRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rifampicin,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2727
72,104,73,ATG_RORE_CIS,1,1,"Data from the assay component ATG_RORE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORA and RORB and RORC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2703
73,105,74,ATG_Sox_CIS,1,1,"Data from the assay component ATG_Sox_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Sox_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SOX1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,HMG box protein,0,0,1,4040,2702
74,106,75,ATG_Sp1_CIS,1,1,"Data from the assay component ATG_Sp1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Sp1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SP1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2702
75,107,76,ATG_SREBP_CIS,1,1,"Data from the assay component ATG_SREBP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_SREBP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SREBF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic helix-loop-helix leucine zipper,0,0,1,4040,2703
76,108,77,ATG_STAT3_CIS,1,1,"Data from the assay component ATG_STAT3_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_STAT3_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene STAT3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,stat protein,0,0,1,4040,2703
77,109,78,ATG_TA_CIS,1,1,"Data from the assay component ATG_TA_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TA_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703
78,110,79,ATG_TAL_CIS,1,1,"Data from the assay component ATG_TAL_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TAL_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703
79,111,80,ATG_TCF_b_cat_CIS,1,1,"Data from the assay component ATG_TCF_b_cat_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TCF_b_cat_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TCF7 and TCF7L2 and LEF1 and TCF7L1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,HMG box protein,0,0,1,4040,2703
80,112,81,ATG_TGFb_CIS,1,1,"Data from the assay component ATG_TGFb_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TGFb_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TGFB1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,growth factor,transforming growth factor beta,0,0,1,4040,2703
81,113,82,ATG_VDRE_CIS,1,1,"Data from the assay component ATG_VDRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_VDRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703
82,114,83,ATG_Xbp1_CIS,1,1,"Data from the assay component ATG_Xbp1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Xbp1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene XBP1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703
83,115,84,ATG_AR_TRANS,1,1,"Data from the assay component ATG_AR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,6a-Fluorotestosterone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2681
84,116,85,ATG_CAR_TRANS,1,1,"Data from the assay component ATG_CAR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CAR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
85,117,86,ATG_ERa_TRANS,1,1,"Data from the assay component ATG_ERa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,17b-Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692
86,118,87,ATG_ERRa_TRANS,1,1,"Data from the assay component ATG_ERRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692
87,119,88,ATG_ERRg_TRANS,1,1,"Data from the assay component ATG_ERRg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERRg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692
88,120,89,ATG_FXR_TRANS,1,1,"Data from the assay component ATG_FXR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FXR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,CDCA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
89,121,90,ATG_GAL4_TRANS,1,1,"Data from the assay component ATG_GAL4_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GAL4_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is baseline control.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,baseline control,0,0,1,3807,2772
90,122,91,ATG_GR_TRANS,1,1,"Data from the assay component ATG_GR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692
91,123,92,ATG_HNF4a_TRANS,1,1,"Data from the assay component ATG_HNF4a_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HNF4a_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HNF4A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692
92,124,93,ATG_Hpa5_TRANS,1,1,"Data from the assay component ATG_Hpa5_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Hpa5_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,311,70
93,125,94,ATG_LXRa_TRANS,1,1,"Data from the assay component ATG_LXRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_LXRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T0901317,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
94,126,95,ATG_LXRb_TRANS,1,1,"Data from the assay component ATG_LXRb_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_LXRb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T0901317,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
95,127,96,ATG_M_06_TRANS,1,1,"Data from the assay component ATG_M_06_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_06_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2929
96,128,97,ATG_M_19_TRANS,1,1,"Data from the assay component ATG_M_19_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_19_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2929
97,129,98,ATG_M_32_TRANS,1,1,"Data from the assay component ATG_M_32_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_32_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2929
98,130,99,ATG_M_61_TRANS,1,1,"Data from the assay component ATG_M_61_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_M_61_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2929
99,131,100,ATG_NURR1_TRANS,1,1,"Data from the assay component ATG_NURR1_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NURR1_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692
100,132,101,ATG_PPARa_TRANS,1,1,"Data from the assay component ATG_PPARa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW0742,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
101,133,102,ATG_PPARd_TRANS,1,1,"Data from the assay component ATG_PPARd_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARd_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARD. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2677
102,134,103,ATG_PPARg_TRANS,1,1,"Data from the assay component ATG_PPARg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rosiglitazone,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
103,135,104,ATG_PXR_TRANS,1,1,"Data from the assay component ATG_PXR_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_PXR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T0901317,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2712
104,136,105,ATG_RARa_TRANS,1,1,"Data from the assay component ATG_RARa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Retinoic Acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
105,137,106,ATG_RARb_TRANS,1,1,"Data from the assay component ATG_RARb_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Retinoic Acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
106,138,107,ATG_RARg_TRANS,1,1,"Data from the assay component ATG_RARg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Retinoic Acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
107,139,108,ATG_RORb_TRANS,1,1,"Data from the assay component ATG_RORb_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692
108,140,109,ATG_RORg_TRANS,1,1,"Data from the assay component ATG_RORg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692
109,141,110,ATG_RXRa_TRANS,1,1,"Data from the assay component ATG_RXRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RXRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,9-cis-Retinoic acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
110,142,111,ATG_RXRb_TRANS,1,1,"Data from the assay component ATG_RXRb_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_RXRb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,9-cis-Retinoic acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
111,143,112,ATG_THRa1_TRANS,1,1,"Data from the assay component ATG_THRa1_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_THRa1_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene THRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T3,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
112,144,113,ATG_VDR_TRANS,1,1,"Data from the assay component ATG_VDR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_VDR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,"1a,25-Dihydroxyvitamin D3",gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692
113,146,114,BSK_3C_Eselectin,1,1,"Data from the assay component BSK_3C_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0
114,148,115,BSK_3C_HLADR,1,1,"Data from the assay component BSK_3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,MHC Class II,0,0,1,1705,0
115,150,116,BSK_3C_ICAM1,1,1,"Data from the assay component BSK_3C_ICAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
116,152,117,BSK_3C_IL8,1,1,"Data from the assay component BSK_3C_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
117,154,118,BSK_3C_MCP1,1,1,"Data from the assay component BSK_3C_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
118,156,119,BSK_3C_MIG,1,1,"Data from the assay component BSK_3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
119,158,120,BSK_3C_Proliferation,1,1,"Data from the assay component BSK_3C_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_3C_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0
120,160,121,BSK_3C_SRB,1,1,"Data from the assay component BSK_3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
121,162,122,BSK_3C_Thrombomodulin,1,1,"Data from the assay component BSK_3C_Thrombomodulin was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Thrombomodulin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,1705,0
122,164,123,BSK_3C_TissueFactor,1,1,"Data from the assay component BSK_3C_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,coagulation factor,0,0,1,1705,0
123,166,124,BSK_3C_uPAR,1,1,"Data from the assay component BSK_3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0
124,168,125,BSK_3C_VCAM1,1,1,"Data from the assay component BSK_3C_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
125,170,126,BSK_3C_Vis,1,1,"Data from the assay component BSK_3C_Vis was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Vis, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",background control,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,1484,0
126,172,127,BSK_4H_Eotaxin3,1,1,"Data from the assay component BSK_4H_Eotaxin3 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_Eotaxin3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL26. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
127,174,128,BSK_4H_MCP1,1,1,"Data from the assay component BSK_4H_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
128,176,129,BSK_4H_Pselectin,1,1,"Data from the assay component BSK_4H_Pselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_Pselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0
129,178,130,BSK_4H_SRB,1,1,"Data from the assay component BSK_4H_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
130,180,131,BSK_4H_uPAR,1,1,"Data from the assay component BSK_4HAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_4HAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0
131,182,132,BSK_4H_VCAM1,1,1,"Data from the assay component BSK_4H_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
132,184,133,BSK_4H_VEGFRII,1,1,"Data from the assay component BSK_4H_VEGFRII was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_VEGFRII, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,1705,0
133,186,134,BSK_BE3C_HLADR,1,1,"Data from the assay component BSK_BE3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,MHC Class II,0,0,1,1705,0
134,188,135,BSK_BE3C_IL1a,1,1,"Data from the assay component BSK_BE3C_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
135,190,136,BSK_BE3C_IP10,1,1,"Data from the assay component BSK_BE3C_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
136,192,137,BSK_BE3C_MIG,1,1,"Data from the assay component BSK_BE3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
137,194,138,BSK_BE3C_MMP1,1,1,"Data from the assay component BSK_BE3C_MMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,1705,0
138,196,139,BSK_BE3C_PAI1,1,1,"Data from the assay component BSK_BE3C_PAI1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_PAI1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,1705,0
139,198,140,BSK_BE3C_SRB,1,1,"Data from the assay component BSK_BE3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
140,200,141,BSK_BE3C_TGFb1,1,1,"Data from the assay component BSK_BE3C_TGFb1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_TGFb1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,growth factor,transforming growth factor beta,0,0,1,1484,0
141,202,142,BSK_BE3C_tPA,1,1,"Data from the assay component BSK_BE3C_tPA was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_tPA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAT. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,1705,0
142,204,143,BSK_BE3C_uPA,1,1,"Data from the assay component BSK_BE3CA was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3CA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,1705,0
143,206,144,BSK_BE3C_uPAR,1,1,"Data from the assay component BSK_BE3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0
144,208,145,BSK_CASM3C_HLADR,1,1,"Data from the assay component BSK_CASM3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,MHC Class II,0,0,1,1705,0
145,210,146,BSK_CASM3C_IL6,1,1,"Data from the assay component BSK_CASM3C_IL6 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_IL6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
146,212,147,BSK_CASM3C_IL8,1,1,"Data from the assay component BSK_CASM3C_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
147,214,148,BSK_CASM3C_LDLR,1,1,"Data from the assay component BSK_CASM3C_LDLR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_LDLR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is LDL receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,misc protein,LDL receptor,0,0,1,1705,0
148,216,149,BSK_CASM3C_MCP1,1,1,"Data from the assay component BSK_CASM3C_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
149,218,150,BSK_CASM3C_MCSF,1,1,"Data from the assay component BSK_CASM3C_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,1705,0
150,220,151,BSK_CASM3C_MIG,1,1,"Data from the assay component BSK_CASM3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
151,222,152,BSK_CASM3C_Proliferation,1,1,"Data from the assay component BSK_CASM3C_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_CASM3C_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0
152,224,153,BSK_CASM3C_SAA,1,1,"Data from the assay component BSK_CASM3C_SAA was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_SAA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is apolipoproteins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,apolipoproteins,0,0,1,1705,0
153,226,154,BSK_CASM3C_SRB,1,1,"Data from the assay component BSK_CASM3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
154,228,155,BSK_CASM3C_Thrombomodulin,1,1,"Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_Thrombomodulin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,1705,0
155,230,156,BSK_CASM3C_TissueFactor,1,1,"Data from the assay component BSK_CASM3C_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,coagulation factor,0,0,1,1705,0
156,232,157,BSK_CASM3C_uPAR,1,1,"Data from the assay component BSK_CASM3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0
157,234,158,BSK_CASM3C_VCAM1,1,1,"Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
158,236,159,BSK_hDFCGF_CollagenIII,1,1,"Data from the assay component BSK_hDFCGF_CollagenIII was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_CollagenIII, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene COL3A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is collagen.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,1705,0
159,238,160,BSK_hDFCGF_EGFR,1,1,"Data from the assay component BSK_hDFCGF_EGFR was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_EGFR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,1705,0
160,240,161,BSK_hDFCGF_IL8,1,1,"Data from the assay component BSK_hDFCGF_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
161,242,162,BSK_hDFCGF_IP10,1,1,"Data from the assay component BSK_hDFCGF_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
162,244,163,BSK_hDFCGF_MCSF,1,1,"Data from the assay component BSK_hDFCGF_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,1705,0
163,246,164,BSK_hDFCGF_MIG,1,1,"Data from the assay component BSK_hDFCGF_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
164,248,165,BSK_hDFCGF_MMP1,1,1,"Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,1705,0
165,250,166,BSK_hDFCGF_PAI1,1,1,"Data from the assay component BSK_hDFCGF_PAI1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_PAI1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,1705,0
166,252,167,BSK_hDFCGF_Proliferation,1,1,"Data from the assay component BSK_hDFCGF_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_hDFCGF_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0
167,254,168,BSK_hDFCGF_SRB,1,1,"Data from the assay component BSK_hDFCGF_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
168,256,169,BSK_hDFCGF_TIMP1,1,1,"Data from the assay component BSK_hDFCGF_TIMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_TIMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease inhibitor,metalloproteinase inhibitor,0,0,1,1705,0
169,258,170,BSK_hDFCGF_VCAM1,1,1,"Data from the assay component BSK_hDFCGF_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
170,260,171,BSK_KF3CT_ICAM1,1,1,"Data from the assay component BSK_KF3CT_ICAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
171,262,172,BSK_KF3CT_IL1a,1,1,"Data from the assay component BSK_KF3CT_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
172,264,173,BSK_KF3CT_IP10,1,1,"Data from the assay component BSK_KF3CT_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
173,266,174,BSK_KF3CT_MCP1,1,1,"Data from the assay component BSK_KF3CT_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
174,268,175,BSK_KF3CT_MMP9,1,1,"Data from the assay component BSK_KF3CT_MMP9 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_MMP9, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,1705,0
175,270,176,BSK_KF3CT_SRB,1,1,"Data from the assay component BSK_KF3CT_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
176,272,177,BSK_KF3CT_TGFb1,1,1,"Data from the assay component BSK_KF3CT_TGFb1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_TGFb1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,growth factor,transforming growth factor beta,0,0,1,1484,0
177,274,178,BSK_KF3CT_TIMP2,1,1,"Data from the assay component BSK_KF3CT_TIMP2 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_TIMP2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease inhibitor,metalloproteinase inhibitor,0,0,1,1705,0
178,276,179,BSK_KF3CT_uPA,1,1,"Data from the assay component BSK_KF3CTA was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CTA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,1705,0
179,278,180,BSK_LPS_CD40,1,1,"Data from the assay component BSK_LPS_CD40 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_CD40, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0
180,280,181,BSK_LPS_Eselectin,1,1,"Data from the assay component BSK_LPS_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0
181,282,182,BSK_LPS_IL1a,1,1,"Data from the assay component BSK_LPS_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
182,284,183,BSK_LPS_IL8,1,1,"Data from the assay component BSK_LPS_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
183,286,184,BSK_LPS_MCP1,1,1,"Data from the assay component BSK_LPS_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
184,288,185,BSK_LPS_MCSF,1,1,"Data from the assay component BSK_LPS_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,1705,0
185,290,186,BSK_LPS_PGE2,1,1,"Data from the assay component BSK_LPS_PGE2 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_PGE2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,1705,0
186,292,187,BSK_LPS_SRB,1,1,"Data from the assay component BSK_LPS_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
187,294,188,BSK_LPS_TissueFactor,1,1,"Data from the assay component BSK_LPS_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,coagulation factor,0,0,1,1705,0
188,296,189,BSK_LPS_TNFa,1,1,"Data from the assay component BSK_LPS_TNFa was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_TNFa, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0
189,298,190,BSK_LPS_VCAM1,1,1,"Data from the assay component BSK_LPS_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0
190,300,191,BSK_SAg_CD38,1,1,"Data from the assay component BSK_SAg_CD38 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD38, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD38. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is other cytokine.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,other cytokine,0,0,1,1705,0
191,302,192,BSK_SAg_CD40,1,1,"Data from the assay component BSK_SAg_CD40 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD40, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0
192,304,193,BSK_SAg_CD69,1,1,"Data from the assay component BSK_SAg_CD69 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD69, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD69. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0
193,306,194,BSK_SAg_Eselectin,1,1,"Data from the assay component BSK_SAg_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0
194,308,195,BSK_SAg_IL8,1,1,"Data from the assay component BSK_SAg_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0
195,310,196,BSK_SAg_MCP1,1,1,"Data from the assay component BSK_SAg_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
196,312,197,BSK_SAg_MIG,1,1,"Data from the assay component BSK_SAg_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0
197,314,198,BSK_SAg_PBMCCytotoxicity,1,1,"Data from the assay component BSK_SAg_PBMCCytotoxicity was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_PBMCCytotoxicity, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,cytotoxicity,0,1,1,1705,0
198,316,199,BSK_SAg_Proliferation,1,1,"Data from the assay component BSK_SAg_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_SAg_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0
199,318,200,BSK_SAg_SRB,1,1,"Data from the assay component BSK_SAg_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0
200,319,201,NVS_ADME_hCYP19A1,1,1,"Data from the assay component NVS_ADME_hCYP19A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP19A1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,steroidogenesis-related,0,0,1,248,144
201,321,202,NVS_ADME_hCYP1A1,1,1,"Data from the assay component NVS_ADME_hCYP1A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP1A1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole;Ketanserin,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,181,396
202,323,203,NVS_ADME_hCYP1A2,1,1,"Data from the assay component NVS_ADME_hCYP1A2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP1A2, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1A2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Furafylline,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,176,372
203,325,204,NVS_ADME_hCYP1B1,1,1,"Data from the assay component NVS_ADME_hCYP1B1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP1B1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP1B1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Alpha-Naphthoflavone,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,17,48
204,327,205,NVS_ADME_hCYP2A6,1,1,"Data from the assay component NVS_ADME_hCYP2A6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2A6, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2A6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Tranylcypromine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,116,228
205,329,206,NVS_ADME_hCYP2B6,1,1,"Data from the assay component NVS_ADME_hCYP2B6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2B6, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2B6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Clotrimazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,141,312
206,331,207,NVS_ADME_hCYP2C18,1,1,"Data from the assay component NVS_ADME_hCYP2C18 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2C18, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C18. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Tranylcypromine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,98,216
207,333,208,NVS_ADME_hCYP2C19,1,1,"Data from the assay component NVS_ADME_hCYP2C19 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2C19, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C19. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Tranylcypromine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,460,1376
208,335,209,NVS_ADME_hCYP2C8,1,1,"Data from the assay component NVS_ADME_hCYP2C8 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2C8, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,quercetin,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,34,24
209,337,210,NVS_ADME_hCYP2C9,1,1,"Data from the assay component NVS_ADME_hCYP2C9 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2C9, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2C9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Sulfaphenazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,267,788
210,339,211,NVS_ADME_hCYP2D6,1,1,"Data from the assay component NVS_ADME_hCYP2D6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2D6, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2D6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,quinidine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,163,520
211,341,212,NVS_ADME_hCYP2E1,1,1,"Data from the assay component NVS_ADME_hCYP2E1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2E1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2E1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,chlormethiazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,14,24
212,343,213,NVS_ADME_hCYP2J2,1,1,"Data from the assay component NVS_ADME_hCYP2J2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP2J2, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP2J2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,52,48
213,345,214,NVS_ADME_hCYP3A4,1,1,"Data from the assay component NVS_ADME_hCYP3A4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP3A4, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP3A4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,226,744
214,347,215,NVS_ADME_hCYP3A5,1,1,"Data from the assay component NVS_ADME_hCYP3A5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP3A5, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP3A5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,5,12
215,349,216,NVS_ADME_hCYP4F12,1,1,"Data from the assay component NVS_ADME_hCYP4F12 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_hCYP4F12, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CYP4F12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,79,48
216,351,217,NVS_ADME_rCYP1A1,1,1,"Data from the assay component NVS_ADME_rCYP1A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP1A1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp1a1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,ellipticine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,12,24
217,353,218,NVS_ADME_rCYP1A2,1,1,"Data from the assay component NVS_ADME_rCYP1A2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP1A2, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp1a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Alpha-Naphthoflavone,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,91,420
218,355,219,NVS_ADME_rCYP2A1,1,1,"Data from the assay component NVS_ADME_rCYP2A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2A1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2a1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Clotrimazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,67,131
219,357,220,NVS_ADME_rCYP2A2,1,1,"Data from the assay component NVS_ADME_rCYP2A2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2A2, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole;Tranylcypromine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,79,204
220,359,221,NVS_ADME_rCYP2B1,1,1,"Data from the assay component NVS_ADME_rCYP2B1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2B1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2b1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,74,168
221,361,222,NVS_ADME_rCYP2C11,1,1,"Data from the assay component NVS_ADME_rCYP2C11 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2C11, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2c11. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,72,168
222,363,223,NVS_ADME_rCYP2C12,1,1,"Data from the assay component NVS_ADME_rCYP2C12 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2C12, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2c12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Tranylcypromine,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,57,120
223,365,224,NVS_ADME_rCYP2C13,1,1,"Data from the assay component NVS_ADME_rCYP2C13 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2C13, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2c13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Clotrimazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,65,156
224,367,225,NVS_ADME_rCYP2C6,1,1,"Data from the assay component NVS_ADME_rCYP2C6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2C6, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2c6v1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Ketoconazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,54,132
225,369,226,NVS_ADME_rCYP2D1,1,1,"Data from the assay component NVS_ADME_rCYP2D1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2D1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2d1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Propranolol HCl,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,46,96
226,371,227,NVS_ADME_rCYP2D2,1,1,"Data from the assay component NVS_ADME_rCYP2D2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2D2, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2d2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,Propranolol HCl,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,57,120
227,373,228,NVS_ADME_rCYP2E1,1,1,"Data from the assay component NVS_ADME_rCYP2E1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP2E1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp2e1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,chlormethiazole,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,18,24
228,375,229,NVS_ADME_rCYP3A1,1,1,"Data from the assay component NVS_ADME_rCYP3A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP3A1, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp3a23/3a1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,(+/-) Verapamil HCl,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,114,240
229,377,230,NVS_ADME_rCYP3A2,1,1,"Data from the assay component NVS_ADME_rCYP3A2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ADME_rCYP3A2, was analyzed in the positive analysis fitting direction relative to Acetonitrile as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Cyp3a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",enzymatic activity,percent_activity,0,(+/-) Verapamil HCl,loss,protein,enzyme,cyp,xenobiotic metabolism,0,0,1,79,156
230,379,231,NVS_ENZ_hAbl,1,1,"Data from the assay component NVS_ENZ_hAbl was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAbl, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ABL1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,18,36
231,381,232,NVS_ENZ_hAChE,1,1,"Data from the assay component NVS_ENZ_hAChE was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAChE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ACHE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is acetylcholinesterase.",enzymatic activity,percent_activity,0,physostigmine,loss,protein,enzyme,esterase,acetylcholinesterase,0,0,1,152,348
232,383,233,NVS_ENZ_hACP1,1,1,"Data from the assay component NVS_ENZ_hACP1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hACP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ACP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is acid phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,acid phosphatase,0,0,1,59,72
233,385,234,NVS_ENZ_hAKT1,1,1,"Data from the assay component NVS_ENZ_hAKT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAKT1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene AKT1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,156,96
234,387,235,NVS_ENZ_hAKT2,1,1,"Data from the assay component NVS_ENZ_hAKT2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAKT2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene AKT2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,114,72
235,389,236,NVS_ENZ_hAKT3,1,1,"Data from the assay component NVS_ENZ_hAKT3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAKT3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene AKT3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,6,12
236,391,237,NVS_ENZ_hAMPKa1,1,1,"Data from the assay component NVS_ENZ_hAMPKa1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAMPKa1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PRKAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,119,96
237,393,238,NVS_ENZ_hAurA,1,1,"Data from the assay component NVS_ENZ_hAurA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hAurA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene AURKA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,101,72
238,395,239,NVS_ENZ_hBACE,1,1,"Data from the assay component NVS_ENZ_hBACE was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hBACE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BACE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is aspartate protease.",enzymatic activity,percent_activity,0,OM99-02,loss,protein,enzyme,protease,aspartate protease,0,0,1,253,888
239,397,240,NVS_ENZ_hBTK,1,1,"Data from the assay component NVS_ENZ_hBTK was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hBTK, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BTK. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,17,24
240,399,241,NVS_ENZ_hCASP1,1,1,"Data from the assay component NVS_ENZ_hCASP1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,Ac-YVAD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,46,132
241,401,242,NVS_ENZ_hCASP10,1,1,"Data from the assay component NVS_ENZ_hCASP10 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP10, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,Ac-DEVD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,38,84
242,403,243,NVS_ENZ_hCASP2,1,1,"Data from the assay component NVS_ENZ_hCASP2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,z-VDVAD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,97,216
243,405,244,NVS_ENZ_hCASP3,1,1,"Data from the assay component NVS_ENZ_hCASP3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,Ac-DEVD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,47,108
244,407,245,NVS_ENZ_hCASP4,1,1,"Data from the assay component NVS_ENZ_hCASP4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,Ac-LEHD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,67,180
245,409,246,NVS_ENZ_hCASP5,1,1,"Data from the assay component NVS_ENZ_hCASP5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP5, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,Ac-LEHD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,129,512
246,411,247,NVS_ENZ_hCASP8,1,1,"Data from the assay component NVS_ENZ_hCASP8 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCASP8, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CASP8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",enzymatic activity,percent_activity,0,Ac-DEVD-CHO,loss,protein,enzyme,protease,cysteine protease,0,0,1,87,192
247,413,248,NVS_ENZ_hCDK2,1,1,"Data from the assay component NVS_ENZ_hCDK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCDK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CDK2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,56,48
248,415,249,NVS_ENZ_hCDK6,1,1,"Data from the assay component NVS_ENZ_hCDK6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCDK6, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CDK6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,12,12
249,417,250,NVS_ENZ_hCHK1,1,1,"Data from the assay component NVS_ENZ_hCHK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCHK1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CHEK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,12
250,419,251,NVS_ENZ_hCK1a,1,1,"Data from the assay component NVS_ENZ_hCK1a was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCK1a, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CSNK1A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,5-iodotubericidin,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,14,12
251,421,252,NVS_ENZ_hCK1D,1,1,"Data from the assay component NVS_ENZ_hCK1D was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCK1D, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CSNK1D. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,5-iodotubericidin,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,139,72
252,423,253,NVS_ENZ_hCK2a2b2,1,1,"Data from the assay component NVS_ENZ_hCK2a2b2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCK2a2b2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CSNK2A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,30,12
253,425,254,NVS_ENZ_hCSF1R,1,1,"Data from the assay component NVS_ENZ_hCSF1R was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hCSF1R, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CSF1R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,107,72
254,427,255,NVS_ENZ_hDUSP3,1,1,"Data from the assay component NVS_ENZ_hDUSP3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hDUSP3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DUSP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is dual-specific phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,dual-specific phosphatase,0,0,1,164,536
255,429,256,NVS_ENZ_hEGFR,1,1,"Data from the assay component NVS_ENZ_hEGFR was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hEGFR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,77,59
256,431,257,NVS_ENZ_hElastase,1,1,"Data from the assay component NVS_ENZ_hElastase was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hElastase, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ELANE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",enzymatic activity,percent_activity,0,Ursolic acid,loss,protein,enzyme,protease,serine protease,0,0,1,123,276
257,433,258,NVS_ENZ_hEphA1,1,1,"Data from the assay component NVS_ENZ_hEphA1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hEphA1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene EPHA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,364,132
258,435,259,NVS_ENZ_hEphA2,1,1,"Data from the assay component NVS_ENZ_hEphA2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hEphA2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene EPHA2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,78,108
259,437,260,NVS_ENZ_hEphB1,1,1,"Data from the assay component NVS_ENZ_hEphB1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hEphB1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene EPHB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,61,18
260,439,261,NVS_ENZ_hEphB2,1,1,"Data from the assay component NVS_ENZ_hEphB2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hEphB2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene EPHB2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,51,48
261,441,262,NVS_ENZ_hES,1,1,"Data from the assay component NVS_ENZ_hES was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hES, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene BCHE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is pseudocholinesterase.",enzymatic activity,percent_activity,0,physostigmine,loss,protein,enzyme,esterase,pseudocholinesterase,0,0,1,188,484
262,443,263,NVS_ENZ_hFGFR1,1,1,"Data from the assay component NVS_ENZ_hFGFR1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hFGFR1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FGFR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,K252a,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,176,108
263,445,264,NVS_ENZ_hFGFR3,1,1,"Data from the assay component NVS_ENZ_hFGFR3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hFGFR3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FGFR3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,28,12
264,447,265,NVS_ENZ_hFyn,1,1,"Data from the assay component NVS_ENZ_hFyn was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hFyn, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FYN. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,68,133
265,449,266,NVS_ENZ_hGSK3b,1,1,"Data from the assay component NVS_ENZ_hGSK3b was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hGSK3b, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene GSK3B. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,227,108
266,451,267,NVS_ENZ_hHDAC3,1,1,"Data from the assay component NVS_ENZ_hHDAC3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hHDAC3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene HDAC3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is histone deacetylase.",enzymatic activity,percent_activity,0,trichostatin,loss,protein,enzyme,hydrolase,histone deacetylase,0,0,1,71,84
267,453,268,NVS_ENZ_hHDAC6,1,1,"Data from the assay component NVS_ENZ_hHDAC6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hHDAC6, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene HDAC6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is histone deacetylase.",enzymatic activity,percent_activity,0,trichostatin,loss,protein,enzyme,hydrolase,histone deacetylase,0,0,1,75,132
268,455,269,NVS_ENZ_hIGF1R,1,1,"Data from the assay component NVS_ENZ_hIGF1R was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hIGF1R, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene IGF1R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,26,60
269,457,270,NVS_ENZ_hIKKa,1,1,"Data from the assay component NVS_ENZ_hIKKa was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hIKKa, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CHUK. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,59,72
270,459,271,NVS_ENZ_hInsR,1,1,"Data from the assay component NVS_ENZ_hInsR was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hInsR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene INSR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,40,72
271,461,272,NVS_ENZ_hIRAK4,1,1,"Data from the assay component NVS_ENZ_hIRAK4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hIRAK4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene IRAK4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,11,24
272,463,273,NVS_ENZ_hJak2,1,1,"Data from the assay component NVS_ENZ_hJak2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hJak2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene JAK2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,92,60
273,465,274,NVS_ENZ_hJNK2,1,1,"Data from the assay component NVS_ENZ_hJNK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hJNK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MAPK9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,SB203580,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,42,36
274,467,275,NVS_ENZ_hLck,1,1,"Data from the assay component NVS_ENZ_hLck was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hLck, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene LCK. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,19,24
275,469,276,NVS_ENZ_hLynA,1,1,"Data from the assay component NVS_ENZ_hLynA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hLynA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene LYN. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,63,72
276,471,277,NVS_ENZ_hLynB,1,1,"Data from the assay component NVS_ENZ_hLynB was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hLynB, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene LYN. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,2,12
277,473,278,NVS_ENZ_hMAPK1,1,1,"Data from the assay component NVS_ENZ_hMAPK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMAPK1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MAPK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,K252a,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,63,48
278,475,279,NVS_ENZ_hMAPK11,1,1,"Data from the assay component NVS_ENZ_hMAPK11 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMAPK11, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MAPK11. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,SB203580,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,12,12
279,477,280,NVS_ENZ_hMAPK3,1,1,"Data from the assay component NVS_ENZ_hMAPK3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMAPK3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MAPK3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,124,96
280,479,281,NVS_ENZ_hMAPKAPK2,1,1,"Data from the assay component NVS_ENZ_hMAPKAPK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMAPKAPK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MAPKAPK2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,109,84
281,481,282,NVS_ENZ_hMAPKAPK5,1,1,"Data from the assay component NVS_ENZ_hMAPKAPK5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMAPKAPK5, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MAPKAPK5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,18,12
282,483,283,NVS_ENZ_hMARK1,1,1,"Data from the assay component NVS_ENZ_hMARK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMARK1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MARK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,22,12
283,485,284,NVS_ENZ_hMet,1,1,"Data from the assay component NVS_ENZ_hMet was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMet, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MET. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,91,84
284,487,285,NVS_ENZ_hMMP1,1,1,"Data from the assay component NVS_ENZ_hMMP1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMMP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",enzymatic activity,percent_activity,0,Galardin (GM6001),loss,protein,enzyme,protease,matrix metalloproteinase,0,0,1,102,204
285,489,286,NVS_ENZ_hMMP13,1,1,"Data from the assay component NVS_ENZ_hMMP13 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMMP13, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",enzymatic activity,percent_activity,0,Tyr-Hydroxamic acid,loss,protein,enzyme,protease,matrix metalloproteinase,0,0,1,90,204
286,491,287,NVS_ENZ_hMMP2,1,1,"Data from the assay component NVS_ENZ_hMMP2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMMP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",enzymatic activity,percent_activity,0,Galardin (GM6001),loss,protein,enzyme,protease,matrix metalloproteinase,0,0,1,92,192
287,493,288,NVS_ENZ_hMMP3,1,1,"Data from the assay component NVS_ENZ_hMMP3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMMP3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",enzymatic activity,percent_activity,0,Galardin (GM6001),loss,protein,enzyme,protease,matrix metalloproteinase,0,0,1,110,240
288,495,289,NVS_ENZ_hMMP7,1,1,"Data from the assay component NVS_ENZ_hMMP7 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMMP7, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",enzymatic activity,percent_activity,0,Galardin (GM6001),loss,protein,enzyme,protease,matrix metalloproteinase,0,0,1,98,216
289,497,290,NVS_ENZ_hMMP9,1,1,"Data from the assay component NVS_ENZ_hMMP9 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMMP9, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",enzymatic activity,percent_activity,0,Galardin (GM6001),loss,protein,enzyme,protease,matrix metalloproteinase,0,0,1,226,982
290,499,291,NVS_ENZ_hMsk1,1,1,"Data from the assay component NVS_ENZ_hMsk1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hMsk1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene RPS6KA5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,67,72
291,501,292,NVS_ENZ_hNEK2,1,1,"Data from the assay component NVS_ENZ_hNEK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hNEK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene NEK2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,62,60
292,503,293,NVS_ENZ_hPAK2,1,1,"Data from the assay component NVS_ENZ_hPAK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPAK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PAK2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,12
293,505,294,NVS_ENZ_hPAK4,1,1,"Data from the assay component NVS_ENZ_hPAK4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPAK4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PAK4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,97,108
294,507,295,NVS_ENZ_hPDE10,1,1,"Data from the assay component NVS_ENZ_hPDE10 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE10, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE10A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,trequinsin,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,315,168
295,509,296,NVS_ENZ_hPDE4A1,1,1,"Data from the assay component NVS_ENZ_hPDE4A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE4A1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE4A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,trequinsin,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,147,127
296,511,297,NVS_ENZ_hPDE5,1,1,"Data from the assay component NVS_ENZ_hPDE5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE5, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE5A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,Dipyridamole,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,190,120
297,513,298,NVS_ENZ_hPI3Ka,1,1,"Data from the assay component NVS_ENZ_hPI3Ka was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPI3Ka, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PIK3CA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is phosphoinositol kinase.",enzymatic activity,percent_activity,0,PI-103,loss,protein,enzyme,kinase,phosphoinositol kinase,0,0,1,264,154
298,515,299,NVS_ENZ_hPKA,1,1,"Data from the assay component NVS_ENZ_hPKA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPKA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PRKACA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,H 89,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,69,72
299,517,300,NVS_ENZ_hPKCz,1,1,"Data from the assay component NVS_ENZ_hPKCz was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPKCz, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PRKCZ. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,11,24
300,519,301,NVS_ENZ_hPKD2,1,1,"Data from the assay component NVS_ENZ_hPKD2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPKD2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PRKD2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,7,24
301,521,302,NVS_ENZ_hPPM1A,1,1,"Data from the assay component NVS_ENZ_hPPM1A was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPPM1A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PPM1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.",enzymatic activity,percent_activity,0,sodium fluoride,loss,protein,enzyme,phosphatase,serine/threonine phosphatase,0,0,1,74,24
302,523,303,NVS_ENZ_hPPP1CA,1,1,"Data from the assay component NVS_ENZ_hPPP1CA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPPP1CA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PPP1CA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.",enzymatic activity,percent_activity,0,calyculin A,loss,protein,enzyme,phosphatase,serine/threonine phosphatase,0,0,1,111,94
303,525,304,NVS_ENZ_hPPP2CA,1,1,"Data from the assay component NVS_ENZ_hPPP2CA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPPP2CA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PPP2CA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.",enzymatic activity,percent_activity,0,calyculin A,loss,protein,enzyme,phosphatase,serine/threonine phosphatase,0,0,1,48,42
304,527,305,NVS_ENZ_hPTEN,1,1,"Data from the assay component NVS_ENZ_hPTEN was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTEN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTEN. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is dual-specific phosphatase.",enzymatic activity,percent_activity,0,bpV (bipy),loss,protein,enzyme,phosphatase,dual-specific phosphatase,0,0,1,398,228
305,529,306,NVS_ENZ_hPTPN1,1,1,"Data from the assay component NVS_ENZ_hPTPN1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,93,108
306,531,307,NVS_ENZ_hPTPN11,1,1,"Data from the assay component NVS_ENZ_hPTPN11 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN11, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN11. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,94,102
307,533,308,NVS_ENZ_hPTPN12,1,1,"Data from the assay component NVS_ENZ_hPTPN12 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN12, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN12. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,86,109
308,535,309,NVS_ENZ_hPTPN13,1,1,"Data from the assay component NVS_ENZ_hPTPN13 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN13, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN13. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,82,112
309,537,310,NVS_ENZ_hPTPN14,1,1,"Data from the assay component NVS_ENZ_hPTPN14 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN14, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN14. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,78,66
310,539,311,NVS_ENZ_hPTPN2,1,1,"Data from the assay component NVS_ENZ_hPTPN2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,89,113
311,541,312,NVS_ENZ_hPTPN4,1,1,"Data from the assay component NVS_ENZ_hPTPN4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,73,76
312,543,313,NVS_ENZ_hPTPN6,1,1,"Data from the assay component NVS_ENZ_hPTPN6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN6, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,151,72
313,545,314,NVS_ENZ_hPTPN9,1,1,"Data from the assay component NVS_ENZ_hPTPN9 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPN9, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPN9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,non-receptor tyrosine phosphatase,0,0,1,115,96
314,547,315,NVS_ENZ_hPTPRB,1,1,"Data from the assay component NVS_ENZ_hPTPRB was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPRB, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPRB. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,receptor tyrosine phosphatase,0,0,1,81,66
315,549,316,NVS_ENZ_hPTPRC,1,1,"Data from the assay component NVS_ENZ_hPTPRC was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPRC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPRC. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,receptor tyrosine phosphatase,0,0,1,71,156
316,551,317,NVS_ENZ_hPTPRF,1,1,"Data from the assay component NVS_ENZ_hPTPRF was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPRF, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPRF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,receptor tyrosine phosphatase,0,0,1,84,108
317,553,318,NVS_ENZ_hPTPRM,1,1,"Data from the assay component NVS_ENZ_hPTPRM was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPTPRM, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTPRM. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,phosphatase,receptor tyrosine phosphatase,0,0,1,97,82
318,555,319,NVS_ENZ_hRAF1,1,1,"Data from the assay component NVS_ENZ_hRAF1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hRAF1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene RAF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,SB203580,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,101,59
319,557,320,NVS_ENZ_hROCK1,1,1,"Data from the assay component NVS_ENZ_hROCK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hROCK1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ROCK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,83,72
320,559,321,NVS_ENZ_hSGK1,1,1,"Data from the assay component NVS_ENZ_hSGK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hSGK1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SGK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,22,24
321,561,322,NVS_ENZ_hSIRT1,1,1,"Data from the assay component NVS_ENZ_hSIRT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hSIRT1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is protein deacetylase.",enzymatic activity,percent_activity,0,Suramin;Ammonium Molybdate (NH4MoO4),loss,protein,enzyme,hydrolase,protein deacetylase,0,0,1,121,84
322,563,323,NVS_ENZ_hSIRT2,1,1,"Data from the assay component NVS_ENZ_hSIRT2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hSIRT2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is protein deacetylase.",enzymatic activity,percent_activity,0,Suramin,loss,protein,enzyme,hydrolase,protein deacetylase,0,0,1,105,96
323,565,324,NVS_ENZ_hSIRT3,1,1,"Data from the assay component NVS_ENZ_hSIRT3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hSIRT3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SIRT3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is protein deacetylase.",enzymatic activity,percent_activity,0,Nicotinamide,loss,protein,enzyme,hydrolase,protein deacetylase,0,0,1,93,84
324,567,325,NVS_ENZ_hSRC,1,1,"Data from the assay component NVS_ENZ_hSRC was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hSRC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SRC. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,73,71
325,569,326,NVS_ENZ_hSyk,1,1,"Data from the assay component NVS_ENZ_hSyk was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hSyk, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene SYK. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,17,12
326,571,327,NVS_ENZ_hTie2,1,1,"Data from the assay component NVS_ENZ_hTie2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hTie2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene TEK. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,146,84
327,573,328,NVS_ENZ_hTrkA,1,1,"Data from the assay component NVS_ENZ_hTrkA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hTrkA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene NTRK1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,68,70
328,575,329,NVS_ENZ_hVEGFR1,1,1,"Data from the assay component NVS_ENZ_hVEGFR1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hVEGFR1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FLT1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,209,137
329,577,330,NVS_ENZ_hVEGFR2,1,1,"Data from the assay component NVS_ENZ_hVEGFR2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hVEGFR2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,162,108
330,579,331,NVS_ENZ_hVEGFR3,1,1,"Data from the assay component NVS_ENZ_hVEGFR3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hVEGFR3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene FLT4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,92,84
331,581,332,NVS_ENZ_hZAP70,1,1,"Data from the assay component NVS_ENZ_hZAP70 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hZAP70, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene ZAP70. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,3,12
332,583,333,NVS_ENZ_oCOX1,1,1,"Data from the assay component NVS_ENZ_oCOX1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_oCOX1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTGS1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is cyclooxygenase.",enzymatic activity,percent_activity,0,SC-560,loss,protein,enzyme,oxidoreductase,cyclooxygenase,0,0,1,318,1364
333,585,334,NVS_ENZ_oCOX2,1,1,"Data from the assay component NVS_ENZ_oCOX2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_oCOX2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PTGS2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is cyclooxygenase.",enzymatic activity,percent_activity,0,DuP-697,loss,protein,enzyme,oxidoreductase,cyclooxygenase,0,0,1,107,239
334,587,335,NVS_ENZ_pMTHFR,1,1,"Data from the assay component NVS_ENZ_pMTHFR was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_pMTHFR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene MTHFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is methylenetetrahydrofolate reductase.",enzymatic activity,percent_activity,0,Sulfasalazine,loss,protein,enzyme,oxidoreductase,methylenetetrahydrofolate reductase,0,0,1,21,72
335,589,336,NVS_ENZ_rabI2C,1,1,"Data from the assay component NVS_ENZ_rabI2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rabI2C, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene CKB. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is imidazoline receptor.",enzymatic activity,percent_activity,0,2-BFI,loss,protein,receptor,oxidoreductase,imidazoline receptor,0,0,1,108,528
336,591,337,NVS_ENZ_rACFSKBinding,1,1,"Data from the assay component NVS_ENZ_rACFSKBinding was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rACFSKBinding, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Adcy5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is adenylyl cyclase.",enzymatic activity,percent_activity,0,Forskolin,loss,protein,enzyme,lyase,adenylyl cyclase,0,0,1,45,216
337,593,338,NVS_ENZ_rAChE,1,1,"Data from the assay component NVS_ENZ_rAChE was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rAChE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Ache. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is acetylcholinesterase.",enzymatic activity,percent_activity,0,Physostigmine,loss,protein,enzyme,esterase,acetylcholinesterase,0,0,1,118,396
338,595,339,NVS_ENZ_rCNOS,1,1,"Data from the assay component NVS_ENZ_rCNOS was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rCNOS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Nos1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is nitric oxide synthase.",enzymatic activity,percent_activity,0,Nitro-L-Arginine,loss,protein,enzyme,oxidoreductase,nitric oxide synthase,0,0,1,97,261
339,597,340,NVS_ENZ_rCOMT,1,1,"Data from the assay component NVS_ENZ_rCOMT was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rCOMT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Comt. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the methyltransferase intended target family, where the subfamily is o-methyltransferase.",enzymatic activity,percent_activity,0,OR-486,loss,protein,enzyme,methyltransferase,o-methyltransferase,0,0,1,64,120
340,599,341,NVS_ENZ_hDYRK1a,1,1,"Data from the assay component NVS_ENZ_hDYRK1a was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hDYRK1a, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DYRK1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is dual-specific kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,dual-specific kinase,0,0,1,29,12
341,601,342,NVS_ENZ_rMAOAC,1,1,"Data from the assay component NVS_ENZ_rMAOAC was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rMAOAC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maoa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is monoamine oxidase.",enzymatic activity,percent_activity,0,Ro 41-1049;Tetrindole mesylate,loss,protein,enzyme,oxidoreductase,monoamine oxidase,0,0,1,190,432
342,603,343,NVS_ENZ_rMAOAP,1,1,"Data from the assay component NVS_ENZ_rMAOAP was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rMAOAP, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maoa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is monoamine oxidase.",enzymatic activity,percent_activity,0,Ro 41-1049;Tetrindole mesylate,loss,protein,enzyme,oxidoreductase,monoamine oxidase,0,0,1,112,276
343,605,344,NVS_ENZ_rMAOBC,1,1,"Data from the assay component NVS_ENZ_rMAOBC was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rMAOBC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maob. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is monoamine oxidase.",enzymatic activity,percent_activity,0,Ro 16-6491,loss,protein,enzyme,oxidoreductase,monoamine oxidase,0,0,1,132,312
344,607,345,NVS_ENZ_rMAOBP,1,1,"Data from the assay component NVS_ENZ_rMAOBP was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_rMAOBP, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene Maob. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is monoamine oxidase.",enzymatic activity,percent_activity,0,Ro 16-6491,loss,protein,enzyme,oxidoreductase,monoamine oxidase,0,0,1,135,324
345,609,346,NVS_GPCR_bAdoR_NonSelective,1,1,"Data from the assay component NVS_GPCR_bAdoR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bAdoR_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,"5""-N-ethylcarboxamidoadenosine (NECA)",loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,113,240
346,610,347,NVS_GPCR_bAT2,1,1,"Data from the assay component NVS_GPCR_bAT2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bAT2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AGTR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Angiotensin II,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,38,96
347,611,348,NVS_GPCR_bDR_NonSelective,1,1,"Data from the assay component NVS_GPCR_bDR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bDR_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Spiperone HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,59,312
348,612,349,NVS_GPCR_bH1,1,1,"Data from the assay component NVS_GPCR_bH1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bH1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HRH1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Tripolidine,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,61,336
349,613,350,NVS_GPCR_bNPY_NonSelective,1,1,"Data from the assay component NVS_GPCR_bNPY_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_bNPY_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NPY. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,porcine neuropeptide Y,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,58,156
350,614,351,NVS_GPCR_g5HT4,1,1,"Data from the assay component NVS_GPCR_g5HT4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_g5HT4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Serotonin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,142,768
351,615,352,NVS_GPCR_gANPA,1,1,"Data from the assay component NVS_GPCR_gANPA was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gANPA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Nppa. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is guanylyl cyclase.",binding,percent_activity,0,rat ANP,loss,protein,receptor,lyase,guanylyl cyclase,0,0,1,56,141
352,616,353,NVS_GPCR_gBK2,1,1,"Data from the assay component NVS_GPCR_gBK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gBK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Bdkrb2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Bradykinin TFA salt,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,41,216
353,617,354,NVS_GPCR_gH2,1,1,"Data from the assay component NVS_GPCR_gH2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gH2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Hrh2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Tiotidine,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,122,276
354,618,355,NVS_GPCR_gLTB4,1,1,"Data from the assay component NVS_GPCR_gLTB4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gLTB4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ltb4r. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Leukotriene B4 (LTB4),loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,93,612
355,619,356,NVS_GPCR_gLTD4,1,1,"Data from the assay component NVS_GPCR_gLTD4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gLTD4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cysltr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Leukotriene D4 (LTD4),loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,115,647
356,620,357,NVS_GPCR_gMPeripheral_NonSelective,1,1,"Data from the assay component NVS_GPCR_gMPeripheral_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gMPeripheral_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Chrm3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Atropine sulfate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,104,480
357,621,358,NVS_GPCR_gOpiateK,1,1,"Data from the assay component NVS_GPCR_gOpiateK was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_gOpiateK, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprk1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,U-69593,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,186,900
358,622,359,NVS_GPCR_h5HT2A,1,1,"Data from the assay component NVS_GPCR_h5HT2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT2A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Ketanserin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,113,540
359,623,360,NVS_GPCR_h5HT5A,1,1,"Data from the assay component NVS_GPCR_h5HT5A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT5A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR5A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methiothepin mesylate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,163,456
360,624,361,NVS_GPCR_h5HT6,1,1,"Data from the assay component NVS_GPCR_h5HT6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT6, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methiothepin mesylate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,105,336
361,625,362,NVS_GPCR_h5HT7,1,1,"Data from the assay component NVS_GPCR_h5HT7 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_h5HT7, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,5-carboxamidotryptamine,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,167,492
362,626,363,NVS_GPCR_hAdoRA1,1,1,"Data from the assay component NVS_GPCR_hAdoRA1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdoRA1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,2-chloroadenosine,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,151,408
363,627,364,NVS_GPCR_hAdoRA2a,1,1,"Data from the assay component NVS_GPCR_hAdoRA2a was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdoRA2a, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADORA2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,"5""-N-ethylcarboxamidoadenosine (NECA)",loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,165,420
364,628,365,NVS_GPCR_hAdra2A,1,1,"Data from the assay component NVS_GPCR_hAdra2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdra2A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRA2A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Oxymetazoline HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,95,456
365,629,366,NVS_GPCR_hAdra2C,1,1,"Data from the assay component NVS_GPCR_hAdra2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdra2C, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRA2C. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Oxymetazoline HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,120,336
366,630,367,NVS_GPCR_hAdrb1,1,1,"Data from the assay component NVS_GPCR_hAdrb1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Alprenolol HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,105,264
367,631,368,NVS_GPCR_hAdrb2,1,1,"Data from the assay component NVS_GPCR_hAdrb2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Alprenolol HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,83,216
368,632,369,NVS_GPCR_hAdrb3,1,1,"Data from the assay component NVS_GPCR_hAdrb3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAdrb3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ADRB3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Propranolol HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,88,443
369,633,370,NVS_GPCR_hAT1,1,1,"Data from the assay component NVS_GPCR_hAT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hAT1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AGTR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Angiotensin II,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,73,204
370,634,371,NVS_GPCR_hC5a,1,1,"Data from the assay component NVS_GPCR_hC5a was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hC5a, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene C5AR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,human rC5a,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,17,48
371,635,372,NVS_GPCR_hDRD1,1,1,"Data from the assay component NVS_GPCR_hDRD1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,R(+)-SCH 23390,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,296,600
372,636,373,NVS_GPCR_hDRD2s,1,1,"Data from the assay component NVS_GPCR_hDRD2s was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD2s, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Haloperidol,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,133,372
373,637,374,NVS_GPCR_hDRD4.4,1,1,"Data from the assay component NVS_GPCR_hDRD4.4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hDRD4.4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene DRD4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Haloperidol,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,84,228
374,638,375,NVS_GPCR_hETA,1,1,"Data from the assay component NVS_GPCR_hETA was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hETA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene EDNRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Endothelin-1,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,43,144
375,639,376,NVS_GPCR_hETB,1,1,"Data from the assay component NVS_GPCR_hETB was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hETB, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene EDNRB. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Endothelin-1,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,52,132
376,640,377,NVS_GPCR_hH1,1,1,"Data from the assay component NVS_GPCR_hH1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hH1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HRH1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Tripolidine,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,98,228
377,641,378,NVS_GPCR_hLTB4_BLT1,1,1,"Data from the assay component NVS_GPCR_hLTB4_BLT1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hLTB4_BLT1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene LTB4R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Leukotriene B4 (LTB4),loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,73,396
378,642,379,NVS_GPCR_hM1,1,1,"Data from the assay component NVS_GPCR_hM1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methylscopolamine bromide,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,89,300
379,643,380,NVS_GPCR_hM2,1,1,"Data from the assay component NVS_GPCR_hM2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methylscopolamine bromide,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,161,396
380,644,381,NVS_GPCR_hM3,1,1,"Data from the assay component NVS_GPCR_hM3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methylscopolamine bromide,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,109,276
381,645,382,NVS_GPCR_hM4,1,1,"Data from the assay component NVS_GPCR_hM4 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM4, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methylscopolamine bromide,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,135,348
382,646,383,NVS_GPCR_hM5,1,1,"Data from the assay component NVS_GPCR_hM5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hM5, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRM5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methylscopolamine bromide,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,79,204
383,647,384,NVS_GPCR_hNK2,1,1,"Data from the assay component NVS_GPCR_hNK2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hNK2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TACR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Neurokinin A,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,245,540
384,648,385,NVS_GPCR_hNPY1,1,1,"Data from the assay component NVS_GPCR_hNPY1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hNPY1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NPY1R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,porcine neuropeptide Y,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,53,156
385,649,386,NVS_GPCR_hNPY2,1,1,"Data from the assay component NVS_GPCR_hNPY2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hNPY2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NPY2R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,porcine neuropeptide Y,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,68,192
386,650,387,NVS_GPCR_hNTS,1,1,"Data from the assay component NVS_GPCR_hNTS was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hNTS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NTSR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,neurotensin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,60,192
387,651,388,NVS_GPCR_hOpiate_D1,1,1,"Data from the assay component NVS_GPCR_hOpiate_D1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hOpiate_D1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRD1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Naltriben methanesulfonate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,115,294
388,652,389,NVS_GPCR_hOpiate_mu,1,1,"Data from the assay component NVS_GPCR_hOpiate_mu was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hOpiate_mu, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Naloxone HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,270,720
389,653,390,NVS_GPCR_hORL1,1,1,"Data from the assay component NVS_GPCR_hORL1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hORL1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene OPRL1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Nociceptin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,55,348
390,654,391,NVS_GPCR_hPY2,1,1,"Data from the assay component NVS_GPCR_hPY2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hPY2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene P2RY1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,ADPbS,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,44,216
391,655,392,NVS_GPCR_hTXA2,1,1,"Data from the assay component NVS_GPCR_hTXA2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hTXA2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TBXA2R. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Pinane-thromboxane A2,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,200,720
392,656,393,NVS_GPCR_hV1A,1,1,"Data from the assay component NVS_GPCR_hV1A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_hV1A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AVPR1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,"(Phenyl[1]ac, D-Tyr(Me)[2],Arg[6,8],Lys-NH2[9])-vasopressin;Arg8-Vasopressin (AVP)",loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,51,120
393,657,394,NVS_GPCR_mCCKAPeripheral,1,1,"Data from the assay component NVS_GPCR_mCCKAPeripheral was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_mCCKAPeripheral, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cckar. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Cholecystokinin 8 (CCK-8) (26-33) sulfated,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,74,216
394,658,395,NVS_GPCR_mCKKBCentral,1,1,"Data from the assay component NVS_GPCR_mCKKBCentral was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_mCKKBCentral, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cckbr. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Cholecystokinin 8 (CCK-8) (26-33) sulfated,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,45,120
395,659,396,NVS_GPCR_p5HT2C,1,1,"Data from the assay component NVS_GPCR_p5HT2C was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_p5HT2C, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR2C. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Mianserin HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,114,600
396,660,397,NVS_GPCR_r5HT_NonSelective,1,1,"Data from the assay component NVS_GPCR_r5HT_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_r5HT_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Methysergide maleate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,94,444
397,661,398,NVS_GPCR_r5HT1_NonSelective,1,1,"Data from the assay component NVS_GPCR_r5HT1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_r5HT1_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Htr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Serotonin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,73,448
398,662,399,NVS_GPCR_rabPAF,1,1,"Data from the assay component NVS_GPCR_rabPAF was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rabPAF, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PTAFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,C16-PAF,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,103,516
399,663,400,NVS_GPCR_rAdra1_NonSelective,1,1,"Data from the assay component NVS_GPCR_rAdra1_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Phentolamine mesylate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,97,432
400,664,401,NVS_GPCR_rAdra1A,1,1,"Data from the assay component NVS_GPCR_rAdra1A was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Phentolamine mesylate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,65,336
401,665,402,NVS_GPCR_rAdra1B,1,1,"Data from the assay component NVS_GPCR_rAdra1B was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra1B, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra1b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Phentolamine mesylate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,99,528
402,666,403,NVS_GPCR_rAdra2_NonSelective,1,1,"Data from the assay component NVS_GPCR_rAdra2_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdra2_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra2a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Phentolamine mesylate,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,105,444
403,667,404,NVS_GPCR_rAdrb_NonSelective,1,1,"Data from the assay component NVS_GPCR_rAdrb_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rAdrb_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adrb1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Alprenolol HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,68,372
404,668,405,NVS_GPCR_rCRF,1,1,"Data from the assay component NVS_GPCR_rCRF was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rCRF, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Crhr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is secretin receptor.",binding,percent_activity,0,Tyr0-oCRF,loss,protein,receptor,gpcr,secretin receptor,0,0,1,54,129
405,669,406,NVS_GPCR_rGABBR,1,1,"Data from the assay component NVS_GPCR_rGABBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rGABBR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Gabbr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is metabotropic glutamate receptor.",binding,percent_activity,0,(+/-)-Baclofen,loss,protein,receptor,gpcr,metabotropic glutamate receptor,0,0,1,45,120
406,670,407,NVS_GPCR_rGalanin,1,1,"Data from the assay component NVS_GPCR_rGalanin was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rGalanin, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Galr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,porcine Galanin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,23,60
407,671,408,NVS_GPCR_rGHB,1,1,"Data from the assay component NVS_GPCR_rGHB was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rGHB, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tspan17. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is metabotropic glutamate receptor.",binding,percent_activity,0,NCS-382,loss,protein,receptor,gpcr,metabotropic glutamate receptor,0,0,1,22,144
408,672,409,NVS_GPCR_rH3,1,1,"Data from the assay component NVS_GPCR_rH3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rH3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Hrh3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,N-a-methylhistamine (NAMH),loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,57,288
409,673,410,NVS_GPCR_rmAdra2B,1,1,"Data from the assay component NVS_GPCR_rmAdra2B was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rmAdra2B, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Adra2b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Oxymetazoline HCl;Norepinephrine,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,107,492
410,674,411,NVS_GPCR_rmMGluR1,1,1,"Data from the assay component NVS_GPCR_rmMGluR1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rmMGluR1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Grm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is metabotropic glutamate receptor.",binding,percent_activity,0,L-Glutamate,loss,protein,receptor,gpcr,metabotropic glutamate receptor,0,0,1,35,131
411,675,412,NVS_GPCR_rmMGluR5,1,1,"Data from the assay component NVS_GPCR_rmMGluR5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rmMGluR5, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Grm5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is metabotropic glutamate receptor.",binding,percent_activity,0,MPEP,loss,protein,receptor,gpcr,metabotropic glutamate receptor,0,0,1,60,300
412,676,413,NVS_GPCR_rNK1,1,1,"Data from the assay component NVS_GPCR_rNK1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNK1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tacr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Substance P,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,115,612
413,677,414,NVS_GPCR_rNK3,1,1,"Data from the assay component NVS_GPCR_rNK3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNK3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tacr3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Eledoisin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,88,516
414,678,415,NVS_GPCR_rNTS,1,1,"Data from the assay component NVS_GPCR_rNTS was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rNTS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ntsr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Neurotensin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,50,252
415,679,416,NVS_GPCR_rOpiate_NonSelective,1,1,"Data from the assay component NVS_GPCR_rOpiate_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOpiate_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Naloxone HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,133,624
416,680,417,NVS_GPCR_rOpiate_NonSelectiveNa,1,1,"Data from the assay component NVS_GPCR_rOpiate_NonSelectiveNa was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOpiate_NonSelectiveNa, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oprm1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Naloxone HCl,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,125,600
417,681,418,NVS_GPCR_rOXT,1,1,"Data from the assay component NVS_GPCR_rOXT was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rOXT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Oxtr. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Oxytocin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,59,336
418,682,419,NVS_GPCR_rSST,1,1,"Data from the assay component NVS_GPCR_rSST was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rSST, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Sstr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,Somatostatin,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,78,228
419,683,420,NVS_GPCR_rTRH,1,1,"Data from the assay component NVS_GPCR_rTRH was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rTRH, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Trhr. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,TRH,loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,1003,4152
420,684,421,NVS_GPCR_rV1,1,1,"Data from the assay component NVS_GPCR_rV1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rV1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Avpr1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",binding,percent_activity,0,"(Phenyl[1]ac, D-Tyr(Me)[2],Arg[6,8],Lys-NH2[9])-vasopressin;Arg8-Vasopressin (AVP)",loss,protein,receptor,gpcr,rhodopsin-like receptor,0,0,1,57,324
421,685,422,NVS_GPCR_rVIP_NonSelective,1,1,"Data from the assay component NVS_GPCR_rVIP_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_GPCR_rVIP_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Vipr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is secretin receptor.",binding,percent_activity,0,Vasoactive intestinal peptide (VIP),loss,protein,receptor,gpcr,secretin receptor,0,0,1,23,84
422,686,423,NVS_IC_hKhERGCh,1,1,"Data from the assay component NVS_IC_hKhERGCh was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_hKhERGCh, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene KCNH2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is potassium channel.",binding,percent_activity,0,Terfenadine,loss,protein,receptor,ion channel,potassium channel,0,0,1,94,444
423,687,424,NVS_IC_rCaBTZCHL,1,1,"Data from the assay component NVS_IC_rCaBTZCHL was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaBTZCHL, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is calcium channel.",binding,percent_activity,0,Diltiazem HCl,loss,protein,receptor,ion channel,calcium channel,0,0,1,180,876
424,688,425,NVS_IC_rCaChN,1,1,"Data from the assay component NVS_IC_rCaChN was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaChN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1b. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is calcium channel.",binding,percent_activity,0,W-Conotoxin GVIA,loss,protein,receptor,ion channel,calcium channel,0,0,1,120,288
425,689,426,NVS_IC_rCaDHPRCh_L,1,1,"Data from the assay component NVS_IC_rCaDHPRCh_L was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rCaDHPRCh_L, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Cacna1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is calcium channel.",binding,percent_activity,0,Nifedipine,loss,protein,receptor,ion channel,calcium channel,0,0,1,93,528
426,690,427,NVS_IC_rKAR,1,1,"Data from the assay component NVS_IC_rKAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rKAR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Grik1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,Kainic acid,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,60,300
427,691,428,NVS_IC_rKATPCh,1,1,"Data from the assay component NVS_IC_rKATPCh was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rKATPCh, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Kcnj1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is potassium channel.",binding,percent_activity,0,Glibenclamide,loss,protein,receptor,ion channel,potassium channel,0,0,1,51,240
428,692,429,NVS_IC_rKCaCh,1,1,"Data from the assay component NVS_IC_rKCaCh was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rKCaCh, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Kcnn1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is potassium channel.",binding,percent_activity,0,Apamin,loss,protein,receptor,ion channel,potassium channel,0,0,1,57,156
429,693,430,NVS_IC_rNaCh_site2,1,1,"Data from the assay component NVS_IC_rNaCh_site2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_IC_rNaCh_site2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Scn1a. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is sodium channel.",binding,percent_activity,0,Aconitine,loss,protein,receptor,ion channel,sodium channel,0,0,1,240,1079
430,694,431,NVS_LGIC_bGABAR_Agonist,1,1,"Data from the assay component NVS_LGIC_bGABAR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_bGABAR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene GABRA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,GABA,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,118,552
431,695,432,NVS_LGIC_bGABARa1,1,1,"Data from the assay component NVS_LGIC_bGABARa1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_bGABARa1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene GABRA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,Ro 15-1788 (Flumazenil),loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,68,360
432,696,433,NVS_LGIC_bGABARa5,1,1,"Data from the assay component NVS_LGIC_bGABARa5 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_bGABARa5, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene GABRA5. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,"L-655,708",loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,51,252
433,697,434,NVS_LGIC_h5HT3,1,1,"Data from the assay component NVS_LGIC_h5HT3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_h5HT3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene HTR3A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,MDL-72222,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,67,156
434,698,435,NVS_LGIC_hNNR_NBungSens,1,1,"Data from the assay component NVS_LGIC_hNNR_NBungSens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_hNNR_NBungSens, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene CHRNA2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,(+/-)-Epibatidine,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,52,263
435,699,436,NVS_LGIC_rAMPA,1,1,"Data from the assay component NVS_LGIC_rAMPA was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rAMPA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Gria1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,(+/-)-AMPA HBr,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,93,432
436,700,437,NVS_LGIC_rGABAR_NonSelective,1,1,"Data from the assay component NVS_LGIC_rGABAR_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGABAR_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Gabra1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,GABA,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,63,372
437,701,438,NVS_LGIC_rGABARa6,1,1,"Data from the assay component NVS_LGIC_rGABARa6 was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGABARa6, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Gabra6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,"L-655,708",loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,46,240
438,702,439,NVS_LGIC_rGluNMDA_Agonist,1,1,"Data from the assay component NVS_LGIC_rGluNMDA_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGluNMDA_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Grin1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,N-methyl-D-aspartate (NMDA),loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,55,288
439,703,440,NVS_LGIC_rGluNMDA_MK801_Agonist,1,1,"Data from the assay component NVS_LGIC_rGluNMDA_MK801_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGluNMDA_MK801_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Grin1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,(+)-MK-801,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,45,204
440,704,441,NVS_LGIC_rGlyRStrySens,1,1,"Data from the assay component NVS_LGIC_rGlyRStrySens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rGlyRStrySens, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Glra1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,Strychnine nitrate,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,41,240
441,705,442,NVS_LGIC_rNNR_BungSens,1,1,"Data from the assay component NVS_LGIC_rNNR_BungSens was analyzed into 1 assay endpoint. This assay endpoint, NVS_LGIC_rNNR_BungSens, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Chrna7. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated ion channel.",binding,percent_activity,0,Methyllycaconitine,loss,protein,receptor,ion channel,ligand-gated ion channel,0,0,1,118,504
442,706,443,NVS_MP_hPBR,1,1,"Data from the assay component NVS_MP_hPBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_MP_hPBR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene TSPO. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is cholesterol transporter.",binding,percent_activity,0,PK11195,loss,protein,transporter,transporter,cholesterol transporter,0,0,1,457,2124
443,707,444,NVS_MP_rPBR,1,1,"Data from the assay component NVS_MP_rPBR was analyzed into 1 assay endpoint. This assay endpoint, NVS_MP_rPBR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Tspo. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is cholesterol transporter.",binding,percent_activity,0,PK11195,loss,protein,transporter,transporter,cholesterol transporter,0,0,1,442,2807
444,708,445,NVS_NR_bER,1,1,"Data from the assay component NVS_NR_bER was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_bER, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,1089,2520
445,709,446,NVS_NR_bPR,1,1,"Data from the assay component NVS_NR_bPR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_bPR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PGR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Promegestone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,196,504
446,710,447,NVS_NR_cAR,1,1,"Data from the assay component NVS_NR_cAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_cAR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Methyltrienolone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,380,789
447,711,448,NVS_NR_hAR,1,1,"Data from the assay component NVS_NR_hAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hAR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Methyltrienolone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,305,743
448,712,449,NVS_NR_hCAR_Agonist,1,1,"Data from the assay component NVS_NR_hCAR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hCAR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,CITCO,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,39,36
449,713,450,NVS_NR_hCAR_Antagonist,1,1,"Data from the assay component NVS_NR_hCAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hCAR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Clotrimazole,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,288,179
450,714,451,NVS_NR_hER,1,1,"Data from the assay component NVS_NR_hER was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hER, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,1178,2904
451,715,452,NVS_NR_hFXR_Agonist,1,1,"Data from the assay component NVS_NR_hFXR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hFXR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,CDCA,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,172,108
452,716,453,NVS_NR_hFXR_Antagonist,1,1,"Data from the assay component NVS_NR_hFXR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hFXR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Guggulsterone,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,266,184
453,717,454,NVS_NR_hGR,1,1,"Data from the assay component NVS_NR_hGR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hGR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR3C1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Triamcinolone acetonide,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,416,1276
454,718,455,NVS_NR_hPPARa,1,1,"Data from the assay component NVS_NR_hPPARa was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPPARa, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PPARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW7647,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,397,228
455,719,456,NVS_NR_hPPARg,1,1,"Data from the assay component NVS_NR_hPPARg was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPPARg, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Ciglitazone,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,815,648
456,720,457,NVS_NR_hPR,1,1,"Data from the assay component NVS_NR_hPR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene PGR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Promegestone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,370,780
457,721,458,NVS_NR_hPXR,1,1,"Data from the assay component NVS_NR_hPXR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hPXR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene NR1I2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,TO901317,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,556,286
458,722,459,NVS_NR_hRAR_Antagonist,1,1,"Data from the assay component NVS_NR_hRAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hRAR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene RARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,RO415253,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,277,156
459,723,460,NVS_NR_hRARa_Agonist,1,1,"Data from the assay component NVS_NR_hRARa_Agonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hRARa_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene RARA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,TTNPB,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,179,108
460,724,461,NVS_NR_hTRa_Antagonist,1,1,"Data from the assay component NVS_NR_hTRa_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_hTRa_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene THRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Bisphenol A,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,231,148
461,725,462,NVS_NR_mERa,1,1,"Data from the assay component NVS_NR_mERa was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_mERa, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Esr1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,959,2892
462,726,463,NVS_NR_rAR,1,1,"Data from the assay component NVS_NR_rAR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_rAR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Ar. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Methyltrienolone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,416,1242
463,727,464,NVS_NR_rMR,1,1,"Data from the assay component NVS_NR_rMR was analyzed into 1 assay endpoint. This assay endpoint, NVS_NR_rMR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Nr3c2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,Spironolactone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,116,324
464,728,465,NVS_OR_gSIGMA_NonSelective,1,1,"Data from the assay component NVS_OR_gSIGMA_NonSelective was analyzed into 1 assay endpoint. This assay endpoint, NVS_OR_gSIGMA_NonSelective, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Sigmar1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is chaperone.",binding,percent_activity,0,Haloperidol,loss,protein,receptor,misc protein,chaperone,0,0,1,191,984
465,729,466,NVS_OR_hFKBP12,1,1,"Data from the assay component NVS_OR_hFKBP12 was analyzed into 1 assay endpoint. This assay endpoint, NVS_OR_hFKBP12, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene FKBP1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is chaperone.",binding,percent_activity,0,FK506,loss,protein,enzyme,misc protein,chaperone,0,0,1,25,144
466,730,467,NVS_TR_gDAT,1,1,"Data from the assay component NVS_TR_gDAT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_gDAT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is neurotransmitter transporter.",binding,percent_activity,0,GBR-12909,loss,protein,transporter,transporter,neurotransmitter transporter,0,0,1,239,1259
467,731,468,NVS_TR_hAdoT,1,1,"Data from the assay component NVS_TR_hAdoT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hAdoT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC29A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is nucleoside transporter.",binding,percent_activity,0,Nitrobenzylthioinosine (NBTI),loss,protein,transporter,transporter,nucleoside transporter,0,0,1,82,192
468,732,469,NVS_TR_hDAT,1,1,"Data from the assay component NVS_TR_hDAT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hDAT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is neurotransmitter transporter.",binding,percent_activity,0,GBR-12909,loss,protein,transporter,transporter,neurotransmitter transporter,0,0,1,344,921
469,733,470,NVS_TR_hNET,1,1,"Data from the assay component NVS_TR_hNET was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hNET, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is neurotransmitter transporter.",binding,percent_activity,0,Desipramine,loss,protein,transporter,transporter,neurotransmitter transporter,0,0,1,362,843
470,734,471,NVS_TR_hSERT,1,1,"Data from the assay component NVS_TR_hSERT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_hSERT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene SLC6A4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is neurotransmitter transporter.",binding,percent_activity,0,Imipramine HCl;Clomipramine HCl,loss,protein,transporter,transporter,neurotransmitter transporter,0,0,1,108,275
471,735,472,NVS_TR_rAdoT,1,1,"Data from the assay component NVS_TR_rAdoT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rAdoT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc29a1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is nucleoside transporter.",binding,percent_activity,0,Nitrobenzylthioinosine (NBTI),loss,protein,transporter,transporter,nucleoside transporter,0,0,1,22,108
472,736,473,NVS_TR_rNET,1,1,"Data from the assay component NVS_TR_rNET was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rNET, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is neurotransmitter transporter.",binding,percent_activity,0,Desipramine,loss,protein,transporter,transporter,neurotransmitter transporter,0,0,1,82,408
473,737,474,NVS_TR_rSERT,1,1,"Data from the assay component NVS_TR_rSERT was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rSERT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc6a4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is neurotransmitter transporter.",binding,percent_activity,0,Imipramine HCl,loss,protein,transporter,transporter,neurotransmitter transporter,0,0,1,149,384
474,738,475,NVS_TR_rVMAT2,1,1,"Data from the assay component NVS_TR_rVMAT2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_TR_rVMAT2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, loss-of-signal activity can be used to understand changes in the binding as they relate to the gene Slc18a2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is vesicular transporter.",binding,percent_activity,0,Reserpine,loss,protein,transporter,transporter,vesicular transporter,0,0,1,177,552
475,739,476,OT_AR_ARELUC_AG_1440,1,1,"Data from the assay component OT_AR_ARELUC_AG_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARELUC_AG_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,6-alpha-Fluorotestosterone,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5168
476,740,477,OT_AR_ARSRC1_0480,1,1,"Data from the assay component OT_AR_ARSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,"4,5-alpha-Dihydrotestosterone",gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
477,741,478,OT_AR_ARSRC1_0960,1,1,"Data from the assay component OT_AR_ARSRC1_0960 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0960, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,"4,5-alpha-Dihydrotestosterone",gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
478,742,479,OT_ER_ERaERa_0480,1,1,"Data from the assay component OT_ER_ERaERa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
479,743,480,OT_ER_ERaERa_1440,1,1,"Data from the assay component OT_ER_ERaERa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
480,744,481,OT_ER_ERaERb_0480,1,1,"Data from the assay component OT_ER_ERaERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
481,745,482,OT_ER_ERaERb_1440,1,1,"Data from the assay component OT_ER_ERaERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
482,746,483,OT_ER_ERbERb_0480,1,1,"Data from the assay component OT_ER_ERbERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
483,747,484,OT_ER_ERbERb_1440,1,1,"Data from the assay component OT_ER_ERbERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
484,750,487,OT_ERa_GFPERaERE_0120,1,1,"Data from the assay component OT_ERa_GFPERaERE_0120 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0120, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,(Z)-4-Hydroxytamoxifen,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
485,751,488,OT_ERa_GFPERaERE_0480,1,1,"Data from the assay component OT_ERa_GFPERaERE_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,(Z)-4-Hydroxytamoxifen,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472
486,753,490,OT_FXR_FXRSRC1_0480,1,1,"Data from the assay component OT_FXR_FXRSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW4064,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1858,5472
487,754,491,OT_FXR_FXRSRC1_1440,1,1,"Data from the assay component OT_FXR_FXRSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW4064,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1858,5472
488,755,492,OT_NURR1_NURR1RXRa_0480,1,1,"Data from the assay component OT_NURR1_NURR1RXRa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Isoproterenol;Fenoterol,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1861,8100
489,756,493,OT_NURR1_NURR1RXRa_1440,1,1,"Data from the assay component OT_NURR1_NURR1RXRa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Isoproterenol;Fenoterol,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1861,8100
490,757,494,OT_PPARg_PPARgSRC1_0480,1,1,"Data from the assay component OT_PPARg_PPARgSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_PPARg_PPARgSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW1929,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1861,8100
491,758,495,OT_PPARg_PPARgSRC1_1440,1,1,"Data from the assay component OT_PPARg_PPARgSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_PPARg_PPARgSRC1_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW1929,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1861,8100
492,759,496,TOX21_AR_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_AR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,R1881,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,91904
493,760,497,TOX21_AR_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_AR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,R1881,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,91904
494,761,498,TOX21_AR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_AR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,R1881,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91904
495,762,499,TOX21_AR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_AR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,Cyproterone acetate,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92032
496,763,500,TOX21_AR_BLA_Antagonist_viability,1,1,"TOX21_AR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,92160
497,764,501,TOX21_AR_LUC_MDAKB2_Agonist,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,R1881,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92160
498,765,502,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,Nilutamide,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91506
499,766,503,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability,1,1,"TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,91378
500,767,504,TOX21_Aromatase_Inhibition,1,1,"Data from the assay component TOX21_Aromatase_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_Aromatase_Inhibition, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is steroidogenesis-related.",inducer,percent_activity,0,Letrozole,loss,protein,enzyme,cyp,steroidogenesis-related,0,0,1,8306,72640
501,768,505,TOX21_Aromatase_Inhibition_viability,1,1,"TOX21_Aromatase_Inhibition_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,72082
502,769,506,TOX21_AutoFluor_HEK293_Cell_blue,1,1,"Data from the assay component TOX21_AutoFluor_HEK293_Cell_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Cell_blue, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
503,770,507,TOX21_AutoFluor_HEK293_Cell_green,1,1,"Data from the assay component TOX21_AutoFluor_HEK293_Cell_green was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Cell_green, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
504,771,508,TOX21_AutoFluor_HEK293_Cell_red,1,1,"Data from the assay component TOX21_AutoFluor_HEK293_Cell_red was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Cell_red, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
505,772,509,TOX21_AutoFluor_HEK293_Media_blue,1,1,"Data from the assay component TOX21_AutoFluor_HEK293_Media_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Media_blue, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
506,773,510,TOX21_AutoFluor_HEK293_Media_green,1,1,"Data from the assay component TOX21_AutoFluor_HEK293_Media_green was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Media_green, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
507,774,511,TOX21_AutoFluor_HEK293_Media_red,1,1,"Data from the assay component TOX21_AutoFluor_HEK293_Media_red was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEK293_Media_red, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
508,775,512,TOX21_AutoFluor_HEPG2_Cell_blue,1,1,"Data from the assay component TOX21_AutoFluor_HEPG2_Cell_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Cell_blue, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
509,776,513,TOX21_AutoFluor_HEPG2_Cell_green,1,1,"Data from the assay component TOX21_AutoFluor_HEPG2_Cell_green was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Cell_green, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
510,777,514,TOX21_AutoFluor_HEPG2_Cell_red,1,1,"Data from the assay component TOX21_AutoFluor_HEPG2_Cell_red was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Cell_red, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
511,778,515,TOX21_AutoFluor_HEPG2_Media_blue,1,1,"Data from the assay component TOX21_AutoFluor_HEPG2_Media_blue was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Media_blue, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
512,779,516,TOX21_AutoFluor_HEPG2_Media_green,1,1,"Data from the assay component TOX21_AutoFluor_HEPG2_Media_green was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Media_green, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
513,780,517,TOX21_AutoFluor_HEPG2_Media_red,1,1,"Data from the assay component TOX21_AutoFluor_HEPG2_Media_red was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AutoFluor_HEPG2_Media_red, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of background reporter, gain-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is artifact fluorescence.",background control,percent_activity,0,Fluorescein;Rose Bengal Sodium;Triamterene,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,8306,17600
514,781,518,TOX21_ELG1_LUC_Agonist,1,1,"Data from the assay component TOX21_ELG1_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ELG1_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATAD5.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is atpase.",agonist,percent_activity,0,5-Fluorouridine,gain,protein,enzyme,hydrolase,atpase,0,0,1,8305,92160
515,782,519,TOX21_ELG1_LUC_Agonist_viability,1,1,"TOX21_ELG1_LUC_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8305,92160
516,783,520,TOX21_ERa_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_ERa_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,17b-Estradiol,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,92160
517,784,521,TOX21_ERa_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_ERa_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,92160
518,785,522,TOX21_ERa_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_ERa_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92160
519,786,523,TOX21_ERa_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_ERa_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92032
520,787,524,TOX21_ERa_BLA_Antagonist_viability,1,1,"TOX21_ERa_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,91506
521,788,525,TOX21_ERa_LUC_VM7_Agonist,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91634
522,789,526,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91534
523,790,527,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability,1,1,"TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,91406
524,791,528,TOX21_GR_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_GR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Dexamethasone,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,92032
525,792,529,TOX21_GR_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_GR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Dexamethasone,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,92032
526,793,530,TOX21_GR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_GR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,Dexamethasone,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92032
527,794,531,TOX21_GR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_GR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand gene activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,Mifeprostone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91534
528,795,532,TOX21_GR_BLA_Antagonist_viability,1,1,"TOX21_GR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,92160
529,796,533,TOX21_MMP_fitc,1,1,"TOX21_MMP_fitc is an assay readout measuring signaling via mitochondrial depolarization and designed using viability reporter (mitochondrial membrane potential) detected with immunofluorescence. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",signaling,percent_activity,0,FCCP,gain,cellular,mitochondria,background measurement,baseline control,0,0,1,8305,91022
530,798,535,TOX21_MMP_rhodamine,1,1,"TOX21_MMP_rhodamine is an assay readout measuring signaling via mitochondrial depolarization and designed using viability reporter (mitochondrial membrane potential) detected with immunofluorescence.  Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",signaling,percent_activity,0,FCCP,loss,cellular,mitochondria,background measurement,baseline control,0,0,1,8305,91022
531,799,536,TOX21_MMP_viability,1,1,"TOX21_MMP_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8305,91904
532,800,537,TOX21_PPARg_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_PPARg_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Rosiglitazone,loss,protein,receptor,channel 1,baseline control,0,0,1,8306,92160
533,801,538,TOX21_PPARg_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_PPARg_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Rosiglitazone,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,92160
534,802,539,TOX21_PPARg_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_PPARg_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Rosiglitazone,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,8306,92160
535,803,540,TOX21_TR_LUC_GH3_Agonist,1,1,"Data from the assay component TOX21_TR_LUC_GH3_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,percent_activity,0,0.092 uM T3,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,8306,92160
536,804,541,TOX21_TR_LUC_GH3_Antagonist,1,1,"Data from the assay component TOX21_TR_LUC_GH3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",antagonist,percent_activity,0,1 nM T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,8306,91776
537,805,542,TOX21_TR_LUC_GH3_Antagonist_viability,1,1,"TOX21_TR_LUC_GH3_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,91648
538,806,543,TOX21_AhR_LUC_Agonist,1,1,"Data from the assay component TOX21_AhR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AhR_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AHR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic helix-loop-helix protein.",agonist,percent_activity,0,Omeprazole,gain,protein,receptor,dna binding,basic helix-loop-helix protein,0,0,1,8306,92160
539,807,544,TOX21_AhR_LUC_Agonist_viability,1,1,"TOX21_AhR_LUC_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,92032
540,891,586,CEETOX_H295R_11DCORT,1,1,"Data from the assay component CEETOX_H295R_11DCORT was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_11DCORT, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,11-Deoxycortisol,steroid hormone,glucocorticoids,0,0,1,577,1083
541,893,587,CEETOX_H295R_OHPREG,1,1,"Data from the assay component CEETOX_H295R_OHPREG was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPREG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxypregnenolone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,17alpha-hydroxypregnenolone,steroid hormone,progestagens,0,0,1,577,1084
542,895,588,CEETOX_H295R_OHPROG,1,1,"Data from the assay component CEETOX_H295R_OHPROG was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPROG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,17alpha-hydroxyprogesterone,steroid hormone,progestagens,0,0,1,577,1083
543,897,589,CEETOX_H295R_ANDR,1,1,"Data from the assay component CEETOX_H295R_ANDR was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ANDR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Androstenedione in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Androstenedione,steroid hormone,androgens,0,0,1,577,1083
544,899,590,CEETOX_H295R_CORTIC,1,1,"Data from the assay component CEETOX_H295R_CORTIC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTIC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Corticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Corticosterone,steroid hormone,glucocorticoids,0,0,1,577,1083
545,901,591,CEETOX_H295R_CORTISOL,1,1,"Data from the assay component CEETOX_H295R_CORTISOL was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTISOL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Cortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Cortisol,steroid hormone,glucocorticoids,0,0,1,577,1084
546,905,593,CEETOX_H295R_DOC,1,1,"Data from the assay component CEETOX_H295R_DOC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_DOC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,11-Deoxycorticosterone,steroid hormone,glucocorticoids,0,0,1,577,1083
547,907,594,CEETOX_H295R_ESTRADIOL,1,1,"Data from the assay component CEETOX_H295R_ESTRADIOL was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRADIOL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Estradiol,steroid hormone,estrogens,0,0,1,577,1079
548,909,595,CEETOX_H295R_ESTRONE,1,1,"Data from the assay component CEETOX_H295R_ESTRONE was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRONE, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Estrone,steroid hormone,estrogens,0,0,1,577,1078
549,913,597,CEETOX_H295R_PROG,1,1,"Data from the assay component CEETOX_H295R_PROG was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_PROG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Progesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Progesterone,steroid hormone,progestagens,0,0,1,577,1084
550,915,598,CEETOX_H295R_TESTO,1,1,"Data from the assay component CEETOX_H295R_TESTO was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_TESTO, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Testosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Testosterone,steroid hormone,androgens,0,0,1,577,1084
551,916,599,LTEA_HepaRG_ABCB1,1,1,"Data from the assay component LTEA_HepaRG_ABCB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3722
552,918,600,LTEA_HepaRG_ABCB11,1,1,"Data from the assay component LTEA_HepaRG_ABCB11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCB11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3086
553,920,601,LTEA_HepaRG_ABCC2,1,1,"Data from the assay component LTEA_HepaRG_ABCC2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCC2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3862
554,922,602,LTEA_HepaRG_ABCC3,1,1,"Data from the assay component LTEA_HepaRG_ABCC3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCC3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3963
555,924,603,LTEA_HepaRG_ABCG2,1,1,"Data from the assay component LTEA_HepaRG_ABCG2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCG2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3281
556,926,604,LTEA_HepaRG_ACLY,1,1,"Data from the assay component LTEA_HepaRG_ACLY was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ACLY, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,lyase,steatosis,0,0,1,1061,3959
557,928,605,LTEA_HepaRG_ACOX1,1,1,"Data from the assay component LTEA_HepaRG_ACOX1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ACOX1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidase intended target family, where the subfamily is steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidase,steatosis,0,0,1,1061,3870
558,930,606,LTEA_HepaRG_ADK,1,1,"Data from the assay component LTEA_HepaRG_ADK was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ADK, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,kinase,steatosis,0,0,1,1061,3635
559,932,607,LTEA_HepaRG_AFP,1,1,"Data from the assay component LTEA_HepaRG_AFP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_AFP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is assay control.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,background measurement,assay control,0,0,1,1061,3164
560,934,608,LTEA_HepaRG_ALPP,1,1,"Data from the assay component LTEA_HepaRG_ALPP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ALPP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,phosphatase,"Cell proliferation, survival, death",0,0,1,1061,3324
561,936,609,LTEA_HepaRG_APOA5,1,1,"Data from the assay component LTEA_HepaRG_APOA5 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_APOA5, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the apolipoprotein intended target family, where the subfamily is Steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,apolipoprotein,Steatosis,0,0,1,1061,3123
562,938,610,LTEA_HepaRG_BAD,1,1,"Data from the assay component LTEA_HepaRG_BAD was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BAD, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3609
563,940,611,LTEA_HepaRG_BAX,1,1,"Data from the assay component LTEA_HepaRG_BAX was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BAX, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3935
564,942,612,LTEA_HepaRG_BCL2,1,1,"Data from the assay component LTEA_HepaRG_BCL2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BCL2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3199
565,944,613,LTEA_HepaRG_BCL2L11,1,1,"Data from the assay component LTEA_HepaRG_BCL2L11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BCL2L11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3828
566,946,614,LTEA_HepaRG_BID,1,1,"Data from the assay component LTEA_HepaRG_BID was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BID, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3534
567,948,615,LTEA_HepaRG_CASP3,1,1,"Data from the assay component LTEA_HepaRG_CASP3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CASP3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,cysteine protease,0,0,1,1061,3784
568,950,616,LTEA_HepaRG_CASP8,1,1,"Data from the assay component LTEA_HepaRG_CASP8 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CASP8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,cysteine protease,0,0,1,1061,3638
569,952,617,LTEA_HepaRG_CAT,1,1,"Data from the assay component LTEA_HepaRG_CAT was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CAT, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the catalase intended target family, where the subfamily is oxidative stress.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,catalase,oxidative stress,0,0,1,1061,4004
570,954,618,LTEA_HepaRG_CCND1,1,1,"Data from the assay component LTEA_HepaRG_CCND1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CCND1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3913
571,956,619,LTEA_HepaRG_CCND2,1,1,"Data from the assay component LTEA_HepaRG_CCND2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CCND2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,878,1743
572,958,620,LTEA_HepaRG_CDKN1A,1,1,"Data from the assay component LTEA_HepaRG_CDKN1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CDKN1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3988
573,960,621,LTEA_HepaRG_CFLAR,1,1,"Data from the assay component LTEA_HepaRG_CFLAR was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CFLAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3836
574,962,622,LTEA_HepaRG_CYP1A1,1,1,"Data from the assay component LTEA_HepaRG_CYP1A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP1A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3293
575,964,623,LTEA_HepaRG_CYP1A2,1,1,"Data from the assay component LTEA_HepaRG_CYP1A2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP1A2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,2769
576,966,624,LTEA_HepaRG_CYP24A1,1,1,"Data from the assay component LTEA_HepaRG_CYP24A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP24A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1059,1940
577,968,625,LTEA_HepaRG_CYP2B6,1,1,"Data from the assay component LTEA_HepaRG_CYP2B6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2B6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3181
578,970,626,LTEA_HepaRG_CYP2C19,1,1,"Data from the assay component LTEA_HepaRG_CYP2C19 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C19, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3245
579,972,627,LTEA_HepaRG_CYP2C8,1,1,"Data from the assay component LTEA_HepaRG_CYP2C8 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3069
580,974,628,LTEA_HepaRG_CYP2C9,1,1,"Data from the assay component LTEA_HepaRG_CYP2C9 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C9, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3617
581,976,629,LTEA_HepaRG_CYP2E1,1,1,"Data from the assay component LTEA_HepaRG_CYP2E1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2E1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3623
582,978,630,LTEA_HepaRG_CYP3A4,1,1,"Data from the assay component LTEA_HepaRG_CYP3A4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3714
583,980,631,LTEA_HepaRG_CYP3A5,1,1,"Data from the assay component LTEA_HepaRG_CYP3A5 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A5, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3701
584,982,632,LTEA_HepaRG_CYP3A7,1,1,"Data from the assay component LTEA_HepaRG_CYP3A7 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A7, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3172
585,984,633,LTEA_HepaRG_CYP4A11,1,1,"Data from the assay component LTEA_HepaRG_CYP4A11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP4A11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3415
586,986,634,LTEA_HepaRG_CYP4A22,1,1,"Data from the assay component LTEA_HepaRG_CYP4A22 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP4A22, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,2858
587,988,635,LTEA_HepaRG_CYP7A1,1,1,"Data from the assay component LTEA_HepaRG_CYP7A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP7A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3341
588,990,636,LTEA_HepaRG_DDIT3,1,1,"Data from the assay component LTEA_HepaRG_DDIT3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_DDIT3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3853
589,992,637,LTEA_HepaRG_EGF,1,1,"Data from the assay component LTEA_HepaRG_EGF was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EGF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is EGF-like domain.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,EGF-like domain,0,0,1,1061,3204
590,994,638,LTEA_HepaRG_EGR1,1,1,"Data from the assay component LTEA_HepaRG_EGR1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EGR1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,zinc finger,0,0,1,1061,3922
591,996,639,LTEA_HepaRG_EZR,1,1,"Data from the assay component LTEA_HepaRG_EZR was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EZR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the membrane protein intended target family, where the subfamily is Cellular remodeling.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,membrane protein,Cellular remodeling,0,0,1,1061,3860
592,998,640,LTEA_HepaRG_FABP1,1,1,"Data from the assay component LTEA_HepaRG_FABP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FABP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is fatty acid carrier protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,fatty acid carrier protein,0,0,1,1061,4024
593,1000,641,LTEA_HepaRG_FAS,1,1,"Data from the assay component LTEA_HepaRG_FAS was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FAS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is TNF receptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine receptor,TNF receptor,0,0,1,1061,3756
594,1002,642,LTEA_HepaRG_FASN,1,1,"Data from the assay component LTEA_HepaRG_FASN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FASN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is fatty acid synthase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,lyase,fatty acid synthase,0,0,1,1061,4083
595,1004,643,LTEA_HepaRG_FMO3,1,1,"Data from the assay component LTEA_HepaRG_FMO3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FMO3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is dioxygenase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidoreductase,dioxygenase,0,0,1,1061,3763
596,1006,644,LTEA_HepaRG_FOXO1,1,1,"Data from the assay component LTEA_HepaRG_FOXO1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FOXO1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,forkhead box protein,0,0,1,1061,3696
597,1008,645,LTEA_HepaRG_FOXO3,1,1,"Data from the assay component LTEA_HepaRG_FOXO3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FOXO3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,forkhead box protein,0,0,1,1061,3922
598,1010,646,LTEA_HepaRG_GADD45A,1,1,"Data from the assay component LTEA_HepaRG_GADD45A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Oxidative Stress.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,Oxidative Stress,0,0,1,1061,3689
599,1012,647,LTEA_HepaRG_GADD45B,1,1,"Data from the assay component LTEA_HepaRG_GADD45B was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45B, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mutagenicity response intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,mutagenicity response,"Cell proliferation, survival, death",0,0,1,1061,3898
600,1014,648,LTEA_HepaRG_GADD45G,1,1,"Data from the assay component LTEA_HepaRG_GADD45G was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45G, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mutagenicity response intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,mutagenicity response,"Cell proliferation, survival, death",0,0,1,1061,3831
601,1016,649,LTEA_HepaRG_GCLC,1,1,"Data from the assay component LTEA_HepaRG_GCLC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GCLC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ligase intended target family, where the subfamily is C-N ligase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,ligase,C-N ligase,0,0,1,1061,3869
602,1018,650,LTEA_HepaRG_GCLM,1,1,"Data from the assay component LTEA_HepaRG_GCLM was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GCLM, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ligase intended target family, where the subfamily is C-N ligase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,ligase,C-N ligase,0,0,1,1061,3872
603,1026,654,LTEA_HepaRG_GSTA2,1,1,"Data from the assay component LTEA_HepaRG_GSTA2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GSTA2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,1061,3553
604,1028,655,LTEA_HepaRG_GSTM3,1,1,"Data from the assay component LTEA_HepaRG_GSTM3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GSTM3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,1061,3275
605,1030,656,LTEA_HepaRG_HGF,1,1,"Data from the assay component LTEA_HepaRG_HGF was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HGF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is hepatocyte growth factor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,hepatocyte growth factor,0,0,1,1061,3167
606,1032,657,LTEA_HepaRG_HIF1A,1,1,"Data from the assay component LTEA_HepaRG_HIF1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HIF1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic helix-loop-helix protein,0,0,1,1061,3988
607,1034,658,LTEA_HepaRG_HMGCS2,1,1,"Data from the assay component LTEA_HepaRG_HMGCS2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HMGCS2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is HMG-CoA synthase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,lyase,HMG-CoA synthase,0,0,1,1061,3616
608,1036,659,LTEA_HepaRG_HSPA1A,1,1,"Data from the assay component LTEA_HepaRG_HSPA1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HSPA1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,heat shock protein,0,0,1,1061,3942
609,1038,660,LTEA_HepaRG_ICAM1,1,1,"Data from the assay component LTEA_HepaRG_ICAM1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1061,3760
610,1040,661,LTEA_HepaRG_IGF1,1,1,"Data from the assay component LTEA_HepaRG_IGF1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IGF1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is insulin-like.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,insulin-like,0,0,1,1061,3232
611,1042,662,LTEA_HepaRG_IGFBP1,1,1,"Data from the assay component LTEA_HepaRG_IGFBP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IGFBP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is hormone carrier protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,hormone carrier protein,0,0,1,1061,3887
612,1044,663,LTEA_HepaRG_IL6,1,1,"Data from the assay component LTEA_HepaRG_IL6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IL6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine,interleukins,0,0,1,1061,3820
613,1046,664,LTEA_HepaRG_IL6R,1,1,"Data from the assay component LTEA_HepaRG_IL6R was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IL6R, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is JAK-STAT cytokine receptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine receptor,JAK-STAT cytokine receptor,0,0,1,1061,3748
614,1048,665,LTEA_HepaRG_JUN,1,1,"Data from the assay component LTEA_HepaRG_JUN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_JUN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3739
615,1050,666,LTEA_HepaRG_KCNK1,1,1,"Data from the assay component LTEA_HepaRG_KCNK1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KCNK1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is potassium channel.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,ion channel,potassium channel,0,0,1,1061,3156
616,1052,667,LTEA_HepaRG_KRT19,1,1,"Data from the assay component LTEA_HepaRG_KRT19 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KRT19, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the filaments intended target family, where the subfamily is keratin.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,filaments,keratin,0,0,1,1061,4033
617,1054,668,LTEA_HepaRG_LIPC,1,1,"Data from the assay component LTEA_HepaRG_LIPC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LIPC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is lipase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,esterase,lipase,0,0,1,1061,3159
618,1056,669,LTEA_HepaRG_LPL,1,1,"Data from the assay component LTEA_HepaRG_LPL was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LPL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is lipase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,esterase,lipase,0,0,1,1061,3819
619,1058,670,LTEA_HepaRG_MIR122,1,1,"Data from the assay component LTEA_HepaRG_MIR122 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MIR122, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the microrna intended target family, where the subfamily is post-transcriptional regulation.",reporter gene,log2_fold_induction,0,,bidirectional,rna,miRNA,microrna,post-transcriptional regulation,0,0,1,1061,2865
620,1060,671,LTEA_HepaRG_MMP10,1,1,"Data from the assay component LTEA_HepaRG_MMP10 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,matrix metalloproteinase,0,0,1,1061,3209
621,1062,672,LTEA_HepaRG_MMP3,1,1,"Data from the assay component LTEA_HepaRG_MMP3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,matrix metalloproteinase,0,0,1,1061,3383
622,1064,673,LTEA_HepaRG_MYC,1,1,"Data from the assay component LTEA_HepaRG_MYC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MYC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic helix-loop-helix leucine zipper,0,0,1,1061,3727
623,1066,674,LTEA_HepaRG_NFE2L2,1,1,"Data from the assay component LTEA_HepaRG_NFE2L2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NFE2L2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3529
624,1068,675,LTEA_HepaRG_NFKB1,1,1,"Data from the assay component LTEA_HepaRG_NFKB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NFKB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,NF-kappa B,0,0,1,1061,3692
625,1070,676,LTEA_HepaRG_NQO1,1,1,"Data from the assay component LTEA_HepaRG_NQO1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NQO1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is quinone-acceptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidoreductase,quinone-acceptor,0,0,1,1061,3345
626,1072,677,LTEA_HepaRG_PDK4,1,1,"Data from the assay component LTEA_HepaRG_PDK4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PDK4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,kinase,serine/threonine kinase,0,0,1,1061,3526
627,1074,678,LTEA_HepaRG_PEG10,1,1,"Data from the assay component LTEA_HepaRG_PEG10 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PEG10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,xenobiotic metabolism,0,0,1,1061,4029
628,1076,679,LTEA_HepaRG_PPP2R4,1,1,"Data from the assay component LTEA_HepaRG_PPP2R4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PPP2R4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,phosphatase,serine/threonine phosphatase,0,0,1,1061,3908
629,1078,680,LTEA_HepaRG_PTEN,1,1,"Data from the assay component LTEA_HepaRG_PTEN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PTEN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is dual-specific phosphatase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,phosphatase,dual-specific phosphatase,0,0,1,1061,3715
630,1080,681,LTEA_HepaRG_SDHB,1,1,"Data from the assay component LTEA_HepaRG_SDHB was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SDHB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is ubiquinone.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidoreductase,ubiquinone,0,0,1,1061,3987
631,1082,682,LTEA_HepaRG_SLC22A1,1,1,"Data from the assay component LTEA_HepaRG_SLC22A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC22A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic cation transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,organic cation transporter,0,0,1,1061,3277
632,1084,683,LTEA_HepaRG_SLCO1B1,1,1,"Data from the assay component LTEA_HepaRG_SLCO1B1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLCO1B1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic anion transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,organic anion transporter,0,0,1,1061,3305
633,1086,684,LTEA_HepaRG_STAT3,1,1,"Data from the assay component LTEA_HepaRG_STAT3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_STAT3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,stat protein,0,0,1,1061,3965
634,1088,685,LTEA_HepaRG_SULT2A1,1,1,"Data from the assay component LTEA_HepaRG_SULT2A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SULT2A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,sulfotransferase,0,0,1,1061,3753
635,1090,686,LTEA_HepaRG_TGFA,1,1,"Data from the assay component LTEA_HepaRG_TGFA was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TGFA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is EGF-like domain.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,EGF-like domain,0,0,1,1061,3637
636,1092,687,LTEA_HepaRG_TGFB1,1,1,"Data from the assay component LTEA_HepaRG_TGFB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TGFB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,transforming growth factor beta,0,0,1,1061,3916
637,1094,688,LTEA_HepaRG_THRSP,1,1,"Data from the assay component LTEA_HepaRG_THRSP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_THRSP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is NR mediated metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,NR mediated metabolism,0,0,1,1061,3138
638,1096,689,LTEA_HepaRG_TIMP1,1,1,"Data from the assay component LTEA_HepaRG_TIMP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TIMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease inhibitor,metalloproteinase inhibitor,0,0,1,1061,4114
639,1098,690,LTEA_HepaRG_TNFRSF1A,1,1,"Data from the assay component LTEA_HepaRG_TNFRSF1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TNFRSF1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is TNF receptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine receptor,TNF receptor,0,0,1,1061,3418
640,1100,691,LTEA_HepaRG_TP53,1,1,"Data from the assay component LTEA_HepaRG_TP53 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TP53, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,tumor suppressor,0,0,1,1061,3734
641,1102,692,LTEA_HepaRG_UGT1A1,1,1,"Data from the assay component LTEA_HepaRG_UGT1A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_UGT1A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,1061,3562
642,1104,693,LTEA_HepaRG_UGT1A6,1,1,"Data from the assay component LTEA_HepaRG_UGT1A6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_UGT1A6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,1061,3593
643,1106,694,LTEA_HepaRG_XBP1,1,1,"Data from the assay component LTEA_HepaRG_XBP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_XBP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3451
644,1108,695,TOX21_ARE_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_ARE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ARE_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Beta-Naphthoflavone,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68362
645,1109,696,TOX21_ARE_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_ARE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ARE_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Beta-Naphthoflavone,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68362
646,1110,697,TOX21_ARE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_ARE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_ARE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.",ratio,percent_activity,0,Beta-Naphthoflavone,gain,pathway,pathway-specified,dna binding,basic leucine zipper,0,0,1,7522,68362
647,1111,698,TOX21_HSE_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_HSE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HSE_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,17-AAG,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68490
648,1112,699,TOX21_HSE_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_HSE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HSE_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,17-AAG,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68490
649,1113,700,TOX21_HSE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_HSE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_HSE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is heat shock protein.",ratio,percent_activity,0,17-AAG,gain,pathway,pathway-specified,dna binding,heat shock protein,0,0,1,7522,68490
650,1114,701,TOX21_p53_BLA_p1_ch1,1,1,"Data from the assay component TOX21_p53_BLA_p1_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Mitomycin C,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,103890
651,1115,702,TOX21_p53_BLA_p1_ch2,1,1,"Data from the assay component TOX21_p53_BLA_p1_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,103890
652,1116,703,TOX21_p53_BLA_p1_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p1_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,103890
653,1117,704,TOX21_FXR_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_FXR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Chenodeoxycholic acid,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68490
654,1118,705,TOX21_FXR_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_FXR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Chenodeoxycholic acid,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68490
655,1119,706,TOX21_FXR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_FXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Chenodeoxycholic acid,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68490
656,1120,707,TOX21_FXR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_FXR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_FXR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Guggulsterone,loss,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,62602
657,1121,708,TOX21_FXR_BLA_Antagonist_viability,1,1,"TOX21_FXR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,62602
658,1122,709,TOX21_PPARd_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_PPARd_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,"L-165,041",loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68490
659,1123,710,TOX21_PPARd_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_PPARd_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,"L-165,041",gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68490
660,1124,711,TOX21_PPARd_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_PPARd_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,"L-165,041",gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68490
661,1125,712,TOX21_PPARd_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_PPARd_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,MK886,loss,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68490
662,1126,713,TOX21_PPARd_BLA_Antagonist_viability,1,1,"TOX21_PPARd_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
663,1127,714,TOX21_PPARg_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_PPARg_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,GW9662,loss,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68362
664,1128,715,TOX21_PPARg_BLA_Antagonist_viability,1,1,"TOX21_PPARg_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
665,1129,716,TOX21_VDR_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_VDR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Calcitriol,loss,protein,receptor,channel 1,baseline control,0,0,1,7522,72202
666,1130,717,TOX21_VDR_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_VDR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Calcitriol,gain,protein,receptor,channel 2,baseline control,0,0,1,7522,72202
667,1131,718,TOX21_VDR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_VDR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Calcitriol,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7522,72202
668,1132,719,TOX21_VDR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_VDR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,"1alpha,25-Dihydroxy vitamin D3",loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7522,68490
669,1133,720,TOX21_VDR_BLA_Antagonist_viability,1,1,"TOX21_VDR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
670,1134,721,TOX21_DT40,1,1,"Data from the assay component TOX21_DT40 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_DT40, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint.",viability,percent_activity,0,Tetraoctyl ammonium bromide,loss,pathway,pathway-specified,cell cycle,DNA repair,0,0,1,8306,91634
671,1136,722,LTEA_HepaRG_LDH_cytotoxicity,1,1,"Data from the assay component LTEA_HepaRG_LDH_cytotoxicity was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LDH_cytotoxicity, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for loss-of-signal activity can be used to understand cell death. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,percent_activity,0,,loss,cellular,cellular,cell cycle,proliferation,0,0,1,1061,3360
672,1185,747,TOX21_ARE_BLA_agonist_viability,1,1,"TOX21_ARE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
673,1186,748,TOX21_HSE_BLA_agonist_viability,1,1,"TOX21_HSE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
674,1187,749,TOX21_p53_BLA_p1_viability,1,1,"TOX21_p53_BLA_p1_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,103890
675,1188,750,TOX21_FXR_BLA_agonist_viability,1,1,"TOX21_FXR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
676,1189,751,TOX21_ERa_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_ERa_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,4-hydroxytamoxifen,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,92032
677,1190,752,TOX21_ERa_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_ERa_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,4-hydroxytamoxifen,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,92032
678,1191,753,TOX21_FXR_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_FXR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Guggulsterone,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,62602
679,1192,754,TOX21_FXR_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_FXR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Guggulsterone,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,62602
680,1193,755,TOX21_GR_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_GR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Mifepristone,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,91534
681,1194,756,TOX21_GR_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_GR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Mifepristone,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,91534
682,1195,757,TOX21_PPARd_BLA_Agonist_viability,1,1,"TOX21_PPARd_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
683,1196,758,TOX21_PPARd_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_PPARd_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,MK886,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68490
684,1197,759,TOX21_PPARd_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_PPARd_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,MK886,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68490
685,1198,760,TOX21_PPARg_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_PPARg_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,GW9662,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68362
686,1199,761,TOX21_PPARg_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_PPARg_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,GW9662,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68362
687,1200,762,TOX21_VDR_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_VDR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Tetraoctyl ammonium bromide,gain,protein,receptor,channel 1,baseline control,0,0,1,7522,68490
688,1201,763,TOX21_VDR_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_VDR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,"1alpha,25-Dihydroxy vitamin D3",loss,protein,receptor,channel 2,baseline control,0,0,1,7522,68490
689,1202,764,TOX21_AR_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_AR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter,increased activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Cyproterone acetate,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,92032
690,1203,765,TOX21_AR_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_AR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Cyproterone acetate,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,92032
691,1204,766,ATG_XTT_Cytotoxicity,1,1,"Data from the assay component ATG_XTT_Cytotoxicity was analyzed into 1 assay endpoint. This assay endpoint, ATG_XTT_Cytotoxicity, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. 

Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,NA,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,3403,12
692,1315,890,TOX21_p53_BLA_p2_ch1,1,1,"Data from the assay component TOX21_p53_BLA_p2_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Mitomycin C;Nutlin3,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,30464
693,1316,891,TOX21_p53_BLA_p2_ch2,1,1,"Data from the assay component TOX21_p53_BLA_p2_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,30464
694,1317,892,TOX21_p53_BLA_p2_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p2_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30464
695,1318,893,TOX21_p53_BLA_p2_viability,1,1,"TOX21_p53_BLA_p2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,30464
696,1319,894,TOX21_p53_BLA_p3_ch1,1,1,"Data from the assay component TOX21_p53_BLA_p3_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p3_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Mitomycin C;Nutlin3,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,30720
697,1320,895,TOX21_p53_BLA_p3_ch2,1,1,"Data from the assay component TOX21_p53_BLA_p3_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p3_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,30720
698,1321,896,TOX21_p53_BLA_p3_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p3_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_p53_BLA_p3_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter,  gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30720
699,1322,897,TOX21_p53_BLA_p3_viability,1,1,"TOX21_p53_BLA_p3_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,30720
700,1323,898,TOX21_p53_BLA_p4_ch1,1,1,"Data from the assay component TOX21_p53_BLA_p4_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Mitomycin C;Nutlin3,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,30720
701,1324,899,TOX21_p53_BLA_p4_ch2,1,1,"Data from the assay component TOX21_p53_BLA_p4_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,30720
702,1325,900,TOX21_p53_BLA_p4_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p4_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30720
703,1326,901,TOX21_p53_BLA_p4_viability,1,1,"TOX21_p53_BLA_p4_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,30720
704,1327,902,TOX21_p53_BLA_p5_ch1,1,1,"Data from the assay component TOX21_p53_BLA_p5_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Mitomycin C;Nutlin3,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,8306,30720
705,1328,903,TOX21_p53_BLA_p5_ch2,1,1,"Data from the assay component TOX21_p53_BLA_p5_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,8306,30720
706,1329,904,TOX21_p53_BLA_p5_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p5_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30720
707,1330,905,TOX21_p53_BLA_p5_viability,1,1,"TOX21_p53_BLA_p5_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,8306,30720
708,1331,906,TOX21_VDR_BLA_Agonist_viability,1,1,"TOX21_VDR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68490
709,1340,907,TOX21_ESRE_BLA_ch1,1,1,"Data from the assay component TOX21_ESRE_BLA_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATF6. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,17-AAG,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68490
710,1341,908,TOX21_ESRE_BLA_ch2,1,1,"Data from the assay component TOX21_ESRE_BLA_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATF6. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,17-AAG,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68490
711,1342,909,TOX21_ESRE_BLA_ratio,1,1,"Data from the assay component TOX21_ESRE_BLA_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ATF6.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.",ratio,percent_activity,0,17-AAG,gain,pathway,pathway-specified,dna binding,basic leucine zipper,0,0,1,7522,68490
712,1343,910,TOX21_ESRE_BLA_viability,1,1,"TOX21_ESRE_BLA_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,67864
713,1344,911,TOX21_NFkB_BLA_agonist_ch1,1,1,"Data from the assay component TOX21_NFkB_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_NFkB_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,TNFa,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7522,68362
714,1345,912,TOX21_NFkB_BLA_agonist_ch2,1,1,"Data from the assay component TOX21_NFkB_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_NFkB_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,TNFa,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7522,68362
715,1346,913,TOX21_NFkB_BLA_agonist_ratio,1,1,"Data from the assay component TOX21_NFkB_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_NFkB_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is NF-kappa B.",ratio,percent_activity,0,TNFa,gain,pathway,pathway-specified,dna binding,NF-kappa B,0,0,1,7522,68362
716,1347,914,TOX21_NFkB_BLA_agonist_viability,1,1,"TOX21_NFkB_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,68106
717,1348,915,ATG_NUR77_TRANS2,1,1,"The assay endpoint, ATG_NUR77_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
718,1349,916,ATG_GCNF_TRANS2,1,1,"The assay endpoint ATG_GCNF_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR6A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
719,1350,917,ATG_COUP_TF2_TRANS2,1,1,"The assay endpoint ATG_COUP_TF2_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2F2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
720,1351,918,ATG_PNR_TRANS2,1,1,"The assay endpoint ATG_PNR_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2E3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
721,1352,919,ATG_LRH1_TRANS2,1,1,"The assay endpoint ATG_LRH1_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR5A2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
722,1353,920,ATG_Rev_ERB_A_TRANS2,1,1,"The assay endpoint ATG_Rev_ERB_A_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1D1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
723,1354,921,ATG_HNF4g_TRANS2,1,1,"The assay endpoint ATG_HNF4g_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HNF4G. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
724,1355,922,ATG_ERRb_TRANS2,1,1,"The assay endpoint ATG_ERRb_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,25,39
725,1356,923,ATG_MR_TRANS2,1,1,"The assay endpoint ATG_MR_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,25,39
726,1357,924,ATG_COUP_TF1_TRANS2,1,1,"The assay endpoint ATG_COUP_TF1_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2F1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
727,1358,925,ATG_NOR1_TRANS2,1,1,"The assay endpoint ATG_NOR1_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
728,1359,926,ATG_TR4_TRANS2,1,1,"The assay endpoint ATG_TR4_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2C2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
729,1360,927,ATG_DAX1_TRANS2,1,1,"The assay endpoint ATG_DAX1_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR0B1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
730,1361,928,ATG_Rev_ERB_B_TRANS2,1,1,"The assay endpoint ATG_Rev_ERB_B_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1D2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
731,1362,929,ATG_RORa_TRANS2,1,1,"The assay endpoint ATG_RORa_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is  orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
732,1363,930,ATG_PR_TRANS2,1,1,"The assay endpoint ATG_PR_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PGR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,25,39
733,1364,931,ATG_RXRg_TRANS2,1,1,"The assay endpoint ATG_RXRg_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,25,39
734,1365,932,ATG_SF_1_TRANS2,1,1,"The assay endpoint ATG_SF_1_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR5A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
735,1366,933,ATG_SHP_TRANS2,1,1,"The assay endpoint ATG_SHP_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR0B2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
736,1367,934,ATG_ERb_TRANS2,1,1,"The assay endpoint ATG_ERb_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,25,39
737,1368,935,ATG_TLX_TRANS2,1,1,"The assay endpoint ATG_TLX_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2E1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
738,1369,936,ATG_THRb_TRANS2,1,1,"The assay endpoint ATG_THRb_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,25,39
739,1370,937,ATG_EAR2_TRANS2,1,1,"The assay endpoint ATG_EAR2_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2F6. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
740,1371,938,ATG_TR2_TRANS2,1,1,"The assay endpoint ATG_TR2_TRANS2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR2C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,25,39
741,1372,939,Tanguay_ZF_120hpf_MORT,1,1,"Data from the assay component Tanguay_ZF_120hpf_MORT was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_MORT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2156
742,1373,940,Tanguay_ZF_120hpf_YSE,1,1,"Data from the assay component Tanguay_ZF_120hpf_YSE was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_YSE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
743,1374,941,Tanguay_ZF_120hpf_AXIS,1,1,"Data from the assay component Tanguay_ZF_120hpf_AXIS was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_AXIS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
744,1375,942,Tanguay_ZF_120hpf_EYE,1,1,"Data from the assay component Tanguay_ZF_120hpf_EYE was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_EYE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
745,1376,943,Tanguay_ZF_120hpf_SNOU,1,1,"Data from the assay component Tanguay_ZF_120hpf_SNOU was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SNOU, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
746,1377,944,Tanguay_ZF_120hpf_JAW,1,1,"Data from the assay component Tanguay_ZF_120hpf_JAW was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_JAW, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
747,1378,945,Tanguay_ZF_120hpf_OTIC,1,1,"Data from the assay component Tanguay_ZF_120hpf_OTIC was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_OTIC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
748,1379,946,Tanguay_ZF_120hpf_PE,1,1,"Data from the assay component Tanguay_ZF_120hpf_PE was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
749,1380,947,Tanguay_ZF_120hpf_BRAI,1,1,"Data from the assay component Tanguay_ZF_120hpf_BRAI was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_BRAI, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
750,1381,948,Tanguay_ZF_120hpf_SOMI,1,1,"Data from the assay component Tanguay_ZF_120hpf_SOMI was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SOMI, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
751,1382,949,Tanguay_ZF_120hpf_PFIN,1,1,"Data from the assay component Tanguay_ZF_120hpf_PFIN was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PFIN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
752,1383,950,Tanguay_ZF_120hpf_CFIN,1,1,"Data from the assay component Tanguay_ZF_120hpf_CFIN was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_CFIN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
753,1384,951,Tanguay_ZF_120hpf_PIG,1,1,"Data from the assay component Tanguay_ZF_120hpf_PIG was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PIG, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
754,1385,952,Tanguay_ZF_120hpf_CIRC,1,1,"Data from the assay component Tanguay_ZF_120hpf_CIRC was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_CIRC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
755,1386,953,Tanguay_ZF_120hpf_TRUN,1,1,"Data from the assay component Tanguay_ZF_120hpf_TRUN was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_TRUN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
756,1387,954,Tanguay_ZF_120hpf_SWIM,1,1,"Data from the assay component Tanguay_ZF_120hpf_SWIM was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SWIM, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
757,1388,955,Tanguay_ZF_120hpf_NC,1,1,"Data from the assay component Tanguay_ZF_120hpf_NC was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_NC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
758,1389,956,Tanguay_ZF_120hpf_TR,1,1,"Data from the assay component Tanguay_ZF_120hpf_TR was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_TR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,NA,0,0,1,1061,2154
759,1390,957,LTEA_HepaRG_SLC22A6,1,1,"Data from the assay component LTEA_HepaRG_SLC22A6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC22A6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic anion transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,organic anion transporter,0,0,1,97,261
760,1392,958,LTEA_HepaRG_KLK3,1,1,"Data from the assay component LTEA_HepaRG_KLK3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KLK3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is Cellular remodeling.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,Cellular remodeling,0,0,1,49,18
761,1394,959,LTEA_HepaRG_SLC10A1,1,1,"Data from the assay component LTEA_HepaRG_SLC10A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC10A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is sodium/bile acid cotransporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,sodium/bile acid cotransporter,0,0,1,97,326
762,1396,960,LTEA_HepaRG_MMP1,1,1,"Data from the assay component LTEA_HepaRG_MMP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,matrix metalloproteinase,0,0,1,97,220
763,1398,961,LTEA_HepaRG_CYP24A1_1,1,1,"Data from the assay component LTEA_HepaRG_CYP24A1_1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP24A1_1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,97,269
764,1507,962,CCTE_Padilla_ZF_144hpf_TERATOSCORE,1,1,"Data from the assay component CCTE_Padilla_ZF_144hpf_TERATOSCORE was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Padilla_ZF_144hpf_TERATOSCORE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defect  as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the malformation intended target family, where the subfamily is total.",developmental defect,percent_activity,0,NA,gain,organism,malformation,malformation,total,0,0,1,723,3581
765,1508,963,CCTE_Simmons_AUR_TPO,1,1,"Data from the assay component CCTE_Simmons_AUR_TPO was analyzed at the endpoint, CCTE_Simmons_AUR_TPO, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, the Amplex UltraRed assay, loss-of-signal activity can be used to understand decreased peroxidase activity in the presence of excess hydrogen peroxidase. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is peroxidase.",binding,percent_activity,0,methimazole (MMI),loss,protein,enzyme,oxidoreductase,peroxidase,0,0,1,581,7872
766,1509,964,CCTE_Simmons_CellTiterGLO_HEK293T,1,1,"Data from the assay component CCTE_Simmons_CellTiterGLO_HEK293T was analyzed at the endpoint, CCTE_Simmons_CellTiterGLO_HEK293T, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, measures of ATP content for loss-of-signal activity can be used to understand the viability. This assay was run in parallel with aeid 1508 as a means of indicating the range of chemical cytotoxicity or reactivity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,LUCINH1;LUCINH2,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,581,8184
767,1611,838,CLD_ABCB1_6hr,1,1,"Data from the assay component CLD_ABCB1_6hr was analyzed at the endpoint, CLD_ABCB1_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,337
768,1612,839,CLD_ABCB11_6hr,1,1,"Data from the assay component CLD_ABCB11_6hr was analyzed at the endpoint, CLD_ABCB11_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB11. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,337
769,1613,840,CLD_ABCG2_6hr,1,1,"Data from the assay component CLD_ABCG2_6hr was analyzed at the endpoint, CLD_ABCG2_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCG2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,337
770,1614,841,CLD_ACTIN_6hr,1,1,"Data from the assay component CLD_ACTIN_6hr was analyzed at the endpoint, CLD_ACTIN_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ACTA1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where subfamily is baseline control.",background control,log2_fold_induction,0,,gain,rna,mRNA,background measurement,baseline control,0,0,1,310,337
771,1615,842,CLD_CYP1A1_6hr,1,1,"Data from the assay component CLD_CYP1A1_6hr was analyzed at the endpoint, CLD_CYP1A1_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337
772,1616,843,CLD_CYP1A2_6hr,1,1,"Data from the assay component CLD_CYP1A2_6hr was analyzed at the endpoint, CLD_CYP1A2_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337
773,1617,844,CLD_CYP2B6_6hr,1,1,"Data from the assay component CLD_CYP2B6_6hr was analyzed at the endpoint, CLD_CYP2B6_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337
774,1618,845,CLD_CYP2C19_6hr,1,1,"Data from the assay component CLD_CYP2C19_6hr was analyzed at the endpoint, CLD_CYP2C19_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2C19. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337
775,1619,846,CLD_CYP2C9_6hr,1,1,"Data from the assay component CLD_CYP2C9_6hr was analyzed at the endpoint, CLD_CYP2C9_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2C9. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337
776,1620,847,CLD_CYP3A4_6hr,1,1,"Data from the assay component CLD_CYP3A4_6hr was analyzed at the endpoint, CLD_CYP3A4_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,300
777,1621,848,CLD_GAPDH_6hr,1,1,"Data from the assay component CLD_GAPDH_6hr was analyzed at the endpoint, CLD_GAPDH_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GAPDH. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where subfamily is baseline control.",background control,log2_fold_induction,0,,gain,rna,mRNA,background measurement,baseline control,0,0,1,310,337
778,1622,849,CLD_GSTA2_6hr,1,1,"Data from the assay component CLD_GSTA2_6hr was analyzed at the endpoint, CLD_GSTA2_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GSTA2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,310,337
779,1623,850,CLD_HMGCS2_6hr,1,1,"Data from the assay component CLD_HMGCS2_6hr was analyzed at the endpoint, CLD_HMGCS2_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HMGCS2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where subfamily is HMG-CoA synthase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,lyase,HMG-CoA synthase,0,0,1,310,337
780,1624,851,CLD_SLCO1B1_6hr,1,1,"Data from the assay component CLD_SLCO1B1_6hr was analyzed at the endpoint, CLD_SLCO1B1_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SLCO1B1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is organic anion transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,organic anion transporter,0,0,1,310,337
781,1625,852,CLD_SULT2A_6hr,1,1,"Data from the assay component CLD_SULT2A_6hr was analyzed at the endpoint, CLD_SULT2A_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,sulfotransferase,0,0,1,308,337
782,1626,853,CLD_UGT1A1_6hr,1,1,"Data from the assay component CLD_UGT1A1_6hr was analyzed at the endpoint, CLD_UGT1A1_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,310,337
783,1627,854,CLD_ABCB1_24hr,1,1,"Data from the assay component CLD_ABCB1_24hr was analyzed at the endpoint, CLD_ABCB1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,345
784,1628,855,CLD_ABCB11_24hr,1,1,"Data from the assay component CLD_ABCB11_24hr was analyzed at the endpoint, CLD_ABCB11_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB11. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,344
785,1629,856,CLD_ABCG2_24hr,1,1,"Data from the assay component CLD_ABCG2_24hr was analyzed at the endpoint, CLD_ABCG2_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCG2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,345
786,1630,857,CLD_ACTIN_24hr,1,1,"Data from the assay component CLD_ACTIN_24hr was analyzed at the endpoint, CLD_ACTIN_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ACTA1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where subfamily is baseline control.",background control,log2_fold_induction,0,,gain,rna,mRNA,background measurement,baseline control,0,0,1,310,345
787,1631,858,CLD_CYP1A1_24hr,1,1,"Data from the assay component CLD_CYP1A1_24hr was analyzed at the endpoint, CLD_CYP1A1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,309
788,1632,859,CLD_CYP1A2_24hr,1,1,"Data from the assay component CLD_CYP1A2_24hr was analyzed at the endpoint, CLD_CYP1A2_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,345
789,1633,860,CLD_CYP2B6_24hr,1,1,"Data from the assay component CLD_CYP2B6_24hr was analyzed at the endpoint, CLD_CYP2B6_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,342
790,1634,861,CLD_CYP2C19_24hr,1,1,"Data from the assay component CLD_CYP2C19_24hr was analyzed at the endpoint, CLD_CYP2C19_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2C19. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,345
791,1635,862,CLD_CYP2C9_24hr,1,1,"Data from the assay component CLD_CYP2C9_24hr was analyzed at the endpoint, CLD_CYP2C9_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2C9. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,344
792,1636,863,CLD_CYP3A4_24hr,1,1,"Data from the assay component CLD_CYP3A4_24hr was analyzed at the endpoint, CLD_CYP3A4_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,289
793,1637,864,CLD_GAPDH_24hr,1,1,"Data from the assay component CLD_GAPDH_24hr was analyzed at the endpoint, CLD_GAPDH_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GAPDH. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where subfamily is baseline control.",background control,log2_fold_induction,0,,gain,rna,mRNA,background measurement,baseline control,0,0,1,310,345
794,1638,865,CLD_GSTA2_24hr,1,1,"Data from the assay component CLD_GSTA2_24hr was analyzed at the endpoint, CLD_GSTA2_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GSTA2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,310,345
795,1639,866,CLD_HMGCS2_24hr,1,1,"Data from the assay component CLD_HMGCS2_24hr was analyzed at the endpoint, CLD_HMGCS2_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HMGCS2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where subfamily is HMG-CoA synthase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,lyase,HMG-CoA synthase,0,0,1,310,345
796,1640,867,CLD_SLCO1B1_24hr,1,1,"Data from the assay component CLD_SLCO1B1_24hr was analyzed at the endpoint, CLD_SLCO1B1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SLCO1B1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is organic anion transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,organic anion transporter,0,0,1,310,345
797,1641,868,CLD_SULT2A_24hr,1,1,"Data from the assay component CLD_SULT2A_24hr was analyzed at the endpoint, CLD_SULT2A_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,sulfotransferase,0,0,1,310,343
798,1642,869,CLD_UGT1A1_24hr,1,1,"Data from the assay component CLD_UGT1A1_24hr was analyzed at the endpoint, CLD_UGT1A1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,310,345
799,1643,870,CLD_ABCB1_48hr,1,1,"Data from the assay component CLD_ABCB1_48hr was analyzed at the endpoint, CLD_ABCB1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,349
800,1644,871,CLD_ABCB11_48hr,1,1,"Data from the assay component CLD_ABCB11_48hr was analyzed at the endpoint, CLD_ABCB11_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB11. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,346
801,1645,872,CLD_ABCG2_48hr,1,1,"Data from the assay component CLD_ABCG2_48hr was analyzed at the endpoint, CLD_ABCG2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCG2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,349
802,1646,873,CLD_ACTIN_48hr,1,1,"Data from the assay component CLD_ACTIN_48hr was analyzed at the endpoint, CLD_ACTIN_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ACTA1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where subfamily is baseline control.",background control,log2_fold_induction,0,,gain,rna,mRNA,background measurement,baseline control,0,0,1,310,349
803,1647,874,CLD_CYP1A1_48hr,1,1,"Data from the assay component CLD_CYP1A1_48hr was analyzed at the endpoint, CLD_CYP1A1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,303
804,1648,875,CLD_CYP1A2_48hr,1,1,"Data from the assay component CLD_CYP1A2_48hr was analyzed at the endpoint, CLD_CYP1A2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,317
805,1649,876,CLD_CYP2B6_48hr,1,1,"Data from the assay component CLD_CYP2B6_48hr was analyzed at the endpoint, CLD_CYP2B6_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,342
806,1650,877,CLD_CYP2C19_48hr,1,1,"Data from the assay component CLD_CYP2C19_48hr was analyzed at the endpoint, CLD_CYP2C19_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2C19. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,349
807,1651,878,CLD_CYP2C9_48hr,1,1,"Data from the assay component CLD_CYP2C9_48hr was analyzed at the endpoint, CLD_CYP2C9_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2C9. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,347
808,1652,879,CLD_CYP3A4_48hr,1,1,"Data from the assay component CLD_CYP3A4_48hr was analyzed at the endpoint, CLD_CYP3A4_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,225
809,1653,880,CLD_GAPDH_48hr,1,1,"Data from the assay component CLD_GAPDH_48hr was analyzed at the endpoint, CLD_GAPDH_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GAPDH. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where subfamily is baseline control.",background control,log2_fold_induction,0,,gain,rna,mRNA,background measurement,baseline control,0,0,1,310,349
810,1654,881,CLD_GSTA2_48hr,1,1,"Data from the assay component CLD_GSTA2_48hr was analyzed at the endpoint, CLD_GSTA2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GSTA2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,310,343
811,1655,882,CLD_HMGCS2_48hr,1,1,"Data from the assay component CLD_HMGCS2_48hr was analyzed at the endpoint, CLD_HMGCS2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HMGCS2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where subfamily is HMG-CoA synthase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,lyase,HMG-CoA synthase,0,0,1,310,344
812,1656,883,CLD_SLCO1B1_48hr,1,1,"Data from the assay component CLD_SLCO1B1_48hr was analyzed at the endpoint, CLD_SLCO1B1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SLCO1B1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is organic anion transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,organic anion transporter,0,0,1,310,341
813,1657,884,CLD_SULT2A_48hr,1,1,"Data from the assay component CLD_SULT2A_48hr was analyzed at the endpoint, CLD_SULT2A_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,sulfotransferase,0,0,1,310,349
814,1658,885,CLD_UGT1A1_48hr,1,1,"Data from the assay component CLD_UGT1A1_48hr was analyzed at the endpoint, CLD_UGT1A1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,310,349
815,1659,1013,TOX21_RAR_LUC_Agonist,1,1,"Data from the assay component TOX21_RAR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RAR_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RARA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",agonist,percent_activity,0,Retinol,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7522,68362
816,1660,1014,TOX21_RAR_LUC_Agonist_viability,1,1,"TOX21_RAR_LUC_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7522,67864
817,1661,1015,TOX21_RORg_LUC_CHO_Antagonist,1,1,"Data from the assay component TOX21_RORg_LUC_CHO_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RORg_LUC_CHO_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1F3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,TO-901317,loss,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52522
818,1662,1016,TOX21_RORg_LUC_CHO_Antagonist_viability,1,1,"TOX21_RORg_LUC_CHO_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
819,1664,1017,CEETOX_H295R_MTT_cell_viability,1,1,"The assay component endpoint CEETOX_H295R_MTT_cell_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter in the MTT cytotoxicity assay, gain or loss-of-signal activity can be used to monitor cellular processes to understand changes in proliferation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is proliferation.",viability,percent_activity,0,,bidirectional,cellular,cellular,cell cycle,proliferation,0,1,1,656,9929
820,1682,1027,STM_H9_CystineISnorm_perc,1,1,"Data from the assay component STM_H9_CystineISnorm_perc was analyzed at the assay endpoint STM_H9_CystineISnorm_perc in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand relative metabolite change.",relative metabolite change,log2_fold_induction,0,Methotrexate,bidirectional,protein,secretome metabolite,metabolite,Cystine,0,0,1,380,3509
821,1688,1030,STM_H9_OrnithineISnorm_perc,1,1,"Data from the assay component STM_H9_OrnithineISnorm_perc was analyzed at the assay endpoint STM_H9_OrnithineISnorm_perc in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand relative metabolite change.",relative metabolite change,log2_fold_induction,0,Methotrexate,bidirectional,protein,secretome metabolite,metabolite,Ornithine,0,0,1,380,2919
822,1690,1031,STM_H9_OrnCyssISnorm_ratio,1,1,"Data from the assay component STM_H9_OrnCyssISnorm_ratio was analyzed at the assay endpoint STM_H9_OrnCyssISnorm_ratio in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand relative metabolite change.",relative metabolite change,log2_fold_induction,0,Methotrexate,bidirectional,protein,secretome metabolite,metabolite,Ornithine/Cystine,0,0,1,429,2942
823,1744,1034,NVS_ENZ_hPPP3CA,1,1,"Data from the assay component NVS_ENZ_hPPP3CA was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPPP3CA, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PPP3CA.
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,phosphatase,serine/threonine phosphatase,0,0,1,0,0
824,1746,1035,ATG_GPCR_ADORA2A_TRANS,1,1,"The assay endpoint ATG_GPCR_ADORA2A_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ADORA2A. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
825,1748,1036,ATG_GPCR_ADORA2B_TRANS,1,1,"The assay endpoint ATG_GPCR_ADORA2B_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ADORA2B. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
826,1750,1037,ATG_GPCR_ADRA1A_TRANS,1,1,"The assay endpoint ATG_GPCR_ADRA1A_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ADRA1A. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
827,1752,1038,ATG_GPCR_ADRA2B_TRANS,1,1,"The assay endpoint ATG_GPCR_ADRA2B_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ADRA2B. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
828,1754,1039,ATG_GPCR_ADRB2_TRANS,1,1,"The assay endpoint ATG_GPCR_ADRB2_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ADRB2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
829,1756,1040,ATG_GPCR_ADRB3_TRANS,1,1,"The assay endpoint ATG_GPCR_ADRB3_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ADRB3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
830,1758,1041,ATG_GPCR_CHRM3_TRANS,1,1,"The assay endpoint ATG_GPCR_CHRM3_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CHRM3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
831,1760,1042,ATG_GPCR_DRD1_TRANS,1,1,"The assay endpoint ATG_GPCR_DRD1_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene DRD1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
832,1762,1043,ATG_GPCR_DRD5_TRANS,1,1,"The assay endpoint ATG_GPCR_DRD5_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene DRD5. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
833,1764,1044,ATG_GPCR_EDNRA_TRANS,1,1,"The assay endpoint ATG_GPCR_EDNRA_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene EDNRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
834,1766,1045,ATG_GPCR_GCGR_TRANS,1,1,"The assay endpoint ATG_GPCR_GCGR_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GCGR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
835,1768,1046,ATG_GPCR_GPBAR1_TRANS,1,1,"The assay endpoint ATG_GPCR_GPBAR1_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GPBAR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
836,1770,1047,ATG_GPCR_GPR40_TRANS,1,1,"The assay endpoint ATG_GPCR_GPR40_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GPR40. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
837,1772,1048,ATG_GPCR_GQ_TRANS,1,1,"The assay endpoint ATG_GPCR_GQ_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GNAQ. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
838,1774,1049,ATG_GPCR_GS1_TRANS,1,1,"The assay endpoint ATG_GPCR_GS1_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GNAS. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
839,1776,1050,ATG_GPCR_GS_TRANS,1,1,"The assay endpoint ATG_GPCR_GS_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GNAS. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
840,1778,1051,ATG_GPCR_HRH1_TRANS,1,1,"The assay endpoint ATG_GPCR_HRH1_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HRH1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
841,1780,1052,ATG_GPCR_HTR6_TRANS,1,1,"The assay endpoint ATG_GPCR_HTR6_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HTR6. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
842,1782,1053,ATG_GPCR_HTR7_TRANS,1,1,"The assay endpoint ATG_GPCR_HTR7_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HTR7. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
843,1784,1054,ATG_GPCR_LPAR4_TRANS,1,1,"The assay endpoint ATG_GPCR_LPAR4_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene LPAR4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
844,1786,1055,ATG_GPCR_MC1R_TRANS,1,1,"The assay endpoint ATG_GPCR_MC1R_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MC1R. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
845,1788,1056,ATG_GPCR_MC2R_TRANS,1,1,"The assay endpoint ATG_GPCR_MC2R_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MC2R. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
846,1790,1057,ATG_GPCR_MC3R_TRANS,1,1,"The assay endpoint ATG_GPCR_MC3R_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MC3R. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
847,1792,1058,ATG_GPCR_MC4R_TRANS,1,1,"The assay endpoint ATG_GPCR_MC4R_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MC4R. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
848,1794,1059,ATG_GPCR_PTGDR_TRANS,1,1,"The assay endpoint ATG_GPCR_PTGDR_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PTGDR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
849,1796,1060,ATG_GPCR_PTGIR_TRANS,1,1,"The assay endpoint ATG_GPCR_PTGIR_TRANS was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PTGIR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,gpcr,NA,0,0,1,25,48
850,1797,1061,Tanguay_ZF_120hpf_ActivityScore,1,1,"Data from the assay component Tanguay_ZF_120hpf_ActivityScore was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_ActivityScore, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",NA,percent_activity,0,NA,gain,organism,malformation,malformation,total,0,0,1,1061,34412
851,1816,1120,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,Nilutamide,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52102
852,1817,1121,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability,1,1,"TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52102
853,1818,1122,TOX21_RXR_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_RXR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RXR_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,9-cis-Retinoic acid,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52248
854,1819,1123,TOX21_RXR_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_RXR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RXR_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,9-cis-Retinoic acid,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52248
855,1820,1124,TOX21_RXR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_RXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RXR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where subfamily is NF-kappa B.",ratio,percent_activity,0,9-cis-Retinoic acid,gain,pathway,pathway-specified,dna binding,NF-kappa B,0,0,1,7872,52248
856,1821,1125,TOX21_RXR_BLA_Agonist_viability,1,1,"TOX21_RXR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,Cyproterone acetate,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
857,1822,1126,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,R1881,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650
858,1823,1127,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability,1,1,"TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52522
859,1824,1128,CCTE_Simmons_GUA_TPO,1,1,"Data from the assay component CCTE_Simmons_GUA_TPO was analyzed at the endpoint, CCTE_Simmons_GUA_TPO, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, measures of enzyme activity for loss-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene TPO. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is peroxidase.",binding,percent_activity,0,,loss,protein,enzyme,oxidoreductase,peroxidase,0,0,1,54,465
860,1825,1129,ArunA_CellTiter_hNP,1,1,"Data from the assay component ArunA_CellTiter_hNP was analyzed at the endpoint, ArunA_CellTiter_hNP, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand the viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,1,1,59,279
861,1826,1130,ArunA_CellTiter_hNC,1,1,"Data from the assay component ArunA_CellTiter_hNC was analyzed at the endpoint, ArunA_CellTiter_hNC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,1,1,59,278
862,1827,1131,ArunA_Migration_hNP,1,1,"Data from the assay component ArunA_Migration_hNP was analyzed at the endpoint, ArunA_Migration_hNP, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of distribution reporter, loss-of-signal activity can be used to understand the cell migration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is migration.",developmental,log2_fold_induction,0,cytochalasin D,loss,cellular,migration,neurodevelopment,migration,0,0,1,59,401
863,1829,1132,ArunA_Migration_hNC,1,1,"Data from the assay component ArunA_Migration_hNC was analyzed at the endpoint, ArunA_Migration_hNC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of distribution reporter, loss-of-signal activity can be used to understand the cell migration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is migration.",developmental,log2_fold_induction,0,cytochalasin D,loss,cellular,migration,neurodevelopment,migration,0,0,1,59,384
864,1831,1133,ArunA_NOG_NucleusCount,1,1,"Data from the assay component ArunA_NOG_NucleusCount was analyzed at the endpoint, ArunA_NOG_NucleusCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,0,1,59,240
865,1833,1134,ArunA_NOG_NeuriteLength,1,1,"Data from the assay component ArunA_NOG_NeuriteLength was analyzed at the endpoint, ArunA_NOG_NeuriteLength, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,log2_fold_induction,0,NA,loss,cellular,morphology,neurodevelopment,neurite outgrowth,0,0,1,59,240
866,1835,1135,ArunA_NOG_NeuritesPerNeuron,1,1,"Data from the assay component ArunA_NOG_NeuritesPerNeuron was analyzed at the endpoint, ArunA_NOG_NeuritesPerNeuron, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,log2_fold_induction,0,NA,loss,cellular,morphology,neurodevelopment,neurite outgrowth,0,0,1,59,240
867,1838,1136,ArunA_NOG_BranchPointsPerNeurite,1,1,"Data from the assay component ArunA_NOG_BranchPointsPerNeurite was analyzed at the endpoint, ArunA_NOG_BranchPointsPerNeurite, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,log2_fold_induction,0,NA,gain,cellular,morphology,neurodevelopment,neurite outgrowth,0,0,1,59,240
868,1839,1137,TOX21_RAR_LUC_Antagonist,1,1,"Data from the assay component TOX21_RAR_LUC_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RAR_LUC_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RARA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.",antagonist,percent_activity,0,ER50891,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7872,52650
869,1840,1138,TOX21_RAR_LUC_Antagonist_viability,1,1,"TOX21_RAR_LUC_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
870,1841,1139,TOX21_H2AX_HTRF_CHO_Agonist_ch1,1,1,"Data from the assay component TOX21_H2AX_HTRF_CHO_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_H2AX_HTRF_CHO_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene H2AFX. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Etoposide,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52650
871,1842,1140,TOX21_H2AX_HTRF_CHO_Agonist_ch2,1,1,"Data from the assay component TOX21_H2AX_HTRF_CHO_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_H2AX_HTRF_CHO_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene H2AFX. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Etoposide,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52650
872,1843,1141,TOX21_H2AX_HTRF_CHO_Agonist_ratio,1,1,"Data from the assay component TOX21_H2AX_HTRF_CHO_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_H2AX_HTRF_CHO_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene H2AFX. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is histone.",ratio,percent_activity,0,Etoposide,gain,pathway,pathway-specified,dna binding,histone H2A,0,0,1,7872,52650
873,1844,1142,TOX21_AP1_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_AP1_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AP1_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene JUN|FOS|JUN. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,EGF,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52650
874,1845,1143,TOX21_AP1_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_AP1_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AP1_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene JUN|FOS|JUN. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,EGF,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52650
875,1846,1144,TOX21_AP1_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_AP1_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AP1_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene JUN|FOS|JUN. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",ratio,percent_activity,0,EGF,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,7872,52650
876,1847,1145,TOX21_AP1_BLA_Agonist_viability,1,1,"TOX21_AP1_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
877,1848,1146,CCTE_Simmons_QuantiLum_inhib_2,1,1,"Data from the assay component CCTE_Simmons_QuantiLum_inhib_2 was analyzed at the endpoint, CCTE_Simmons_QuantiLum_inhib_2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, measures of enzyme activity for loss-of-signal activity can be used to understand inhibition of firefly luciferase. This is an assay endpoint to indicate nonspecific protein inhibition for comparison to aeid 1508 for thyroperoxidase inhibition. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is monooxygenase.",binding,percent_activity,0,b-naphthoquinone,loss,protein,enzyme,oxidoreductase,monooxygenase,0,0,1,581,8184
878,1850,1802,ACEA_AR_agonist_AUC_viability,1,1,"Data from the assay component ACEA_AR_AUC_viability was analyzed  in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,MG 132,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,1831,16370
879,1852,1804,ACEA_ER_AUC_viability,1,1,"Data from the assay component ACEA_ER_AUC_viability was analyzed  in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,MG 132,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,3184,15499
880,1854,534,TOX21_MMP_ratio,1,1,"Data from the assay component TOX21_MMP_ratio was analyzed into 1 assay endpoint. The assay endpoin, TOX21_MMP_ratio, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of membrane potential reporter, gain-of-signal activity can be used to understand changes in the signaling. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,percent_activity,0,FCCP,gain,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,8305,91022
881,1855,1829,ACEA_AR_agonist_80hr,1,1,"Data from the assay component ACEA_AR_agonist_80hr was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, measures of the cells for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the geneAR 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",signaling,percent_activity,0,testosterone,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1831,16305
882,1856,1830,ACEA_AR_antagonist_80hr,1,1,"Data from the assay component ACEA_AR_antagonist_80hr was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, measures of the cells for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",signaling,log2_fold_induction,0,NA,loss,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1836,16476
883,1857,1831,ACEA_AR_antagonist_AUC_viability,1,1,"Data from the assay component ACEA_AR_antagonist_AUC_viability was analyzed  in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,MG 132,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,1836,16610
884,1858,1114,STM_H9_NormalizedViability,1,1,"Data from the assay component STM_H9_Viability was analyzed at the assay endpoint STM_H9_Viability_Norm in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability.",viability,percent_activity,0,NA,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,429,3951
885,1913,1856,ATG_chAR_XSP1,1,1,"The assay endpoint ATG_chAR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
886,1915,1857,ATG_frAR_XSP1,1,1,"The assay endpoint ATG_frAR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
887,1917,1858,ATG_hAR_XSP1,1,1,"The assay endpoint ATG_hAR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
888,1919,1859,ATG_trAR_XSP1,1,1,"The assay endpoint ATG_trAR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
889,1921,1860,ATG_zfAR_XSP1,1,1,"The assay endpoint ATG_zfAR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
890,1923,1861,ATG_frER1_XSP1,1,1,"The assay endpoint ATG_frER1_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
891,1925,1862,ATG_zfER1_XSP1,1,1,"The assay endpoint ATG_zfER1_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
892,1927,1863,ATG_zfER2a_XSP1,1,1,"The assay endpoint ATG_zfER2a_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
893,1929,1864,ATG_zfER2b_XSP1,1,1,"The assay endpoint ATG_zfER2b_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
894,1931,1865,ATG_frER2_XSP1,1,1,"The assay endpoint ATG_frER2_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
895,1933,1866,ATG_chERa_XSP1,1,1,"The assay endpoint ATG_chERa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
896,1935,1867,ATG_hERa_XSP1,1,1,"The assay endpoint ATG_hERa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
897,1937,1868,ATG_trERa_XSP1,1,1,"The assay endpoint ATG_trERa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
898,1939,1869,ATG_hERb_XSP1,1,1,"The assay endpoint ATG_hERb_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48
899,1941,1870,ATG_GAL4_XSP1,1,1,"This assay endpoint, ATG_GAL4_XSP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is baseline control.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,baseline control,0,0,1,99,48
900,1943,1871,ATG_M_06_XSP1,1,1,"This assay endpoint, ATG_M_06_XSP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,99,48
901,1945,1872,ATG_M_19_XSP1,1,1,"This assay endpoint, ATG_M_19_XSP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,99,48
902,1947,1873,ATG_M_32_XSP1,1,1,"This assay endpoint, ATG_M_32_XSP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,99,48
903,1949,1874,ATG_M_61_XSP1,1,1,"This assay endpoint, ATG_M_61_XSP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,99,48
904,1951,1875,ATG_hPPARg_XSP1,1,1,"The assay endpoint ATG_hPPARg_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
905,1953,1876,ATG_mPPARg_XSP1,1,1,"The assay endpoint ATG_mPPARg_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
906,1955,1877,ATG_zfPPARg_XSP1,1,1,"The assay endpoint ATG_zfPPARg_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
907,1957,1878,ATG_mPXR_XSP1,1,1,"The assay endpoint ATG_mPXR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PXR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
908,1959,1879,ATG_frTRa_XSP1,1,1,"The assay endpoint ATG_frTRa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
909,1961,1880,ATG_hTRa_XSP1,1,1,"The assay endpoint ATG_hTRa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
910,1963,1881,ATG_trTRa_XSP1,1,1,"The assay endpoint ATG_trTRa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
911,1965,1882,ATG_zfTRa_XSP1,1,1,"The assay endpoint ATG_zfTRa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
912,1967,1883,ATG_hTRb_XSP1,1,1,"The assay endpoint ATG_hTRb_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
913,1969,1884,ATG_zfTRb_XSP1,1,1,"The assay endpoint ATG_zfTRb_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48
914,1971,1885,ATG_XTT_Cytotoxicity_XSP1,1,1,"This assay endpoint, ATG_XTT_Cytotoxicity_XSP1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,NA,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,98,0
915,1973,1886,ATG_M_06_XSP2,1,1,"This assay endpoint, ATG_M_06_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,189,96
916,1975,1887,ATG_trERa_XSP2,1,1,"The assay endpoint ATG_trERa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
917,1977,1888,ATG_hERb_XSP2,1,1,"The assay endpoint ATG_hERb_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
918,1979,1889,ATG_trAR_XSP2,1,1,"The assay endpoint ATG_trAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
919,1981,1890,ATG_GAL4_XSP2,1,1,"This assay endpoint, ATG_GAL4_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is baseline control.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,baseline control,0,0,1,189,96
920,1983,1891,ATG_zfER1_XSP2,1,1,"The assay endpoint ATG_zfER1_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
921,1985,1892,ATG_chERa_XSP2,1,1,"The assay endpoint ATG_chERa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
922,1987,1893,ATG_zfER2a_XSP2,1,1,"The assay endpoint ATG_zfER2a_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
923,1989,1894,ATG_hAR_XSP2,1,1,"The assay endpoint ATG_hAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
924,1991,1895,ATG_chAR_XSP2,1,1,"The assay endpoint ATG_chAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
925,1993,1896,ATG_frER1_XSP2,1,1,"The assay endpoint ATG_frER1_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
926,1995,1897,ATG_frAR_XSP2,1,1,"The assay endpoint ATG_frAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
927,1997,1898,ATG_zfAR_XSP2,1,1,"The assay endpoint ATG_zfAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
928,1999,1899,ATG_zfER2b_XSP2,1,1,"The assay endpoint ATG_zfER2b_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
929,2001,1900,ATG_hERa_XSP2,1,1,"The assay endpoint ATG_hERa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
930,2003,1901,ATG_M_19_XSP2,1,1,"This assay endpoint, ATG_M_19_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,189,96
931,2005,1902,ATG_M_32_XSP2,1,1,"This assay endpoint, ATG_M_32_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,189,96
932,2007,1903,ATG_frER2_XSP2,1,1,"The assay endpoint ATG_frER2_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150
933,2009,1904,ATG_mPPARg_XSP2,1,1,"The assay endpoint ATG_mPPARg_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
934,2011,1905,ATG_zfPPARg_XSP2,1,1,"The assay endpoint ATG_zfPPARg_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
935,2013,1906,ATG_hPPARg_XSP2,1,1,"The assay endpoint ATG_hPPARg_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
936,2015,1907,ATG_mPXR_XSP2,1,1,"The assay endpoint ATG_mPXR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PXR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
937,2017,1908,ATG_trTRa_XSP2,1,1,"The assay endpoint ATG_trTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
938,2019,1909,ATG_zfTRa_XSP2,1,1,"The assay endpoint ATG_zfTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
939,2021,1910,ATG_zfTRb_XSP2,1,1,"The assay endpoint ATG_zfTRb_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
940,2023,1911,ATG_M_61_XSP2,1,1,"This assay endpoint, ATG_M_61_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,189,96
941,2025,1912,ATG_frTRa_XSP2,1,1,"The assay endpoint ATG_frTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
942,2027,1913,ATG_hTRa_XSP2,1,1,"The assay endpoint ATG_hTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150
943,2029,1914,ATG_hTRb_XSP2,1,1,"The assay endpoint ATG_hTRb_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,149
944,2031,1915,ATG_XTT_Cytotoxicity_XSP2,1,1,"Data from the assay component ATG_XTT_Cytotoxicity_XSP2 was analyzed into 1 assay endpoint. This assay endpoint, ATG_XTT_Cytotoxicity_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,log2_fold_induction,0,NA,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,90,0
945,2037,1919,CPHEA_Stoker_NIS_Inhibition_RAIU,1,1,"Data from the assay component CPHEA_Stoker_NIS_Inhibition_RAIU was analyzed at the endpoint, CPHEA_Stoker_NIS_Inhibition_RAIU, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Measures of radioactive substrate uptake for loss-of-signal activity can be used to understand the effects on transporter function at the pathway level as they relate to the sodium-iodide symporter, gene SLC5A5. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is sodium-iodide symporter (NIS).",transporter,percent_activity,0,NaClO4,loss,protein,protein-specified,transporter,sodium-iodide symporter (NIS),0,0,1,642,8207
946,2038,1920,TOX21_TSHR_HTRF_Agonist_ch1,1,1,"Data from the assay component TOX21_TSHR_HTRF_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,TSH,loss,pathway,pathway-specified,background measurement,baseline control,0,0,1,7872,52650
947,2039,1921,TOX21_TSHR_HTRF_Agonist_ch2,1,1,"Data from the assay component TOX21_TSHR_HTRF_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,TSH,gain,pathway,pathway-specified,background measurement,baseline control,0,0,1,7872,52650
948,2040,1922,TOX21_TSHR_HTRF_Agonist_ratio,1,1,"Data from the assay component TOX21_TSHR_HTRF_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",ratio,percent_activity,0,TSH,gain,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,52650
949,2041,1923,TOX21_TSHR_HTRF_Antagonist_ch1,1,1,"Data from the assay component TOX21_TSHR_HTRF_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,no TSH stimulation,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52650
950,2042,1924,TOX21_TSHR_HTRF_Antagonist_ch2,1,1,"Data from the assay component TOX21_TSHR_HTFR_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTFR_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,no TSH stimulation,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52650
951,2043,1925,TOX21_TSHR_HTRF_Antagonist_ratio,1,1,"Data from the assay component TOX21_TSHR_HTRF_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this one serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",ratio,percent_activity,0,no TSH stimulation,loss,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,52650
952,2044,1926,TOX21_TSHR_wt_Agonist_HTRF_ch1,1,1,"Data from the assay component TOX21_TSHR_HTRF_wt_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_wt_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss of signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Forskolin,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52522
953,2045,1927,TOX21_TSHR_wt_Agonist_HTRF_ch2,1,1,"Data from the assay component TOX21_TSHR_HTRF_wt_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_wt_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Forskolin,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52522
954,2046,1928,TOX21_TSHR_wt_Agonist_HTRF_ratio,1,1,"Data from the assay component TOX21_TSHR_HTRF_wt_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_wt_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",ratio,percent_activity,0,Forskolin,gain,pathway,pathway-specified,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,52522
955,2047,1929,TOX21_CAR_Agonist,1,1,"Data from the assay component TOX21_CAR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_CAR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1I3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",agonist,percent_activity,0,CITCO,gain,protein,receptor,nuclear receptor,xenobiotic,0,0,1,7872,52650
956,2048,1930,TOX21_CAR_Agonist_viability,1,1,"TOX21_CAR_Agonist_viabillity used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
957,2049,1931,TOX21_CAR_Antagonist,1,1,"Data from the assay component TOX21_CAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_CAR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1I3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,PK11195,loss,protein,receptor,nuclear receptor,xenobiotic,0,0,1,7872,52102
958,2050,1932,TOX21_CAR_Antagonist_viability,1,1,"TOX21_CAR_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52102
959,2053,1935,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650
960,2054,1936,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability,1,1,"TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
961,2055,1937,TOX21_ERR_Agonist,1,1,"Data from the assay component TOX21_ERR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",agonist,percent_activity,0,Genistein,gain,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650
962,2057,1939,TOX21_ERR_Antagonist,1,1,"Data from the assay component TOX21_ERR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,XCT790,loss,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650
963,2059,1941,TOX21_ERR_viability,1,1,"TOX21_ERR_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
964,2060,1942,TOX21_H2AX_HTRF_CHO_viability,1,1,"TOX21_H2AX_HTRF_CHO_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52522
965,2061,1943,TOX21_HDAC_Inhibition,1,1,"Data from the assay component TOX21_HDAC_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HDAC_Inhibition, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HDAC1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.",reporter gene,percent_activity,0,Trichostatin A,loss,pathway,pathway-specified,hydrolase,NA,0,0,1,7872,52650
966,2062,1944,TOX21_HDAC_Inhibition_viability,1,1,"TOX21_HDAC_Inhibition_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
967,2063,1945,TOX21_HRE_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_HRE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HRE_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HIF1A. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,Cobalt(II)chloride hexahydrate,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,56490
968,2064,1946,TOX21_HRE_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_HRE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HRE_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HIF1A. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,Cobalt(II)chloride hexahydrate,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,56490
969,2065,1947,TOX21_HRE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_HRE_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HRE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HIF1A. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is hypoxia-response element.",ratio,percent_activity,0,Cobalt(II)chloride hexahydrate,gain,pathway,pathway-specified,dna binding,hypoxia-response element,0,0,1,7872,56490
970,2066,1948,TOX21_HRE_BLA_Agonist_viability,1,1,"TOX21_HRE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
971,2067,1949,TOX21_LUC_Biochem,1,1,"TOX21_LUC_Biochem used a type of viability reporter where loss-of-signal activity can be used to understand inhibition of luciferase enzymatic activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the enzyme intended target family, where the subfamily is luciferase.",reporter gene,percent_activity,0,PTC124,loss,protein,enzyme,enzyme,luciferase,0,0,1,7872,52650
972,2068,1950,TOX21_PGC_ERR_Agonist,1,1,"Data from the assay component TOX21_PGC_ERR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PGC_ERR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",agonist,percent_activity,0,Genistein,gain,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650
973,2070,1952,TOX21_PGC_ERR_Antagonist,1,1,"Data from the assay component TOX21_PGC_ERR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PGC_ERR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",antagonist,percent_activity,0,XCT790,loss,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650
974,2072,1954,TOX21_PGC_ERR_viability,1,1,"TOX21_PGC_ERR_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,51828
975,2074,1956,TOX21_RT_HEK293_FLO_00hr_viability,1,1,"TOX21_RT_HEK293_FLO_00hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,0,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
976,2075,1957,TOX21_RT_HEK293_FLO_08hr_viability,1,1,"TOX21_RT_HEK293_FLO_08hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
977,2077,1959,TOX21_RT_HEK293_FLO_16hr_viability,1,1,"TOX21_RT_HEK293_FLO_16hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
978,2078,1960,TOX21_RT_HEK293_FLO_24hr_viability,1,1,"TOX21_RT_HEK293_FLO_24hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
979,2080,1962,TOX21_RT_HEK293_FLO_32hr_viability,1,1,"TOX21_RT_HEK293_FLO_32hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
980,2082,1964,TOX21_RT_HEK293_FLO_40hr_viability,1,1,"TOX21_RT_HEK293_FLO_40hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
981,2084,1966,TOX21_RT_HEK293_GLO_00hr_viability,1,1,"TOX21_RT_HEK293_GLO_00hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
982,2086,1968,TOX21_RT_HEK293_GLO_08hr_viability,1,1,"TOX21_RT_HEK293_GLO_08hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
983,2088,1970,TOX21_RT_HEK293_GLO_16hr_viability,1,1,"TOX21_RT_HEK293_GLO_16hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
984,2089,1971,TOX21_RT_HEK293_GLO_24hr_viability,1,1,"TOX21_RT_HEK293_GLO_24hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
985,2091,1973,TOX21_RT_HEK293_GLO_32hr_viability,1,1,"TOX21_RT_HEK293_GLO_32hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
986,2093,1975,TOX21_RT_HEK293_GLO_40hr_viability,1,1,"TOX21_RT_HEK293_GLO_40hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
987,2094,1976,TOX21_RT_HEPG2_FLO_00hr_viability,1,1,"TOX21_RT_HEPG2_FLO_00hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,0,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
988,2095,1977,TOX21_RT_HEPG2_FLO_08hr_viability,1,1,"TOX21_RT_HEPG2_FLO_08hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
989,2096,1978,TOX21_RT_HEPG2_FLO_16hr_viability,1,1,"TOX21_RT_HEPG2_FLO_16hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
990,2097,1979,TOX21_RT_HEPG2_FLO_24hr_viability,1,1,"TOX21_RT_HEPG2_FLO_24hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
991,2098,1980,TOX21_RT_HEPG2_FLO_32hr_viability,1,1,"TOX21_RT_HEPG2_FLO_32hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
992,2099,1981,TOX21_RT_HEPG2_FLO_40hr_viability,1,1,"TOX21_RT_HEPG2_FLO_40hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
993,2100,1982,TOX21_RT_HEPG2_GLO_00hr_viability,1,1,"TOX21_RT_HEPG2_GLO_00hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
994,2101,1983,TOX21_RT_HEPG2_GLO_08hr_viability,1,1,"TOX21_RT_HEPG2_GLO_08hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
995,2102,1984,TOX21_RT_HEPG2_GLO_16hr_viability,1,1,"TOX21_RT_HEPG2_GLO_16hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
996,2103,1985,TOX21_RT_HEPG2_GLO_32hr_viability,1,1,"TOX21_RT_HEPG2_GLO_32hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
997,2105,1987,TOX21_RT_HEPG2_GLO_40hr_viability,1,1,"TOX21_RT_HEPG2_GLO_40hr_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
998,2106,1988,TOX21_SHH_3T3_GLI3_Agonist,1,1,"Data from the assay component TOX21_SHH_3T3_GLI3_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SHH_3T3_GLI3_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GLI3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.",agonist,percent_activity,0,SAG,gain,pathway,pathway-specified,dna binding,zinc finger,0,0,1,7872,52650
999,2107,1989,TOX21_SHH_3T3_GLI3_Agonist_viability,1,1,"TOX21_SHH_3T3_GLI3_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
1000,2108,1990,TOX21_SHH_3T3_GLI3_Antagonist,1,1,"Data from the assay component TOX21_SHH_3T3_GLI3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SHH_3T3_GLI3_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GLI3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.",antagonist,percent_activity,0,Cyclopamine,loss,pathway,pathway-specified,dna binding,zinc finger,0,0,1,7872,52650
1001,2109,1991,TOX21_SHH_3T3_GLI3_Antagonist_viability,1,1,"TOX21_SHH_3T3_GLI3_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
1002,2110,1992,CPHEA_Stoker_NIS_Cytotoxicity,1,1,"Data from the assay component CPHEA_Stoker_NIS_Cytotoxicity was analyzed at the endpoint, CPHEA_Stoker_NIS_Cytotoxicity, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, measures of ATP content for loss-of-signal activity can be used to understand the viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,b-naphthoquinone,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,580,7008
1003,2113,1999,TOX21_ERb_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_ERb_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,17b-Estradiol,loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52394
1004,2114,2000,TOX21_ERb_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_ERb_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52394
1005,2115,2001,TOX21_ERb_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_ERb_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52394
1006,2116,2002,TOX21_ERb_BLA_Agonist_viability,1,1,"TOX21_ERb_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52522
1007,2117,1995,TOX21_ERb_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_ERb_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,4-hydroxytamoxifen,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52650
1008,2118,1996,TOX21_ERb_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_ERb_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,4-hydroxytamoxifen,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52650
1009,2119,1997,TOX21_ERb_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_ERb_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650
1010,2120,1998,TOX21_ERb_BLA_Antagonist_viability,1,1,"TOX21_ERb_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
1011,2121,2003,TOX21_PR_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_PR_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,promegestone (R5020),loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52522
1012,2122,2004,TOX21_PR_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_PR_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,promegestone (R5020),gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52522
1013,2123,2005,TOX21_PR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,promegestone (R5020),gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52522
1014,2124,2006,TOX21_PR_BLA_Agonist_viability,1,1,"TOX21_PR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52522
1015,2125,2007,TOX21_PR_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_PR_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,RU486,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,7872,52102
1016,2126,2008,TOX21_PR_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_PR_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,RU486,loss,pathway,pathway-specified,channel 2,baseline control,0,0,1,7872,52102
1017,2127,2009,TOX21_PR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity an be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,RU486,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52102
1018,2128,2010,TOX21_PR_BLA_Antagonist_viability,1,1,"TOX21_PR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,51700
1019,2130,2012,TOX21_DT40_100,1,1,"Data from the assay component TOX21_DT40_100 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_DT40_100, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability as they relate to the gene Ku70 - Rad54 (-/-). Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA repair family.",viability,percent_activity,0,Tetraoctyl ammonium bromide,loss,pathway,pathway-specified,cell cycle,DNA repair,0,0,1,8306,92160
1020,2131,2013,TOX21_DT40_657,1,1,"Data from the assay component TOX21_DT40_657 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_DT40_657, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene Rev3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA repair family.",viability,percent_activity,0,Tetraoctyl ammonium bromide,loss,pathway,pathway-specified,cell cycle,DNA repair,0,0,1,8306,92032
1021,2143,2023,CEETOX_H295R_11DCORT_noMTC,1,1,"Data from the assay component CEETOX_H295R_11DCORT_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_11DCORT_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,11-Deoxycortisol,steroid hormone,glucocorticoids,0,0,1,85,132
1022,2145,2024,CEETOX_H295R_OHPREG_noMTC,1,1,"Data from the assay component CEETOX_H295R_OHPREG_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPREG_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxypregnenolone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,17alpha-hydroxypregnenolone,steroid hormone,progestagens,0,0,1,85,132
1023,2147,2025,CEETOX_H295R_OHPROG_noMTC,1,1,"Data from the assay component CEETOX_H295R_OHPROG_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPROG_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,17alpha-hydroxyprogesterone,steroid hormone,progestagens,0,0,1,85,132
1024,2149,2026,CEETOX_H295R_ANDR_noMTC,1,1,"Data from the assay component CEETOX_H295R_ANDR_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ANDR_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Androstenedione in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Androstenedione,steroid hormone,androgens,0,0,1,85,132
1025,2151,2027,CEETOX_H295R_CORTIC_noMTC,1,1,"Data from the assay component CEETOX_H295R_CORTIC_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTIC_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Corticosterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Corticosterone,steroid hormone,glucocorticoids,0,0,1,85,132
1026,2153,2028,CEETOX_H295R_CORTISOL_noMTC,1,1,"Data from the assay component CEETOX_H295R_CORTISOL_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTISOL_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Cortisol in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Cortisol ,steroid hormone,glucocorticoids,0,0,1,85,132
1027,2157,2030,CEETOX_H295R_DOC_noMTC,1,1,"Data from the assay component CEETOX_H295R_DOC_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_DOC_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,11-Deoxycorticosterone,steroid hormone,glucocorticoids,0,0,1,85,132
1028,2159,2031,CEETOX_H295R_ESTRADIOL_noMTC,1,1,"Data from the assay component CEETOX_H295R_ESTRADIOL_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRADIOL_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Estradiol,steroid hormone,estrogens,0,0,1,85,132
1029,2161,2032,CEETOX_H295R_ESTRONE_noMTC,1,1,"Data from the assay component CEETOX_H295R_ESTRONE_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRONE_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Estrone,steroid hormone,estrogens,0,0,1,85,132
1030,2165,2034,CEETOX_H295R_PROG_noMTC,1,1,"Data from the assay component CEETOX_H295R_PROG_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_PROG_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Progesterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Progesterone,steroid hormone,progestagens,0,0,1,85,132
1031,2167,2035,CEETOX_H295R_TESTO_noMTC,1,1,"Data from the assay component CEETOX_H295R_TESTO_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_TESTO_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Testosterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Testosterone,steroid hormone,androgens,0,0,1,85,132
1032,2211,2073,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650
1033,2212,2074,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability,1,1,"TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,52650
1034,2213,2075,TOX21_RT_HEPG2_GLO_24hr_viability,1,1,"TOX21_RT_HEPG2_GLO_24hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,17550
1035,2214,2275,TOX21_PR_BLA_Followup_Agonist_ch1,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,promegestone (R5020),loss,pathway,pathway-specified,channel 1,baseline control,0,0,1,231,480
1036,2215,2276,TOX21_PR_BLA_Followup_Antagonist_ch1,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,RU486,gain,pathway,pathway-specified,channel 1,baseline control,0,0,1,231,432
1037,2216,2277,TOX21_PR_BLA_Followup_Agonist_ch2,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,promegestone (R5020),gain,pathway,pathway-specified,channel 2,baseline control,0,0,1,231,480
1038,2217,2278,TOX21_PR_BLA_Followup_Antagonist_ch2,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,RU486,loss,protein,receptor,channel 2,baseline control,0,0,1,231,432
1039,2218,2279,TOX21_PR_BLA_Followup_Agonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,promegestone (R5020),gain,protein,receptor,nuclear receptor,steroidal,0,0,1,231,480
1040,2219,2280,TOX21_PR_BLA_Followup_Antagonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,RU486,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,231,432
1041,2220,2281,TOX21_PR_BLA_Followup_Agonist_viability,1,1,"TOX21_PR_BLA_Followup_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,231,384
1042,2221,2282,TOX21_PR_BLA_Followup_Antagonist_viability,1,1,"TOX21_PR_BLA_Followup_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,231,384
1043,2222,2283,TOX21_PR_LUC_Followup_Agonist,1,1,"Data from the assay component TOX21_PR_LUC_Followup_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_LUC_Followup_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is steroidal.",agonist,percent_activity,0,promegestone (R5020),gain,protein,receptor,nuclear receptor,steroidal,0,0,1,231,480
1044,2223,2284,TOX21_PR_LUC_Followup_Antagonist,1,1,"Data from the assay component TOX21_PR_LUC_Followup_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_LUC_Followup_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is steroidal.",antagonist,percent_activity,0,RU486,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,231,432
1045,2224,2285,TOX21_PR_LUC_Followup_Agonist_viability,1,1,"TOX21_PR_LUC_Followup_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,231,384
1046,2225,2286,TOX21_PR_LUC_Followup_Antagonist_viability,1,1,"TOX21_PR_LUC_Followup_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,231,288
1047,2226,2287,TOX21_TR_LUC_GH3_Agonist_Followup,1,1,"Data from the assay component TOX21_TR_LUC_GH3_Agonist_Followup was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Agonist_Followup, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB in the GH3 cell line using a luciferase reporter. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. This assay endpoint is designated followup because it was a confirmatory screen following the primary qHTS assay.",agonist,percent_activity,0,T3,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,74,294
1048,2227,2288,TOX21_TR_LUC_GH3_Antagonist_Followup,1,1,"Data from the assay component TOX21_TR_LUC_GH3_Antagonist_Followup was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Antagonist_Followup, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB in the GH3 cell line using a luciferase reporter. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. This assay endpoint is designated followup because it was a confirmatory screen following the primary qHTS assay.",antagonist,percent_activity,0,T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,369
1049,2228,2289,TOX21_TRA_COA_Agonist_Followup_ch1,1,1,"Data from the assay component TOX21_TRA_COA_Agonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRA_COA_Agonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,T3,loss,protein,receptor,channel 1,baseline control,0,0,1,74,288
1050,2229,2290,TOX21_TRA_COA_Agonist_Followup_ch2,1,1,"Data from the assay component TOX21_TRA_COA_Agonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRA_COA_Agonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,T3,gain,protein,receptor,channel 2,baseline control,0,0,1,74,288
1051,2230,2291,TOX21_TRA_COA_Agonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRA_COA_Agonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRA_COA_Agonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA. Furthermore, this assay endpoint can be referred to as a primary readout,  because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,T3,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,74,288
1052,2231,2292,TOX21_TRA_COA_Antagonist_Followup_ch1,1,1,"Data from the assay component TOX21_TRA_COA_Antagonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRA_COA_Antagonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,T3,gain,protein,receptor,channel 1,baseline control,0,0,1,121,288
1053,2232,2293,TOX21_TRA_COA_Antagonist_Followup_ch2,1,1,"Data from the assay component TOX21_TRA_COA_Antagonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRA_COA_Antagonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,T3,loss,protein,receptor,channel 2,baseline control,0,0,1,121,288
1054,2233,2294,TOX21_TRA_COA_Antagonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRA_COA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRA_COA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA. 

Furthermore, this assay endpoint can be referred to as a primary readout,  because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,288
1055,2234,2295,TOX21_TRB_BLA_Agonist_Followup_ch1,1,1,"Data from the assay component TOX21_TRB_BLA_Agonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Agonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,T3,loss,protein,receptor,channel 1,baseline control,0,0,1,74,196
1056,2235,2296,TOX21_TRB_BLA_Agonist_Followup_ch2,1,1,"Data from the assay component TOX21_TRB_BLA_Agonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Agonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,T3,gain,protein,receptor,channel 2,baseline control,0,0,1,74,196
1057,2236,2297,TOX21_TRB_BLA_Agonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRB_BLA_Agonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Agonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.",ratio,percent_activity,0,T3,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,74,196
1058,2237,2298,TOX21_TRB_BLA_Agonist_Followup_viability,1,1,"The assay component endpoint  TOX21_TRB_BLA_Agonist_Followup_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,74,98
1059,2238,2299,TOX21_TRB_BLA_Antagonist_Followup_ch1,1,1,"Data from the assay component TOX21_TRB_BLA_Antagonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Antagonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,T3,gain,protein,receptor,channel 1,baseline control,0,0,1,121,252
1060,2239,2300,TOX21_TRB_BLA_Antagonist_Followup_ch2,1,1,"Data from the assay component TOX21_TRB_BLA_Antagonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Antagonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,T3,loss,protein,receptor,channel 2,baseline control,0,0,1,121,252
1061,2240,2301,TOX21_TRB_BLA_Antagonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRB_BLA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. 

Furthermore, this assay endpoint can be referred to as a primary readout,  because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,252
1062,2241,2302,TOX21_TRB_BLA_Antagonist_Followup_viability,1,1,"TOX21_TRB_BLA_Antagonist_Followup_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,121,66
1063,2242,2303,TOX21_TRB_COA_Agonist_Followup_ch1,1,1,"Data from the assay component TOX21_TRB_COA_Agonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_COA_Agonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,T3,loss,protein,receptor,channel 1,baseline control,0,0,1,74,288
1064,2243,2304,TOX21_TRB_COA_Agonist_Followup_ch2,1,1,"Data from the assay component TOX21_TRB_COA_Agonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_COA_Antagonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,T3,gain,protein,receptor,channel 2,baseline control,0,0,1,74,288
1065,2244,2305,TOX21_TRB_COA_Agonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRB_COA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_COA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a primary readout,  because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,T3,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,74,288
1066,2245,2306,TOX21_TRB_COA_Antagonist_Followup_ch1,1,1,"Data from the assay component TOX21_TRB_COA_Antagonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_COA_Antagonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,T3,gain,protein,receptor,channel 1,baseline control,0,0,1,121,288
1067,2246,2307,TOX21_TRB_COA_Antagonist_Followup_ch2,1,1,"Data from the assay component TOX21_TRB_COA_Antagonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_COA_Antagonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,T3,loss,protein,receptor,channel 2,baseline control,0,0,1,121,288
1068,2247,2308,TOX21_TRB_COA_Antagonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRB_COA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_COA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. 

Furthermore, this assay endpoint can be referred to as a primary readout,  because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,288
1069,2251,2312,TOX21_TR_RXR_BLA_Agonist_Followup_ch1,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Agonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Agonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,9-cis-Retinoic acid,loss,protein,receptor,channel 1,baseline control,0,0,1,74,288
1070,2252,2313,TOX21_TR_RXR_BLA_Agonist_Followup_ch2,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Agonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Agonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,9-cis-Retinoic acid,gain,protein,receptor,channel 2,baseline control,0,0,1,74,288
1071,2253,2314,TOX21_TR_RXR_BLA_Agonist_Followup_ratio,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Agonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Agonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.",ratio,percent_activity,0,9-cis-Retinoic acid,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,74,288
1072,2254,2315,TOX21_TR_RXR_BLA_Agonist_Followup_viability,1,1,"The assay component endpoint  TOX21_TR_RXR_BLA_Agonist_Followup_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,74,288
1073,2255,2316,TOX21_TR_RXR_BLA_Antagonist_Followup_ch1,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Antagonist_Followup_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Antagonist_Followup_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,1 nM TA_Antagonist,gain,protein,receptor,channel 1,baseline control,0,0,1,121,288
1074,2256,2317,TOX21_TR_RXR_BLA_Antagonist_Followup_ch2,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Antagonist_Followup_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Antagonist_Followup_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,1 nM TA_Antagonist,loss,protein,receptor,channel 2,baseline control,0,0,1,121,288
1075,2257,2318,TOX21_TR_RXR_BLA_Antagonist_Followup_ratio,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.",ratio,percent_activity,0,1 nM T21_TR_RXR_BLA_Antagonist,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,288
1076,2258,2319,TOX21_TR_RXR_BLA_Antagonist_Followup_viability,1,1,"The assay component endpoint  TOX21_TR_RXR_BLA_Antagonist_Followup_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,121,240
1077,2277,2320,NVS_ENZ_hPDE1A1,1,1,"Data from the assay component NVS_ENZ_hPDE1A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE1A1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PD1A1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1078,2279,2321,NVS_ENZ_hPDE1B1,1,1,"Data from the assay component NVS_ENZ_hPDE1B1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE1B1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE1B1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1079,2281,2322,NVS_ENZ_hPDE2A,1,1,"Data from the assay component NVS_ENZ_hPDE2A was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE2A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE2A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1080,2283,2323,NVS_ENZ_hPDE3A,1,1,"Data from the assay component NVS_ENZ_hPDE3A was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE3A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PD3A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1081,2285,2324,NVS_ENZ_hPDE4B1,1,1,"Data from the assay component NVS_ENZ_hPDE4B1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPD4B1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PD4B1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1082,2287,2325,NVS_ENZ_hPDE4C1,1,1,"Data from the assay component NVS_ENZ_hPD4C1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPD4C1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE4C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1083,2289,2326,NVS_ENZ_hPDE4D3,1,1,"Data from the assay component NVS_ENZ_hPDE4D3 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE4D3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE4D3.

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1084,2291,2327,NVS_ENZ_hPDE7A,1,1,"Data from the assay component NVS_ENZ_hPDE7A was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE7A, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE7A.

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1085,2293,2328,NVS_ENZ_hPDE8A1,1,1,"Data from the assay component NVS_ENZ_hPDE8A1 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE8A1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE8A1.

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1086,2295,2329,NVS_ENZ_hPDE9A2,1,1,"Data from the assay component NVS_ENZ_hPDE9A2 was analyzed into 1 assay endpoint. This assay endpoint, NVS_ENZ_hPDE9A2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene PDE9A2.

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a enzymatic activity function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,0,0
1087,2297,2330,CCTE_Harrill_HTTr_Viability_DMEM_6hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_DMEM_6hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter  to understand changes in cytotoxicity, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM Nlity,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,45,128
1088,2298,2334,CCTE_Harrill_HTTr_Viability_DMEM_12hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_DMEM_12hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter  to understand changes in cytotoxicity, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM Nlity,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,45,128
1089,2299,2335,CCTE_Harrill_HTTr_Viability_DMEM_24hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_DMEM_24hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter  to understand changes in cytotoxicity, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM Nlity,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,45,128
1090,2300,2331,CCTE_Harrill_HTTr_Viability_PRF_DMEM_6hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_PRF_DMEM_6hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter  to understand changes in cytotoxicity, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM N6,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,45,128
1091,2301,2336,CCTE_Harrill_HTTr_Viability_PRF_DMEM_12hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_PRF_DMEM_12hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter  to understand changes in cytotoxicity, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM N12,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,45,96
1092,2302,2337,CCTE_Harrill_HTTr_Viability_PRF_DMEM_24hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_PRF_DMEM_24hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter  to understand changes in cytotoxicity, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM N24,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,45,96
1093,2303,2332,CCTE_Harrill_HTTr_Apoptosis_DMEM_6hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_DMEM_6hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM Nosis,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,45,128
1094,2304,2338,CCTE_Harrill_HTTr_Apoptosis_DMEM_12hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_DMEM_12hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM Nosis,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,45,96
1095,2305,2339,CCTE_Harrill_HTTr_Apoptosis_DMEM_24hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_DMEM_24hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM Nosis,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,45,128
1096,2306,2333,CCTE_Harrill_HTTr_Apoptosis_PRF_DMEM_6hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_PRF_DMEM_6hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM N6,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,45,128
1097,2307,2340,CCTE_Harrill_HTTr_Apoptosis_PRF_DMEM_12hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_PRF_DMEM_12hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM N12,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,45,128
1098,2308,2341,CCTE_Harrill_HTTr_Apoptosis_PRF_DMEM_24hr,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_PRF_DMEM_24hr was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM N24,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,45,128
1099,2309,2342,CCTE_GLTED_hDIO1,1,1,"Data from the assay component CCTE_GLTED_hDIO1 was analyzed into 1 assay endpoint. This assay endpoint, CCTE_GLTED_hDIO1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DIO1. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'deiodinase' intended target family, where the subfamily is 'deiodinase Type 1'.",enzymatic activity,percent_activity,0,6-propyl-thiouracil (PTU),loss,protein,enzyme,deiodinase,deiodinase Type 1,0,0,1,161,419
1100,2362,2369,TOX21_PXR_viability,1,1,"The assay component endpoint  TOX21_PXR_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,1,46 uM rifampicin ,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,45994
1101,2363,2370,TOX21_PXR_agonist,1,1,"Data from the assay component TOX21_PXR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PXR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is non-steroidal.",agonist,percent_activity,0,46 uM rifampicin ,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7872,46890
1102,2364,2371,TOX21_TRHR_HEK293_agonist,1,1,"TOX21_TRHR_HEK293_Agonist  used a type of biochemical reporter where gain-of-signal activity can be used to understand changes in the receptor activation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",agonist,percent_activity,0,TRH,gain,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,43086
1103,2365,2372,TOX21_TRHR_HEK293_antagonist,1,1,"TOX21_TRHR_HEK293_Antagonist  used a type of biochemical reporter where loss-of-signal activity can be used to understand changes in the receptor activation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",antagonist,percent_activity,0,1 nM T293,loss,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,43086
1104,2366,2373,TOX21_CASP3_HEPG2,1,1,"The assay component endpoint  TOX21_CASP3_HEPG2 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. The TOX21_CASP3_HEPG2 assay is a homogeneous, luminescent assay that measures caspase-3 activity following compound treatment as an indicator of induction of apoptosis. Gain-of-signal activity can be used to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to apoptosis, where the subfamily is caspase.",inducer,percent_activity,0,Staurosporine,gain,cellular,cellular,apoptosis,caspase,0,0,1,7872,46890
1105,2367,2374,TOX21_CASP3_HEPG2_viability,1,1,"The assay component endpoint  TOX21_CASP3_HEPG2_viability uses a type of viability reporter where loss-of-signal activity can be used to understand changes in viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,46890
1106,2368,2375,TOX21_CASP3_CHO,1,1,"The assay component endpoint  TOX21_CASP3_CHO was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. The TOX21_CASP3_CHO assay is a homogeneous, luminescent assay that measures caspase-3 activity following chemical treatment as an indicator of induction of apoptosis. Gain-of-signal activity can be used to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to apoptosis, where the subfamily is caspase.",inducer,percent_activity,0,Staurosporine,gain,cellular,cellular,apoptosis,caspase,0,0,1,7872,46890
1107,2369,2376,TOX21_CASP3_CHO_viability,1,1,"The assay component endpoint  TOX21_CASP3_CHO_viability uses a type of viability reporter where loss-of-signal activity can be used to understand changes in viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,46330
1108,2370,2377,TOX21_SBE_BLA_Antagonist_ch1,1,1,"Data from the assay component TOX21_SBE_BLA_Antagonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Antagonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,NA,gain,protein,receptor,channel 1,baseline control,0,0,1,7872,46890
1109,2371,2378,TOX21_SBE_BLA_Antagonist_ch2,1,1,"Data from the assay component TOX21_SBE_BLA_Antagonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Antagonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,NA,loss,protein,receptor,channel 2,baseline control,0,0,1,7872,46890
1110,2372,2379,TOX21_SBE_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_SBE_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor receptor intended target family, where subfamily is transforming growth factor beta.",ratio,percent_activity,0,NA,loss,protein,receptor,growth factor receptor,transforming growth factor beta,0,0,1,7872,46890
1111,2373,2380,TOX21_SBE_BLA_Antagonist_viability,1,1,"The assay component endpoint  TOX21_SBE_BLA_Antagonist_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,1,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,29610
1112,2374,2381,TOX21_SBE_BLA_Agonist_ch1,1,1,"Data from the assay component TOX21_SBE_BLA_Agonist_ch1 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Agonist_ch1, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",substrate,percent_activity,0,TGFb,loss,protein,receptor,channel 1,baseline control,0,0,1,7872,46778
1113,2375,2382,TOX21_SBE_BLA_Agonist_ch2,1,1,"Data from the assay component TOX21_SBE_BLA_Agonist_ch2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RXR_SBE_Agonist_ch2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, increased activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as artifact detection function.",product,percent_activity,0,TGFb,gain,protein,receptor,channel 2,baseline control,0,0,1,7872,46778
1114,2376,2383,TOX21_SBE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_SBE_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor receptor intended target family, where subfamily is transforming growth factor beta.",ratio,percent_activity,0,TGFb,gain,protein,receptor,growth factor receptor,transforming growth factor beta,0,0,1,7872,46778
1115,2377,2384,TOX21_SBE_BLA_Agonist_viability,1,1,"The assay component endpoint  TOX21_SBE_BLA_Agonist_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,7872,46666
1116,2386,2393,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist, was analyzed in the positive analysis fitting direction relative to DHT as the baseline of activity. 

Using a type of binding reporter, measures of receptor for loss-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,DMSO,loss,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13769
1117,2387,2394,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the baseline of activity. 

Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,dihydroxytestosterone (DHT),gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13742
1118,2390,2397,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist, was analyzed in the positive analysis fitting direction relative to DHT as the baseline of activity. 

Using a type of binding reporter, measures of receptor for loss-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,DMSO,loss,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13769
1119,2391,2398,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the baseline of activity. 

Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,dihydroxytestosterone (DHT),gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13742
1120,2442,2440,CCTE_Simmons_MITO_basal_resp_rate,1,1,"Data from the assay component CCTE_Simmons_MITO_basal_resp_rate was analyzed at the endpoint, CCTE_Simmons_MITO_basal_resp_rate_OCR, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of respirometric reporter, measures of basal respiration for gain or loss-of-signal activity can be used to understand cellular oxygen consumption as it relates to cellular respiration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mitochondria intended target family, where the subfamily is respiration.",cellular respiration,fold_induction,0,Fenpyroximate,bidirectional,cellular,cellular,mitochondria,respiration,0,0,1,265,539
1121,2444,2441,CCTE_Simmons_MITO_max_resp_rate,1,1,"Data from the assay component CCTE_Simmons_MITO_max_resp_rate was analyzed at the endpoint, CCTE_Simmons_MITO_max_resp_rate_OCR, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of respirometric reporter, measures of maximal respiration for gain or loss-of-signal activity can be used to understand cellular oxygen consumption as it relates to cellular respiration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mitochondria intended target family, where the subfamily is respiration.",cellular respiration,fold_induction,0,Fenpyroximate,bidirectional,cellular,cellular,mitochondria,respiration,0,0,1,265,539
1122,2446,2442,CCTE_Simmons_MITO_inhib_resp_rate,1,1,"Data from the assay component CCTE_Simmons_MITO_inhib_resp_rate was analyzed at the endpoint, CCTE_Simmons_MITO_inhib_resp_rate_OCR, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of respirometric reporter, measures of inhibited respiration for gain or loss-of-signal activity can be used to understand cellular oxygen consumption as it relates to cellular respiration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mitochondria intended target family, where the subfamily is respiration.",cellular respiration,fold_induction,0,none,bidirectional,cellular,cellular,mitochondria,respiration,0,0,1,265,539
1123,2450,2443,CCTE_Simmons_MITO_viability,1,1,"Data from the assay component CCTE_Simmons_MITO_viability was analyzed at the endpoint, CCTE_Simmons_MITO_viability, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, measures of ATP content for loss-of-signal activity can be used to understand the viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,blank wells,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,241,770
1124,2451,2445,CCTE_Harrill_HTTr_Viability_MCF7,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_MCF7 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion to understand changes in cytotoxicity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM N6,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,2050,4576
1125,2452,2446,CCTE_Harrill_HTTr_Apoptosis_MCF7,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Apoptosis_MCF7 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate activation of caspase-3/7 using the CellEvent Caspase 3/7 Green detection reagent to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is apoptosis.",viability,percent_activity,0,1 nM N6,gain,cellular,cellular,cell cycle,apoptosis,0,0,1,2050,4576
1126,2453,2444,CCTE_Harrill_HTTr_CellCount_MCF7,1,1,"The assay component endpoint CCTE_Harrill_HTTr_CellCount_MCF7 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in cell count. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cell count.",viability,percent_activity,0,1 nM N6,loss,cellular,cellular,cell cycle,cell count,0,0,1,2050,4576
1127,2454,2447,CCTE_Shafer_MEA_acute_spike_number,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_spike_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_spike_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,tetrodotoxin,bidirectional,extracellular,action potential,neuroactivity,neural network function: activity,0,0,1,509,1496
1128,2456,2448,CCTE_Shafer_MEA_acute_firing_rate_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_firing_rate_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_firing_rate_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,tetrodotoxin,bidirectional,extracellular,action potential,neuroactivity,neural network function: activity,0,0,1,509,1496
1129,2458,2449,CCTE_Shafer_MEA_acute_burst_number,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: activity,0,0,1,509,1496
1130,2460,2450,CCTE_Shafer_MEA_acute_burst_duration_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_duration_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_duration_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1226
1131,2462,2451,CCTE_Shafer_MEA_acute_per_burst_spike_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_per_burst_spike_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_per_burst_spike_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1226
1132,2464,2452,CCTE_Shafer_MEA_acute_interburst_interval_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_interburst_interval_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_interburst_interval_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1224
1133,2466,2453,CCTE_Shafer_MEA_acute_burst_percentage_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_percentage_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_percentage_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1327
1134,2468,2454,CCTE_Shafer_MEA_acute_burst_percentage_std,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_percentage_std was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_percentage_std, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1274
1135,2470,2455,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1239
1136,2472,2456,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_std,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_spike_number_std was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_spike_number_std, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1219
1137,2474,2457,CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1239
1138,2476,2458,CCTE_Shafer_MEA_acute_network_burst_percentage,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_network_burst_percentage was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_network_burst_percentage, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1239
1139,2478,2459,CCTE_Shafer_MEA_acute_cross_correlation_area,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_cross_correlation_area was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_cross_correlation_area, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1496
1140,2480,2460,CCTE_Shafer_MEA_acute_cross_correlation_HWHM,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_cross_correlation_HWHM was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_cross_correlation_HWHM, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1496
1141,2482,2461,CCTE_Shafer_MEA_acute_synchrony_index,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_synchrony_index was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_synchrony_index, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1274
1142,2484,2462,CCTE_Deisenroth_AIME_96WELL_LUC_Active,1,1,"CCTE_Deisenroth_AIME_96WELL_LUC_Active is a component of the CCTE_Deisenroth_AIME_96WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism positive mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_96WELL_LUC_Active, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,74,270
1143,2485,2463,CCTE_Deisenroth_AIME_96WELL_CTox_Active,1,1,"CCTE_Deisenroth_AIME_96WELL_CTox_Active is a component of the CCTE_Deisenroth_AIME_96WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates cytotoxicity in metabolism positive mode. Using a type of flourescent probe in VM7Luc cells, loss-of-signal activity can be used to understand loss of viability. This assay endpoint, CCTE_Deisenroth_AIME_96WELL_CTox_Active, was analyzed with bidirectional fitting in the ERTA assay.",viability,log2_fold_induction,0,NA,loss,protein,protein-unspecified,protease,NA,0,1,1,74,269
1144,2486,2464,CCTE_Deisenroth_AIME_96WELL_LUC_Inactive,1,1,"CCTE_Deisenroth_AIME_96WELL_LUC_Inactive is a component of the CCTE_Deisenroth_AIME_96WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism negative mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_96WELL_LUC_Inactive, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,74,270
1145,2487,2465,CCTE_Deisenroth_AIME_96WELL_CTox_Inactive,1,1,"CCTE_Deisenroth_AIME_96WELL_CTox_Inactive is a component of the CCTE_Deisenroth_AIME_96WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates cytotoxicity in metabolism negative mode. Using a type of flourescent probe in VM7Luc cells, loss-of-signal activity can be used to understand loss of viability. This assay endpoint, CCTE_Deisenroth_AIME_96WELL_CTox_Inactive, was analyzed with bidirectional fitting in the ERTA assay.",viability,log2_fold_induction,0,NA,loss,protein,protein-unspecified,protease,NA,0,1,1,74,270
1146,2488,2466,CCTE_Deisenroth_AIME_384WELL_LUC_Active,1,1,"CCTE_Deisenroth_AIME_384WELL_LUC_Active is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism positive mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_LUC_Active, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,769,4495
1147,2489,2467,CCTE_Deisenroth_AIME_384WELL_CTox_Active,1,1,"CCTE_Deisenroth_AIME_384WELL_CTox_Active is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates cytotoxicity in metabolism positive mode. Using a type of flourescent probe in VM7Luc cells, loss-of-signal activity can be used to understand loss of viability. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_CTox_Active, was analyzed with bidirectional fitting in the ERTA assay.",viability,log2_fold_induction,0,NA,loss,protein,protein-unspecified,protease,NA,0,0,1,769,3290
1148,2490,2468,CCTE_Deisenroth_AIME_384WELL_LUC_Inactive,1,1,"CCTE_Deisenroth_AIME_384WELL_LUC_Inactive is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism negative mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_LUC_Inactive, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,769,4464
1149,2491,2469,CCTE_Deisenroth_AIME_384WELL_CTox_Inactive,1,1,"CCTE_Deisenroth_AIME_384WELL_CTox_Inactive is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates cytotoxicity in metabolism negative mode. Using a type of flourescent probe in VM7Luc cells, loss-of-signal activity can be used to understand loss of viability. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_CTox_Inactive, was analyzed with bidirectional fitting in the ERTA assay.",viability,log2_fold_induction,0,NA,loss,protein,protein-unspecified,protease,NA,0,0,1,769,3197
1150,2492,2470,CCTE_Deisenroth_AIME_384WELL_LUC_Shift,1,1,"CCTE_Deisenroth_AIME_384WELL_LUC_Shift is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively.                                                                                                                                                                                                                                                                                      This endpoint evaluates the shift in metabolism-dependent changes between positive (active) and negative (inactive) assay modes. The metabolic curve shift response is defined as the pairwise difference between the positive (AEID 2488) and negative (AEID 2490) normalized response values at each concentration for a given chemical across replicate experiments. The pairwise differences form the basis for a concentration-response curve. Standard curve fit analysis identfiied chemicals where the calculated shift was greater than the shift-derived baseline cutoff. A positive hit designation in this endpoint indicates a significant shift trend in the positive direction for bioactivation. ",reporter gene,percent_activity,0,17beta-estradiol,bidirectional,protein,transcription factor,nuclear receptor,steroidal,0,0,1,768,0
1151,2494,2471,CCTE_Shafer_MEA_dev_firing_rate_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_firing_rate_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_firing_rate_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683
1152,2496,2472,CCTE_Shafer_MEA_dev_burst_rate,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_burst_rate was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_burst_rate, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683
1153,2498,2473,CCTE_Shafer_MEA_dev_active_electrodes_number,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_active_electrodes_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_active_electrodes_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683
1154,2500,2474,CCTE_Shafer_MEA_dev_bursting_electrodes_number,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_bursting_electrodes_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_bursting_electrodes_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683
1155,2502,2475,CCTE_Shafer_MEA_dev_per_burst_interspike_interval,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_burst_interspike_interval was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_burst_interspike_interval, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683
1156,2504,2476,CCTE_Shafer_MEA_dev_per_burst_spike_percent,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_burst_spike_percent was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_burst_spike_percent, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683
1157,2506,2477,CCTE_Shafer_MEA_dev_burst_duration_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_burst_duration_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_burst_duration_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683
1158,2508,2478,CCTE_Shafer_MEA_dev_interburst_interval_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_interburst_interval_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_interburst_interval_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683
1159,2510,2479,CCTE_Shafer_MEA_dev_network_spike_number,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_network_spike_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_network_spike_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1160,2512,2480,CCTE_Shafer_MEA_dev_network_spike_peak,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_network_spike_peak was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_network_spike_peak, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1161,2514,2481,CCTE_Shafer_MEA_dev_spike_duration_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_spike_duration_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_spike_duration_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1162,2516,2482,CCTE_Shafer_MEA_dev_network_spike_duration_std,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_network_spike_duration_std was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_network_spike_duration_std, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1163,2518,2483,CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1164,2520,2484,CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1165,2522,2485,CCTE_Shafer_MEA_dev_per_network_spike_spike_percent,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_network_spike_spike_percent was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_network_spike_spike_percent, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1166,2524,2486,CCTE_Shafer_MEA_dev_correlation_coefficient_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_correlation_coefficient_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_correlation_coefficient_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1167,2526,2487,CCTE_Shafer_MEA_dev_mutual_information_norm,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_mutual_information_norm was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_mutual_information_norm, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,NA,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683
1168,2529,2488,CCTE_Shafer_MEA_dev_LDH,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_LDH was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_LDH, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand cell viability.",cell viability,percent_activity,0,NA,loss,cellular,cellular,cell cycle,cytotoxicity,0,1,1,396,1589
1169,2530,2489,CCTE_Shafer_MEA_dev_AB,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_AB was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_AB, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand cell viability.",cell viability,percent_activity,0,NA,loss,cellular,mitochondria,cell cycle,cytotoxicity,0,1,1,396,1677
1170,2532,2490,CCTE_GLTED_hDIO2,1,1,"Data from the assay component CCTE_GLTED_hDIO2 was analyzed into 1 assay endpoint. This assay endpoint, CCTE_GLTED_hDIO2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DIO2. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'deiodinase' intended target family, where the subfamily is 'deiodinase Type 2'.",enzymatic activity,percent_activity,0,xanthohumol,loss,protein,enzyme,deiodinase,deiodinase Type 2,1,0,1,231,414
1171,2533,2491,CCTE_GLTED_hDIO3,1,1,"Data from the assay component CCTE_GLTED_hDIO3 was analyzed into 1 assay endpoint. This assay endpoint, CCTE_GLTED_hDIO3, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in the enzymatic activity as they relate to the gene DIO3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'deiodinase' intended target family, where the subfamily is 'deiodinase Type 3'.",enzymatic activity,percent_activity,0,xanthohumol,loss,protein,enzyme,deiodinase,deiodinase Type 3,1,0,1,228,413
1172,2540,2495,CCTE_Shafer_MEA_acute_LDH,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_LDH was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_LDH, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to understand cell viability.",cell viability,percent_activity,0,Tritonx100,gain,cellular,cellular,cell cycle,cytotoxicity,0,1,1,509,2187
1173,2541,2496,CCTE_Shafer_MEA_acute_AB,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_AB was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_AB, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand cell viability.",cell viability,percent_activity,0,NA,loss,cellular,mitochondria,cell cycle,cytotoxicity,0,1,1,504,1638
1174,2545,2500,UKN5_HCS_SBAD2_neurite_outgrowth,1,1,"The assay endpoint UKN5_HCS_SBAD2_neurite_outgrowth was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,percent_activity,0,Narciclasine,bidirectional,cellular,cellular,neurodevelopment,neurite outgrowth,0,0,1,72,702
1175,2547,2501,UKN5_HCS_SBAD2_cell_viability,1,1,"The assay endpoint UKN5_HCS_SBAD2_cell_viability was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand viability effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is viability.",viability,percent_activity,0,NA,bidirectional,cellular,nucleus,cell cycle,viability,0,1,1,72,702
1176,2549,2502,ERF_CR_ADME_hCYP2A6,1,1,"Data from the assay component ERF_CR_ADME_hCYP2A6 was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2A6, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2A6. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,1,0
1177,2550,2503,ERF_CR_ADME_hCYP2B6,1,1,"Data from the assay component ERF_CR_ADME_hCYP2B6 was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2B6, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2B6. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,1,0
1178,2551,2504,ERF_CR_ADME_hCYP2C19_CEC,1,1,"Data from the assay component ERF_CR_ADME_hCYP2C19_CEC was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2C19_CEC, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2C19. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,3,0
1179,2552,2505,ERF_CR_ADME_hCYP2C19_Omeprazole,1,1,"Data from the assay component ERF_CR_ADME_hCYP2C19_Omeprazole was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2C19_Omeprazole, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2C19. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,2,0
1180,2553,2506,ERF_CR_ADME_hCYP2C8,1,1,"Data from the assay component ERF_CR_ADME_hCYP2C8 was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2C8, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2C8. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,3,0
1181,2554,2507,ERF_CR_ADME_hCYP2C9,1,1,"Data from the assay component ERF_CR_ADME_hCYP2C9 was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2C9, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2C9. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,2,0
1182,2555,2508,ERF_CR_ADME_hCYP2E1,1,1,"Data from the assay component ERF_CR_ADME_hCYP2E1 was analyzed at the assay endpoint, ERF_CR_ADME_hCYP2E1, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP2E1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,5,6
1183,2556,2509,ERF_CR_ADME_hCYP3A4,1,1,"Data from the assay component ERF_CR_ADME_hCYP3A4 was analyzed at the assay endpoint, ERF_CR_ADME_hCYP3A4, in the positive analysis fitting direction relative to acetonitrile as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP3A4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp  intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,NA,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,1,0
1184,2557,2510,ERF_PL_ENZ_bPDE1,1,1,"Data from the assay component ERF_PL_ENZ_bPDE1 was analyzed at the assay endpoint, ERF_PL_ENZ_bPDE1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PDE1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphodiesterase intended target family, where the subfamily is cyclic nucleotide signaling.",enzymatic activity,percent_activity,0,3-Isobutyl-1-methylxanthine,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,1,0
1185,2558,2511,ERF_CR_ENZ_hABL1,1,1,"Data from the assay component ERF_CR_ENZ_hABL1 was analyzed at the assay endpoint, ERF_CR_ENZ_hABL1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene ABL1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,0
1186,2559,2512,ERF_CR_ENZ_hAKT2,1,1,"Data from the assay component ERF_CR_ENZ_hAKT2 was analyzed at the assay endpoint, ERF_CR_ENZ_hAKT2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene AKT2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,0
1187,2560,2513,ERF_CR_ENZ_hAKT3,1,1,"Data from the assay component ERF_CR_ENZ_hAKT3 was analyzed at the assay endpoint, ERF_CR_ENZ_hAKT3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene AKT3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,0
1188,2561,2514,ERF_CR_ENZ_hAURKA,1,1,"Data from the assay component ERF_CR_ENZ_hAURKA was analyzed at the assay endpoint, ERF_CR_ENZ_hAURKA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene AURKA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,receptor,kinase,serine/threonine kinase,0,0,1,2,0
1189,2562,2515,ERF_PL_ENZ_hBTK,1,1,"Data from the assay component ERF_PL_ENZ_hBTK was analyzed at the assay endpoint, ERF_PL_ENZ_hBTK, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene BTK. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is  tyrosine kinase (tk).",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase, tyrosine kinase (tk),0,0,1,2,0
1190,2563,2516,ERF_CR_ENZ_hCDK2,1,1,"Data from the assay component ERF_CR_ENZ_hCDK2 was analyzed at the assay endpoint, ERF_CR_ENZ_hCDK2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CDK2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1191,2564,2517,ERF_PL_ENZ_hCHK1,1,1,"Data from the assay component ERF_PL_ENZ_hCHK1 was analyzed at the assay endpoint, ERF_PL_ENZ_hCHK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CHEK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,0
1192,2566,2519,ERF_CR_ENZ_hCSF1R,1,1,"Data from the assay component ERF_CR_ENZ_hCSF1R was analyzed at the assay endpoint, ERF_CR_ENZ_hCSF1R, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CSF1R. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1193,2567,2520,ERF_PL_ENZ_hCSNK1A1,1,1,"Data from the assay component ERF_PL_ENZ_hCSNK1A1 was analyzed at the assay endpoint, ERF_PL_ENZ_hCSNK1A1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CSNK1A1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,IC 261,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1194,2568,2521,ERF_PL_ENZ_hCSNK1D,1,1,"Data from the assay component ERF_PL_ENZ_hCSNK1D was analyzed at the assay endpoint, ERF_PL_ENZ_hCSNK1D, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CSNK1D. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,IC 261,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1195,2569,2522,ERF_PL_ENZ_hCSNK2A1,1,1,"Data from the assay component ERF_PL_ENZ_hCSNK2A1 was analyzed at the assay endpoint, ERF_PL_ENZ_hCSNK2A1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CSNK2A1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,hypericin,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1196,2570,2523,ERF_PL_ENZ_hCYP19A1,1,1,"Data from the assay component ERF_PL_ENZ_hCYP19A1 was analyzed at the assay endpoint, ERF_PL_ENZ_hCYP19A1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene CYP19A1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is steroidogenesis-related.",enzymatic activity,percent_activity,0,testosterone,loss,protein,enzyme,cyp ,steroidogenesis-related,0,0,1,2,0
1197,2571,2524,ERF_CR_ENZ_hDUSP3,1,1,"Data from the assay component ERF_CR_ENZ_hDUSP3 was analyzed at the assay endpoint, ERF_CR_ENZ_hDUSP3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene DUSP3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is dual-specific kinase.",enzymatic activity,percent_activity,0,sodium orthovanadate,loss,protein,enzyme,kinase,dual-specific kinase,0,0,1,2,0
1198,2572,2525,ERF_CR_ENZ_hDYRK1A,1,1,"Data from the assay component ERF_CR_ENZ_hDYRK1A was analyzed at the assay endpoint, ERF_CR_ENZ_hDYRK1A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene DYRK1A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1199,2573,2526,ERF_CR_ENZ_hEGFR,1,1,"Data from the assay component ERF_CR_ENZ_hEGFR was analyzed at the assay endpoint, ERF_CR_ENZ_hEGFR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene EGFR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,hydrochloride,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,4,0
1200,2574,2527,ERF_CR_ENZ_hELANE,1,1,"Data from the assay component ERF_CR_ENZ_hELANE was analyzed at the assay endpoint, ERF_CR_ENZ_hELANE, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene ELANE. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine peptidase.",enzymatic activity,percent_activity,0,"3',4'dichloroisocoumarin",loss,protein,enzyme,protease,serine peptidase,0,0,1,4,0
1201,2575,2528,ERF_CR_ENZ_hEPHA1,1,1,"Data from the assay component ERF_CR_ENZ_hEPHA1 was analyzed at the assay endpoint, ERF_CR_ENZ_hEPHA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene EPHA1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,3,0
1202,2576,2529,ERF_CR_ENZ_hEPHA2,1,1,"Data from the assay component ERF_CR_ENZ_hEPHA2 was analyzed at the assay endpoint, ERF_CR_ENZ_hEPHA2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene EPHA2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,1,0
1203,2577,2530,ERF_CR_ENZ_hEPHB2,1,1,"Data from the assay component ERF_CR_ENZ_hEPHB2 was analyzed at the assay endpoint, ERF_CR_ENZ_hEPHB2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene EPHB2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,PP2,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1204,2578,2531,ERF_CR_ENZ_hFGFR1,1,1,"Data from the assay component ERF_CR_ENZ_hFGFR1 was analyzed at the assay endpoint, ERF_CR_ENZ_hFGFR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene FGFR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1205,2579,2532,ERF_CR_ENZ_hFGFR3,1,1,"Data from the assay component ERF_CR_ENZ_hFGFR3 was analyzed at the assay endpoint, ERF_CR_ENZ_hFGFR3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene FGFR3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1206,2580,2533,ERF_CR_ENZ_hFLT1,1,1,"Data from the assay component ERF_CR_ENZ_hFLT1 was analyzed at the assay endpoint, ERF_CR_ENZ_hFLT1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene FLT1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1207,2581,2534,ERF_CR_ENZ_hFLT4,1,1,"Data from the assay component ERF_CR_ENZ_hFLT4 was analyzed at the assay endpoint, ERF_CR_ENZ_hFLT4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene FLT4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1208,2582,2535,ERF_CR_ENZ_hFYN,1,1,"Data from the assay component ERF_CR_ENZ_hFYN was analyzed at the assay endpoint, ERF_CR_ENZ_hFYN, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene FYN. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine phosphatase.",enzymatic activity,percent_activity,0,PP1,loss,protein,enzyme,kinase,non-receptor tyrosine phosphatase,0,0,1,2,0
1209,2583,2536,ERF_CR_ENZ_hGSK3b,1,1,"Data from the assay component ERF_CR_ENZ_hGSK3b was analyzed at the assay endpoint, ERF_CR_ENZ_hGSK3b, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene GSK3B. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1210,2584,2537,ERF_CR_ENZ_hHDAC6,1,1,"Data from the assay component ERF_CR_ENZ_hHDAC6 was analyzed at the assay endpoint, ERF_CR_ENZ_hHDAC6, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene HDAC6. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the epigenetic enzyme intended target family, where the subfamily is histone deacetylase.",enzymatic activity,percent_activity,0,trichostatin A,loss,protein,enzyme,epigenetic enzyme,histone deacetylase,0,0,1,1,0
1211,2585,2538,ERF_CR_ENZ_hIRAK4,1,1,"Data from the assay component ERF_CR_ENZ_hIRAK4 was analyzed at the assay endpoint, ERF_CR_ENZ_hIRAK4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene IRAK4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,1,0
1212,2586,2539,ERF_CR_ENZ_hJAK2,1,1,"Data from the assay component ERF_CR_ENZ_hJAK2 was analyzed at the assay endpoint, ERF_CR_ENZ_hJAK2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene JAK2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,2,0
1213,2587,2540,ERF_CR_ENZ_hKDR,1,1,"Data from the assay component ERF_CR_ENZ_hKDR was analyzed at the assay endpoint, ERF_CR_ENZ_hKDR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene KDR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1214,2588,2541,ERF_CR_ENZ_hLCK,1,1,"Data from the assay component ERF_CR_ENZ_hLCK was analyzed at the assay endpoint, ERF_CR_ENZ_hLCK, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene LCK. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,3,0
1215,2589,2542,ERF_CR_ENZ_hLYN,1,1,"Data from the assay component ERF_CR_ENZ_hLYN was analyzed at the assay endpoint, ERF_CR_ENZ_hLYN, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene LYN. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,4,0
1216,2590,2543,ERF_CR_ENZ_hMAOA,1,1,"Data from the assay component ERF_CR_ENZ_hMAOA was analyzed at the assay endpoint, ERF_CR_ENZ_hMAOA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MAOA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the stress response intended target family, where the subfamily is monoamine oxidase.",enzymatic activity,percent_activity,0,clorgiline,loss,protein,enzyme,stress response,monoamine oxidase,0,0,1,4,0
1217,2591,2544,ERF_CR_ENZ_hMAOB,1,1,"Data from the assay component ERF_CR_ENZ_hMAOB was analyzed at the assay endpoint, ERF_CR_ENZ_hMAOB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MAOB. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the stress response intended target family, where the subfamily is monoamine oxidase.",enzymatic activity,percent_activity,0,deprenyl,loss,protein,enzyme,stress response,monoamine oxidase,0,0,1,1,0
1218,2592,2545,ERF_CR_ENZ_hMAPK1,1,1,"Data from the assay component ERF_CR_ENZ_hMAPK1 was analyzed at the assay endpoint, ERF_CR_ENZ_hMAPK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MAPK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1219,2593,2546,ERF_KP_ENZ_hMAPK11,1,1,"Data from the assay component ERF_KP_ENZ_hMAPK11 was analyzed at the assay endpoint, ERF_KP_ENZ_hMAPK11, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MAPK11. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,PP1 Analog II. 1NM-PP1,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1220,2594,2547,ERF_CR_ENZ_hMAPKAPK2,1,1,"Data from the assay component ERF_CR_ENZ_hMAPKAPK2 was analyzed at the assay endpoint, ERF_CR_ENZ_hMAPKAPK2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MAPKAPK2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1221,2595,2548,ERF_PL_ENZ_hMAPKAPK5,1,1,"Data from the assay component ERF_PL_ENZ_hMAPKAPK5 was analyzed at the assay endpoint, ERF_PL_ENZ_hMAPKAPK5, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MAPKAPK5. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,1,0
1222,2596,2549,ERF_CR_ENZ_hMARK1,1,1,"Data from the assay component ERF_CR_ENZ_hMARK1 was analyzed at the assay endpoint, ERF_CR_ENZ_hMARK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MARK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1223,2597,2550,ERF_CR_ENZ_hMET,1,1,"Data from the assay component ERF_CR_ENZ_hMET was analyzed at the assay endpoint, ERF_CR_ENZ_hMET, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MET. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,2,0
1224,2598,2551,ERF_CR_ENZ_hMMP3,1,1,"Data from the assay component ERF_CR_ENZ_hMMP3 was analyzed at the assay endpoint, ERF_CR_ENZ_hMMP3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MMP3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metallopeptidase.",enzymatic activity,percent_activity,0,Ilomastat,loss,protein,enzyme,protease,matrix metallopeptidase,0,0,1,2,0
1225,2599,2552,ERF_CR_ENZ_hMMP9,1,1,"Data from the assay component ERF_CR_ENZ_hMMP9 was analyzed at the assay endpoint, ERF_CR_ENZ_hMMP9, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MMP9. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metallopeptidase.",enzymatic activity,percent_activity,0,Ilomastat,loss,protein,enzyme,protease,matrix metallopeptidase,0,0,1,1,0
1226,2600,2553,ERF_CR_ENZ_hMSK1,1,1,"Data from the assay component ERF_CR_ENZ_hMSK1 was analyzed at the assay endpoint, ERF_CR_ENZ_hMSK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene MSK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1227,2601,2554,ERF_CR_ENZ_hNEK2,1,1,"Data from the assay component ERF_CR_ENZ_hNEK2 was analyzed at the assay endpoint, ERF_CR_ENZ_hNEK2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene NEK2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1228,2602,2555,ERF_CR_ENZ_hNTRK1,1,1,"Data from the assay component ERF_CR_ENZ_hNTRK1 was analyzed at the assay endpoint, ERF_CR_ENZ_hNTRK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene NTRK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,receptor tyrosine kinase,0,0,1,4,0
1229,2603,2556,ERF_CR_ENZ_hPAK4,1,1,"Data from the assay component ERF_CR_ENZ_hPAK4 was analyzed at the assay endpoint, ERF_CR_ENZ_hPAK4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PAK4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1230,2604,2557,ERF_CR_ENZ_hPDE10A,1,1,"Data from the assay component ERF_CR_ENZ_hPDE10A was analyzed at the assay endpoint, ERF_CR_ENZ_hPDE10A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PDE10A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphodiesterase intended target family, where the subfamily is cyclic nucleotide signaling.",enzymatic activity,percent_activity,0,papaverine,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,2,0
1231,2605,2558,ERF_CR_ENZ_hPDE4A,1,1,"Data from the assay component ERF_CR_ENZ_hPDE4A was analyzed at the assay endpoint, ERF_CR_ENZ_hPDE4A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PDE4A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphodiesterase intended target family, where the subfamily is cyclic nucleotide signaling.",enzymatic activity,percent_activity,0,Ro 20-1724,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,2,0
1232,2606,2559,ERF_PL_ENZ_hPDE4D2,1,1,"Data from the assay component ERF_PL_ENZ_hPDE4D2 was analyzed at the assay endpoint, ERF_PL_ENZ_hPDE4D2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PDE4D. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is phosphodiesterase.",enzymatic activity,percent_activity,0,rolipram,loss,protein,enzyme,esterase,phosphodiesterase,0,0,1,1,0
1233,2607,2560,ERF_KP_ENZ_hPKD2,1,1,"Data from the assay component ERF_KP_ENZ_hPKD2 was analyzed at the assay endpoint, ERF_KP_ENZ_hPKD2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PRKD2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1234,2608,2561,ERF_KP_ENZ_hPRKAA1,1,1,"Data from the assay component ERF_KP_ENZ_hPRKAA1 was analyzed at the assay endpoint, ERF_KP_ENZ_hPRKAA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PRKAA1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1235,2609,2562,ERF_PL_ENZ_hPRKACA,1,1,"Data from the assay component ERF_PL_ENZ_hPRKACA was analyzed at the assay endpoint, ERF_PL_ENZ_hPRKACA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PRKACA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,1-(5-ISOQUINOLINESULFONYL)-2-M,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,0
1236,2610,2563,ERF_PL_ENZ_hPRKCZ,1,1,"Data from the assay component ERF_PL_ENZ_hPRKCZ was analyzed at the assay endpoint, ERF_PL_ENZ_hPRKCZ, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PRKCZ. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,Staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,1,0
1237,2611,2564,ERF_PL_ENZ_hPTEN,1,1,"Data from the assay component ERF_PL_ENZ_hPTEN was analyzed at the assay endpoint, ERF_PL_ENZ_hPTEN, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PTEN. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is dual-specific phosphatase.",enzymatic activity,percent_activity,0,(NH4)6Mo7O24,loss,protein,enzyme,phosphatase,dual-specific phosphatase,0,0,1,3,0
1238,2612,2565,ERF_CR_ENZ_hPTGS2,1,1,"Data from the assay component ERF_CR_ENZ_hPTGS2 was analyzed at the assay endpoint, ERF_CR_ENZ_hPTGS2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene PTGS2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the stress response intended target family, where the subfamily is cyclooxygenase.",binding,percent_activity,0,ns-398,loss,protein,enzyme,stress response,cyclooxygenase,0,0,1,1,0
1239,2613,2566,ERF_CR_ENZ_hPTPN11,1,1,"Data from the assay component ERF_CR_ENZ_hPTPN11 was analyzed at the assay endpoint, ERF_CR_ENZ_hPTPN11, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PTPN11. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is protein tyrosine phosphatase.",enzymatic activity,percent_activity,0,sodium orthovanadate,loss,protein,enzyme,phosphatase,protein tyrosine phosphatase,0,0,1,1,0
1240,2614,2567,ERF_CR_ENZ_hPTPRB,1,1,"Data from the assay component ERF_CR_ENZ_hPTPRB was analyzed at the assay endpoint, ERF_CR_ENZ_hPTPRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene PTPRB. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is protein tyrosine phosphatase.",binding,percent_activity,0,NA,loss,protein,receptor,phosphatase,protein tyrosine phosphatase,0,0,1,1,0
1241,2615,2568,ERF_PL_ENZ_hPTPRF,1,1,"Data from the assay component ERF_PL_ENZ_hPTPRF was analyzed at the assay endpoint, ERF_PL_ENZ_hPTPRF, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene PTPRF. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is receptortyrosine phosphatase.",enzymatic activity,percent_activity,0,(NH4)6Mo7O24,loss,protein,enzyme,phosphatase,receptortyrosine phosphatase,0,0,1,2,0
1242,2617,2570,ERF_CR_ENZ_hRAF1,1,1,"Data from the assay component ERF_CR_ENZ_hRAF1 was analyzed at the assay endpoint, ERF_CR_ENZ_hRAF1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene RAF1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,2,0
1243,2618,2571,ERF_CR_ENZ_hROCK1,1,1,"Data from the assay component ERF_CR_ENZ_hROCK1 was analyzed at the assay endpoint, ERF_CR_ENZ_hROCK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene ROCK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,3,0
1244,2619,2572,ERF_CR_ENZ_hSGK1,1,1,"Data from the assay component ERF_CR_ENZ_hSGK1 was analyzed at the assay endpoint, ERF_CR_ENZ_hSGK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene SGK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,serine/threonine kinase,0,0,1,4,0
1245,2620,2573,ERF_CR_ENZ_hSIRT3,1,1,"Data from the assay component ERF_CR_ENZ_hSIRT3 was analyzed at the assay endpoint, ERF_CR_ENZ_hSIRT3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene SIRT3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the epigenetic enzyme intended target family, where the subfamily is histone deacetylase.",enzymatic activity,percent_activity,0,nicotinamide,loss,protein,enzyme,epigenetic enzyme,histone deacetylase,0,0,1,1,0
1246,2621,2574,ERF_CR_ENZ_hSRC,1,1,"Data from the assay component ERF_CR_ENZ_hSRC was analyzed at the assay endpoint, ERF_CR_ENZ_hSRC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene SRC. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is non-receptor tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,non-receptor tyrosine kinase,0,0,1,2,0
1247,2622,2575,ERF_CR_ENZ_hSYK,1,1,"Data from the assay component ERF_CR_ENZ_hSYK was analyzed at the assay endpoint, ERF_CR_ENZ_hSYK, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene SYK. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is spleen tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,spleen tyrosine kinase,0,0,1,3,0
1248,2623,2576,ERF_CR_ENZ_hZAP70,1,1,"Data from the assay component ERF_CR_ENZ_hZAP70 was analyzed at the assay endpoint, ERF_CR_ENZ_hZAP70, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene ZAP70. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is protein tyrosine kinase.",enzymatic activity,percent_activity,0,staurosporine,loss,protein,enzyme,kinase,protein tyrosine kinase,0,0,1,2,0
1249,2624,2577,ERF_CR_ENZ_rACFSK_Agonist,1,1,"Data from the assay component ERF_CR_ENZ_rACFSK_Agonist was analyzed at the assay endpoint, ERF_CR_ENZ_rACFSK_Agonist, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene ADCY5. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adenylyl cyclase.",binding,percent_activity,0,cAMP,gain,protein,receptor,gpcr,adenylyl cyclase,0,0,1,4,0
1250,2625,2578,ERF_CR_ENZ_rACFSK_Antagonist,1,1,"Data from the assay component ERF_CR_ENZ_rACFSK_Antagonist was analyzed at the assay endpoint, ERF_CR_ENZ_rACFSK_Antagonist, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene ADCY5. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adenylyl cyclase.",binding,percent_activity,0,cAMP,loss,protein,receptor,gpcr,adenylyl cyclase,0,0,1,4,0
1251,2626,2579,ERF_PL_GPCR_binding_g5HT4,1,1,"Data from the assay component ERF_PL_GPCR_binding_g5HT4 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_g5HT4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene HTR4 (homolog). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is serotonin.",radioligand binding,percent_activity,0,CHEMBL83954,loss,protein,receptor,gpcr,serotonin,0,0,1,2,0
1252,2627,2580,ERF_PL_GPCR_binding_gANPA,1,1,"Data from the assay component ERF_PL_GPCR_binding_gANPA was analyzed at the assay endpoint, ERF_PL_GPCR_binding_gANPA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene ANPA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is guanylyl cyclase.",binding,percent_activity,0,ANF (rat),loss,protein,receptor,gpcr,guanylyl cyclase,0,0,1,1,0
1253,2628,2581,ERF_CR_GPCR_binding_hADORA1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hADORA1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hADORA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene ADORA1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adenosine.",binding,percent_activity,0,CPA,gain,protein,receptor,gpcr,adenosine,0,0,1,2,0
1254,2629,2582,ERF_CR_GPCR_binding_hADORA2A,1,1,"Data from the assay component ERF_CR_GPCR_binding_hADORA2A was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hADORA2A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene ADORA2A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adenosine.",binding,percent_activity,0,NECA,gain,protein,receptor,gpcr,adenosine,0,0,1,1,0
1255,2630,2583,ERF_CR_GPCR_binding_hADRA1A,1,1,"Data from the assay component ERF_CR_GPCR_binding_hADRA1A was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hADRA1A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene ADRA1A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adrenoceptor.",binding,percent_activity,0,WB-4101,loss,protein,receptor,gpcr,adrenoceptor,0,0,1,4,0
1256,2631,2584,ERF_PL_GPCR_binding_hADRA2A,1,1,"Data from the assay component ERF_PL_GPCR_binding_hADRA2A was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hADRA2A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene ADRA2A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adrenoceptor.",radioligand binding,percent_activity,0,yohimbine,loss,protein,receptor  ,gpcr,adrenoceptor,0,0,1,3,0
1257,2632,2585,ERF_PL_GPCR_binding_hADRA2C,1,1,"Data from the assay component ERF_PL_GPCR_binding_hADRA2C was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hADRA2C, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene ADRA2C. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adrenoceptor.",radioligand binding,percent_activity,0,yohimbine,loss,protein,receptor  ,gpcr,adrenoceptor,0,0,1,2,0
1258,2633,2586,ERF_PL_GPCR_binding_hADRB1,1,1,"Data from the assay component ERF_PL_GPCR_binding_hADRB1 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hADRB1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene ADRB1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adrenoceptor.",radioligand binding,percent_activity,0,S(-)-Propranolol,loss,protein,receptor  ,gpcr,adrenoceptor,0,0,1,2,0
1259,2634,2587,ERF_CR_GPCR_binding_hADRB2,1,1,"Data from the assay component ERF_CR_GPCR_binding_hADRB2 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hADRB2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene ADRB2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adrenoceptor.",binding,percent_activity,0,ICI 118551,loss,protein,receptor,gpcr,adrenoceptor,0,0,1,3,0
1260,2635,2588,ERF_PL_GPCR_binding_hADRB3,1,1,"Data from the assay component ERF_PL_GPCR_binding_hADRB3 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hADRB3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene ADRB3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is adrenoceptor.",radioligand binding,percent_activity,0,alprenolol ,loss,protein,receptor  ,gpcr,adrenoceptor,0,0,1,1,0
1261,2636,2589,ERF_PL_GPCR_binding_hAGTR1,1,1,"Data from the assay component ERF_PL_GPCR_binding_hAGTR1 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hAGTR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in radioligand binding as they relate to gene AGTR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is angiotensin.",radioligand binding,percent_activity,0,saralasin,gain,protein,receptor  ,gpcr,angiotensin,0,0,1,1,0
1262,2637,2590,ERF_PL_GPCR_binding_hAGTR2,1,1,"Data from the assay component ERF_PL_GPCR_binding_hAGTR2 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hAGTR2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in radioligand binding as they relate to gene AGTR2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is angiotensin.",radioligand binding,percent_activity,0,saralasin,gain,protein,receptor  ,gpcr,angiotensin,0,0,1,2,0
1263,2638,2591,ERF_CR_GPCR_binding_hAVPR1A,1,1,"Data from the assay component ERF_CR_GPCR_binding_hAVPR1A was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hAVPR1A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene AVPR1A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is vasopressin and oxytocin.",binding,percent_activity,0,"[d(CH2)51,Tyr(Me)2]-AVP",gain,protein,receptor,gpcr,vasopressin and oxytocin,0,0,1,1,0
1264,2639,2592,ERF_CR_GPCR_binding_hBDKRB2,1,1,"Data from the assay component ERF_CR_GPCR_binding_hBDKRB2 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hBDKRB2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene BDKRB2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is bradykinin.",binding,percent_activity,0,Npc 567,gain,protein,receptor,gpcr,bradykinin,0,0,1,1,0
1265,2640,2593,ERF_PL_GPCR_binding_hCCKAR,1,1,"Data from the assay component ERF_PL_GPCR_binding_hCCKAR was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hCCKAR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CCKAR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is cholecystokinin.",binding,percent_activity,0,devazepide,loss,protein,receptor,gpcr,cholecystokinin,0,0,1,3,0
1266,2641,2594,ERF_CR_GPCR_binding_hCCKBR,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCCKBR was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCCKBR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene CCKBR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is cholecystokinin.",binding,percent_activity,0,CCK-8s,gain,protein,receptor,gpcr,cholecystokinin,0,0,1,2,0
1267,2642,2595,ERF_CR_GPCR_binding_hCHRM1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCHRM1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCHRM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CHRM1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is acetylcholine (Muscarinic).",binding,percent_activity,0,pirenzepine,loss,protein,receptor,gpcr,acetylcholine (Muscarinic),0,0,1,3,0
1268,2643,2596,ERF_CR_GPCR_binding_hCHRM2,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCHRM2 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCHRM2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CHRM2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is acetylcholine (Muscarinic).",binding,percent_activity,0,methoctramine,loss,protein,receptor,gpcr,acetylcholine (Muscarinic),0,0,1,3,0
1269,2644,2597,ERF_CR_GPCR_binding_hCHRM3,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCHRM3 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCHRM3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CHRM3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is acetylcholine (Muscarinic).",binding,percent_activity,0,4-Damp methiodide,loss,protein,receptor,gpcr,acetylcholine (Muscarinic),0,0,1,3,0
1270,2645,2598,ERF_CR_GPCR_binding_hCHRM4,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCHRM4 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCHRM4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CHRM4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is acetylcholine (Muscarinic).",binding,percent_activity,0,4-Damp methiodide,loss,protein,receptor,gpcr,acetylcholine (Muscarinic),0,0,1,2,0
1271,2646,2599,ERF_CR_GPCR_binding_hCHRM5,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCHRM5 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCHRM5, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CHRM5. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is acetylcholine (Muscarinic).",binding,percent_activity,0,4-Damp methiodide,loss,protein,receptor,gpcr,acetylcholine (Muscarinic),0,0,1,2,0
1272,2647,2600,ERF_CR_GPCR_binding_hCYSLTR1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hCYSLTR1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hCYSLTR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene CYSLTR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is leukotriene.",binding,percent_activity,0,leukotriene D4,gain,protein,receptor,gpcr,leukotriene,0,0,1,2,0
1273,2648,2601,ERF_CR_GPCR_binding_hDRD1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hDRD1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hDRD1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene DRD1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is dopamine.",binding,percent_activity,0,SCH 23390,loss,protein,receptor,gpcr,dopamine,0,0,1,4,0
1274,2649,2602,ERF_CR_GPCR_binding_hDRD2,1,1,"Data from the assay component ERF_CR_GPCR_binding_hDRD2 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hDRD2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene DRD2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is dopamine.",binding,percent_activity,0,butaclamol,loss,protein,receptor,gpcr,dopamine,0,0,1,2,0
1275,2650,2603,ERF_PL_GPCR_binding_hDRD4,1,1,"Data from the assay component ERF_PL_GPCR_binding_hDRD4 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hDRD4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene DRD4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is dopamine.",binding,percent_activity,0,spiperone,loss,protein,receptor,gpcr,dopamine,0,0,1,2,0
1276,2651,2604,ERF_CR_GPCR_binding_hGALR1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hGALR1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hGALR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene GALR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is galanin.",binding,percent_activity,0,galanin,gain,protein,receptor,gpcr,galanin,0,0,1,1,0
1277,2652,2605,ERF_CR_GPCR_binding_hHRH1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hHRH1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hHRH1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene HRH1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is histamine.",binding,percent_activity,0,pyrilamine,loss,protein,receptor,gpcr,histamine,0,0,1,2,0
1278,2653,2606,ERF_CR_GPCR_binding_hHTR1A,1,1,"Data from the assay component ERF_CR_GPCR_binding_hHTR1A was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hHTR1A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene HTR1A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is serotonin.",binding,percent_activity,0,8-OH-DPAT,gain,protein,receptor,gpcr,serotonin,0,0,1,4,0
1279,2654,2607,ERF_CR_GPCR_binding_hHTR5A,1,1,"Data from the assay component ERF_CR_GPCR_binding_hHTR5A was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hHTR5A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene HTR5A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is serotonin.",binding,percent_activity,0,serotonin,gain,protein,receptor,gpcr,serotonin,0,0,1,2,0
1280,2655,2608,ERF_CR_GPCR_binding_hHTR6,1,1,"Data from the assay component ERF_CR_GPCR_binding_hHTR6 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hHTR6, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene HTR6. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is serotonin.",binding,percent_activity,0,serotonin,gain,protein,receptor,gpcr,serotonin,0,0,1,2,0
1281,2656,2609,ERF_CR_GPCR_binding_hHTR7,1,1,"Data from the assay component ERF_CR_GPCR_binding_hHTR7 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hHTR7, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene HTR7. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is serotonin.",binding,percent_activity,0,serotonin,gain,protein,receptor,gpcr,serotonin,0,0,1,3,0
1282,2657,2610,ERF_PL_GPCR_binding_hLTB4R,1,1,"Data from the assay component ERF_PL_GPCR_binding_hLTB4R was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hLTB4R, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene LTB4R. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is leukotriene.",binding,percent_activity,0,LTB4,gain,protein,receptor,gpcr,leukotriene,0,0,1,1,0
1283,2658,2611,ERF_CR_GPCR_binding_hNPY1R,1,1,"Data from the assay component ERF_CR_GPCR_binding_hNPY1R was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hNPY1R, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene NPY1R. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is neuropeptide Y.",binding,percent_activity,0,NPY,gain,protein,receptor,gpcr,neuropeptide Y,0,0,1,3,0
1284,2659,2612,ERF_CR_GPCR_binding_hNPY2R,1,1,"Data from the assay component ERF_CR_GPCR_binding_hNPY2R was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hNPY2R, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene NPY2R. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is neuropeptide Y.",binding,percent_activity,0,NPY,gain,protein,receptor,gpcr,neuropeptide Y,0,0,1,3,0
1285,2660,2613,ERF_CR_GPCR_binding_hNTSR1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hNTSR1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hNTSR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene NTSR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is neurotensin.",binding,percent_activity,0,neurotensin,gain,protein,receptor,gpcr,neurotensin,0,0,1,4,0
1286,2661,2614,ERF_CR_GPCR_binding_hOPRD1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hOPRD1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hOPRD1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene OPRD1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is opioid.",binding,percent_activity,0,DPDPE,gain,protein,receptor,gpcr,opioid,0,0,1,2,0
1287,2662,2615,ERF_CR_GPCR_binding_hOPRL1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hOPRL1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hOPRL1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene OPRL1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is opioid.",binding,percent_activity,0,nociceptin,gain,protein,receptor,gpcr,opioid,0,0,1,5,0
1288,2663,2616,ERF_CR_GPCR_binding_hOPRM1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hOPRM1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hOPRM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene OPRM1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is opioid.",binding,percent_activity,0,DAMGO,gain,protein,receptor,gpcr,opioid,0,0,1,2,0
1289,2664,2617,ERF_CR_GPCR_binding_hOXTR,1,1,"Data from the assay component ERF_CR_GPCR_binding_hOXTR was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hOXTR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene OXTR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is vasopressin and oxytocin.",binding,percent_activity,0,oxytocin,gain,protein,receptor,gpcr,vasopressin and oxytocin,0,0,1,2,0
1290,2665,2618,ERF_PL_GPCR_binding_hTACR1,1,1,"Data from the assay component ERF_PL_GPCR_binding_hTACR1 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hTACR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in radioligand binding as they relate to gene TACR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is tachykinin.",radioligand binding,percent_activity,0,L-703606,gain,protein,receptor,gpcr,tachykinin,0,0,1,3,0
1291,2666,2619,ERF_PL_GPCR_binding_hTACR2,1,1,"Data from the assay component ERF_PL_GPCR_binding_hTACR2 was analyzed at the assay endpoint, ERF_PL_GPCR_binding_hTACR2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene TACR2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is tachykinin.",radioligand binding,percent_activity,0,MEN-10376,loss,protein,receptor,gpcr,tachykinin,0,0,1,2,0
1292,2667,2620,ERF_CR_GPCR_binding_hVIPR1,1,1,"Data from the assay component ERF_CR_GPCR_binding_hVIPR1 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_hVIPR1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene VIPR1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is VIP and PACAP.",binding,percent_activity,0,VIP ,gain,protein,receptor,gpcr,VIP and PACAP,0,0,1,5,0
1293,2668,2621,ERF_CR_GPCR_binding_rGHB,1,1,"Data from the assay component ERF_CR_GPCR_binding_rGHB was analyzed at the assay endpoint, ERF_CR_GPCR_binding_rGHB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene TSPAN17. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is ghb  .",binding,percent_activity,0,NCS382,loss,protein,receptor,gpcr,ghb  ,0,0,1,4,0
1294,2669,2622,ERF_CR_GPCR_binding_rPY2,1,1,"Data from the assay component ERF_CR_GPCR_binding_rPY2 was analyzed at the assay endpoint, ERF_CR_GPCR_binding_rPY2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene P2RY1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is P2Y.",binding,percent_activity,0,datpalphas,gain,protein,receptor,gpcr,P2Y,0,0,1,2,0
1295,2670,2623,ERF_CR_IC_binding_rCACNA1C_Dihydropyridine,1,1,"Data from the assay component ERF_CR_IC_binding_rCACNA1C_Dihydropyridine was analyzed at the assay endpoint, ERF_CR_IC_binding_rCACNA1C_Dihydropyridine, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CACNA1C. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is voltage gated (Calcium).",binding,percent_activity,0,nitrendipine,loss,protein,transporter,ion channel,voltage gated (Calcium),0,0,1,2,0
1296,2671,2624,ERF_CR_IC_binding_rCACNA1C_Diltiazem,1,1,"Data from the assay component ERF_CR_IC_binding_rCACNA1C_Diltiazem was analyzed at the assay endpoint, ERF_CR_IC_binding_rCACNA1C_Diltiazem, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene CACNA1C. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is voltage gated (Calcium).",binding,percent_activity,0,diltiazem,loss,protein,transporter,ion channel,voltage gated (Calcium),0,0,1,2,0
1297,2672,2625,ERF_CR_IC_binding_rKCNJ1,1,1,"Data from the assay component ERF_CR_IC_binding_rKCNJ1 was analyzed at the assay endpoint, ERF_CR_IC_binding_rKCNJ1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene KCNJ1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is voltage gated (Potassium).",binding,percent_activity,0,glyburide potassium salt,loss,protein,transporter,ion channel,voltage gated (Potassium),0,0,1,2,0
1298,2673,2626,ERF_CR_IC_binding_rKCNN1,1,1,"Data from the assay component ERF_CR_IC_binding_rKCNN1  was analyzed at the assay endpoint, ERF_CR_IC_binding_rKCNN1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene Kcnn1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is voltage gated (Potassium).",binding,percent_activity,0,apamin,loss,protein,transporter,ion channel,voltage gated (Potassium),0,0,1,2,0
1299,2674,2627,ERF_CR_IC_binding_rSCN1A,1,1,"Data from the assay component ERF_CR_IC_binding_rSCN1A was analyzed at the assay endpoint, ERF_CR_IC_binding_rSCN1A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene SCN1A. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is voltage gated (Sodium).",binding,percent_activity,0,veratridine,loss,protein,transporter,ion channel,voltage gated (Sodium),0,0,1,1,0
1300,2675,2628,ERF_CR_LGIC_binding_hGABRA1,1,1,"Data from the assay component ERF_CR_LGIC_binding_hGABRA1 was analyzed at the assay endpoint, ERF_CR_LGIC_binding_hGABRA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene GABRA1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated.",binding,percent_activity,0,muscimol,gain,protein,transporter,ion channel,ligand-gated ion channel,0,0,1,2,0
1301,2676,2629,ERF_CR_LGIC_binding_rGLRA1,1,1,"Data from the assay component ERF_CR_LGIC_binding_rGLRA1 was analyzed at the assay endpoint, ERF_CR_LGIC_binding_rGLRA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene GLRA1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated (glycine).",binding,percent_activity,0,strychnine,loss,protein,transporter,ion channel,ligand-gated (glycine),0,0,1,1,0
1302,2677,2630,ERF_CR_LGIC_binding_rGRIA1,1,1,"Data from the assay component ERF_CR_LGIC_binding_rGRIA1 was analyzed at the assay endpoint, ERF_CR_LGIC_binding_rGRIA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene GRIA1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated (glutamate, Ionotropic).",binding,percent_activity,0,L-Glutamate,loss,protein,transporter,ion channel,"ligand-gated (glutamate, Ionotropic)",0,0,1,1,0
1303,2678,2631,ERF_CR_LGIC_binding_rGRIK1,1,1,"Data from the assay component ERF_CR_LGIC_binding_rGRIK1 was analyzed at the assay endpoint, ERF_CR_LGIC_binding_rGRIK1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene GRIK1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated (glutamate, Ionotropic).",binding,percent_activity,0,kainic acid,loss,protein,transporter,ion channel,"ligand-gated (glutamate, Ionotropic)",0,0,1,2,0
1304,2679,2632,ERF_PL_LGIC_binding_rGRIN1,1,1,"Data from the assay component ERF_PL_LGIC_binding_rGRIN1 was analyzed at the assay endpoint, ERF_PL_LGIC_binding_rGRIN1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene GRIN1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is ligand-gated (glutamate, Ionotropic).",binding,percent_activity,0,NA,loss,protein,transporter,ion channel,"ligand-gated (glutamate, Ionotropic)",0,0,1,1,0
1305,2680,2633,ERF_CR_MP_binding_hTSPO,1,1,"Data from the assay component ERF_CR_MP_binding_hTSPO was analyzed at the assay endpoint, ERF_CR_MP_binding_hTSPO, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene TSPO. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the membrane protein intended target family, where the subfamily is mitochondrial associated translocator protein.",binding,percent_activity,0,PK 11195,loss,protein,receptor,membrane protein,mitochondrial associated translocator protein,0,0,1,3,0
1306,2681,2634,ERF_PL_NR_binding_hAR,1,1,"Data from the assay component ERF_PL_NR_binding_hAR was analyzed at the assay endpoint, ERF_PL_NR_binding_hAR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in radioligand binding as they relate to gene AR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is androgens.",radioligand binding,percent_activity,0,testosterone,gain,protein,receptor,nuclear receptor,androgens,0,0,1,4,0
1307,2682,2635,ERF_PL_NR_COA_hFXR_Antagonist,1,1,"Data from the assay component ERF_PL_NR_COA_hFXR_Antagonist was analyzed at the assay endpoint, ERF_PL_NR_COA_hFXR_Antagonist, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene NR1H4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is liver X receptor.",binding,percent_activity,0,Z-Guggulsterone,loss,protein,receptor,nuclear receptor,liver X receptor,0,0,1,1,0
1308,2683,2636,ERF_CR_NR_binding_hGR,1,1,"Data from the assay component ERF_CR_NR_binding_hGR was analyzed at the assay endpoint, ERF_CR_NR_binding_hGR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene NR3C1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,triamcinolone,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,2,0
1309,2684,2637,ERF_PL_NR_binding_hHTR2C,1,1,"Data from the assay component ERF_PL_NR_binding_hHTR2C was analyzed at the assay endpoint, ERF_PL_NR_binding_hHTR2C, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene HTR2C. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is serotonin.",binding,percent_activity,0,SB 242084,loss,protein,receptor,gpcr,serotonin,0,0,1,2,0
1310,2685,2638,ERF_CR_NR_binding_hPGR,1,1,"Data from the assay component ERF_CR_NR_binding_hPGR was analyzed at the assay endpoint, ERF_CR_NR_binding_hPGR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene PGR. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,promegestone,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,1,0
1311,2686,2639,ERF_CR_NR_binding_hPPARA,1,1,"Data from the assay component ERF_CR_NR_binding_hPPARA was analyzed at the assay endpoint, ERF_CR_NR_binding_hPPARA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene PPARA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW 7647,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,1,0
1312,2687,2640,ERF_CR_NR_binding_hPPARG,1,1,"Data from the assay component ERF_CR_NR_binding_hPPARG was analyzed at the assay endpoint, ERF_CR_NR_binding_hPPARG, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in binding as they relate to gene PPARG. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,rosiglitazone,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,1,0
1313,2688,2641,ERF_PL_NR_binding_hRARa,1,1,"Data from the assay component ERF_PL_NR_binding_hRARa was analyzed at the assay endpoint, ERF_PL_NR_binding_hRARa, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in radioligand binding as they relate to gene RARA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is retinoic acid receptor.",binding,percent_activity,0,9-cis-Retinoic acid,gain,protein,receptor,nuclear receptor,retinoic acid receptor,0,0,1,2,0
1314,2689,2642,ERF_PL_NR_COA_hTHRA,1,1,"Data from the assay component ERF_PL_NR_COA_hTHRA_Agonist was analyzed at the assay endpoint, ERF_PL_NR_COA_hTHRA_Agonist, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of agonist, gain-of-signal activity can be used to understand changes in protein-protein interaction as they relate to gene THRA. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",agonist,percent_activity,0,NA,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,3,0
1315,2690,2643,ERF_PL_NR_binding_rI2,1,1,"Data from the assay component ERF_PL_NR_binding_rI2 was analyzed at the assay endpoint, ERF_PL_NR_binding_rI2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in radioligand binding as they relate to gene NISCH (homolog). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is imidazoline receptor.",binding,percent_activity,0,idazoxan,loss,protein,receptor,oxidoreductase,imidazoline receptor,0,0,1,1,0
1316,2691,2644,ERF_PL_TR_binding_hSLC35B3,1,1,"Data from the assay component ERF_PL_TR_binding_hSLC35B3 was analyzed at the assay endpoint, ERF_PL_TR_binding_hSLC35B3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in transporter binding as they relate to gene SLC29A1. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is nucleoside transporter.",binding,percent_activity,0,nitrobenzylthioinosine,loss,protein,transporter,transporter,nucleoside transporter,0,0,1,4,0
1317,2692,2645,ERF_CR_TR_binding_hSLC6A2,1,1,"Data from the assay component ERF_CR_TR_binding_hSLC6A2 was analyzed at the assay endpoint, ERF_CR_TR_binding_hSLC6A2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene SLC6A2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is SLC6 / Monoamine.",binding,percent_activity,0,protriptyline,loss,protein,transporter,transporter,SLC6 / Monoamine,0,0,1,4,0
1318,2693,2646,ERF_CR_TR_binding_hSLC6A3,1,1,"Data from the assay component ERF_CR_TR_binding_hSLC6A3 was analyzed at the assay endpoint, ERF_CR_TR_binding_hSLC6A3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in binding as they relate to gene SLC6A3. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is SLC6 / Monoamine.",binding,percent_activity,0,BTCP,loss,protein,transporter,transporter,SLC6 / Monoamine,0,0,1,3,0
1319,2694,2647,ERF_CR_TR_binding_hSLC6A4,1,1,"Data from the assay component ERF_CR_TR_binding_hSLC6A4 was analyzed at the assay endpoint, ERF_CR_TR_binding_hSLC6A4, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene SLC6A4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is SLC6 / Monoamine.",binding,percent_activity,0,imipramine,loss,protein,transporter,transporter,SLC6 / Monoamine,0,0,1,4,0
1320,2695,2648,ERF_PL_TR_binding_rSLC18A2,1,1,"Data from the assay component ERF_PL_TR_binding_rSLC18A2 was analyzed at the assay endpoint, ERF_PL_TR_binding_rSLC18A2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in transporter binding as they relate to gene SLC18A2. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is vesicular transporter.",binding,percent_activity,0,tetrabenazine,loss,protein,transporter,transporter,vesicular transporter,0,0,1,3,0
1321,2696,2649,ERF_PL_TR_binding_rTSPO,1,1,"Data from the assay component ERF_PL_TR_binding_rTSPO was analyzed at the assay endpoint, ERF_PL_TR_binding_rTSPO, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand changes in transporter binding as they relate to gene TSPO. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is cholesterol transporter.",binding,percent_activity,0,diazepam,loss,protein,transporter,transporter,cholesterol transporter,0,0,1,3,0
1322,2697,2650,UKN2_HCS_IMR90_neural_migration,1,1,"The assay endpoint UKN2_HCS_IMR90_neural_migration was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neural crest cell migration.",developmental,percent_activity,0,Cytochalasin D,bidirectional,cellular,cellular,neurodevelopment,neural crest cell migration,0,0,1,71,2005
1323,2699,2651,UKN2_HCS_IMR90_cell_viability,1,1,"The assay endpoint UKN2_HCS_IMR90_cell_viability was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand viability effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is viability.",viability,percent_activity,0,NA,bidirectional,cellular,nucleus,cell cycle,viability,0,1,1,71,2005
1324,2701,2652,UKN4_HCS_LUHMES_neurite_outgrowth,1,1,"The assay endpoint UKN4_HCS_LUHMES_neurite_outgrowth was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,percent_activity,0,Narciclasine,bidirectional,cellular,cellular,neurodevelopment,neurite outgrowth,0,0,1,76,2666
1325,2703,2653,UKN4_HCS_LUHMES_cell_viability,1,1,"The assay endpoint UKN4_HCS_LUHMES_cell_viability was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand viability effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is viability.",viability,percent_activity,0,NA,bidirectional,cellular,nucleus,cell cycle,viability,0,1,1,76,2666
1326,2705,2654,ERF_PL_NR_binding_hPPARG,1,1,"Data from the assay component ERF_PL_NR_binding_hPPARG was analyzed at the assay endpoint, ERF_PL_NR_binding_hPPARG, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding receptor, gain-of-signal activity can be used to understand changes in binding receptor as they relate to gene PPARG.To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Rosiglitazone,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,6,10
1327,2731,2667,TAMU_HCS_1.5hr_SingleDonor1434_Cytotoxicity,1,1,"Data from the assay component  TAMU_HCS_1.5hr_Cytotoxicity was analyzed into 1 assay endpoint. This assay endpoint,  TAMU_HCS_1.5hr_Cytotoxicity, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,NA,loss,cellular,nucleus,cell cycle,cytotoxicity,0,1,1,95,392
1328,2760,2682,TAMU_PeakParms_SingleDonor1434_QT,1,1,"Data from the assay component TAMU_PeakParms_SingleDonor1434_QT was analyzed into 1 assay endpoints. This assay endpoint, TAMU_PeakParms_SingleDonor1434_QT_Prolongation, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain-of-signal activity can be used to understand changes in the cardiac function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cardiomyocyte function intended target family, where the subfamily is QT interval.",cardiac function,percent_activity,0,NA,gain,extracellular,action potential ,cardiomyocyte function,QT interval,0,0,1,95,324
1329,2767,2685,TAMU_PeakParms_SingleDonor1434_Chronotropy,1,1,"Data from the assay component TAMU_PeakParms_SingleDonor1434_Chronotropy was analyzed into 1 assay endpoint. This assay endpoint, TAMU_PeakParms_SingleDonor1434_Chronotropy_Negative, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand changes in the cardiac function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cardiomyocyte function intended target family, where the subfamily is lowered beat rate.",cardiac function,percent_activity,0,NA,bidirectional,extracellular,action potential ,cardiomyocyte function,lowered beat rate,0,0,1,95,323
1330,2771,2687,IUF_NPC1b_proliferation_BrdU_72hr,1,1,"Data from the IUF_NPC1b_proliferation_BrdU component was analyzed at the endpoint IUF_NPC1b_proliferation_BrdU in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, gain or loss-of-signal activity can be used to understand cell proliferation effects.",cell proliferation,percent_activity,0,media without growth factors,bidirectional,dna,dna-unspecified,cell cycle,proliferation,1,0,1,124,5652
1331,2773,2688,IUF_NPC1a_proliferation_area_72hr,1,1,"Data from the IUF_NPC1a_proliferation_area component was analyzed at the endpoint IUF_NPC1a_proliferation_area in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, gain or loss-of-signal activity can be used to understand cell proliferation effects.",cell proliferation,percent_activity,0,media without growth factors,bidirectional,cellular,sphere size,cell cycle,proliferation,1,0,1,118,3536
1332,2775,2689,IUF_NPC1_viability_72hr,1,1,"Data from the IUF_NPC1_viability component was analyzed at the endpoint IUF_NPC1_viability in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand viability effects.",viability,percent_activity,0,lysed cells,bidirectional,cellular,mitochondria,cell cycle,viability,1,1,1,124,9661
1333,2776,2690,ERF_PL_NR_COA_hFXR_Agonist,1,1,"Data from the assay component ERF_PL_NR_COA_hFXR_Agonist was analyzed at the assay endpoint, ERF_PL_NR_COA_hFXR_Agonist, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain-of-signal activity can be used to understand changes in enzymatic activity as they relate to gene NR1H4. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is liver X receptor.",binding,percent_activity,0,CDCA,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,0,0
1334,2777,2699,CCTE_Mundy_HCI_Cortical_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,152,601
1335,2778,2698,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,152,601
1336,2779,2697,CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,180,676
1337,2780,2696,CCTE_Mundy_HCI_Cortical_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,180,674
1338,2781,2707,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,151,264
1339,2782,2702,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339
1340,2783,2706,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,151,264
1341,2784,2705,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339
1342,2785,2704,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339
1343,2786,2703,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339
1344,2787,2701,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339
1345,2788,2708,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339
1346,2789,2695,CCTE_Mundy_HCI_hN2_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects. This assay component endpoint is considered less reliable by experts on the assay due to low occurrence of branch points in the hN2 cells. Use data with caution.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,83,108
1347,2790,2694,CCTE_Mundy_HCI_hN2_NOG_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,83,108
1348,2791,2693,CCTE_Mundy_HCI_hN2_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,85,117
1349,2792,2692,CCTE_Mundy_HCI_hN2_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,85,117
1350,2793,2691,CCTE_Mundy_HCI_hNP1_Casp3_7,1,1,"Data from the assay component CCTE_Mundy_HCI_hNP1_Casp3_7 was analyzed at the endpoint CCTE_Mundy_HCI_hNP1_Casp3_7_gain in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain -of-signal activity can be used to understand viability effects.",viability,percent_activity,0,staurosporine (0.1 uM),gain,cellular,cellular,cell cycle,apoptosis,0,0,1,229,1219
1351,2794,2700,CCTE_Mundy_HCI_hNP1_CellTiter,1,1,"Data from the assay component CCTE_Mundy_HCI_hNP1_CellTiter was analyzed at the endpoint CCTE_Mundy_HCI_hNP1_CellTiter in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss -of-signal activity can be used to understand viability effects.",viability,percent_activity,0,staurosporine (0.1 uM),loss,cellular,cell count,cell cycle,cell count,0,0,1,202,1087
1352,2797,2710,CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten,1,1,"Data from the assay component CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten was analyzed at the endpoint CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, loss -of-signal activity can be used to understand viability effects.",viability,percent_activity,0,aphidicolin (10uM),loss,cellular,cellular,cell cycle,proliferation,0,0,1,230,1059
1353,2808,2717,UTOR_hL-FABP_binding_Kd,1,1,"Data from the assay component UTOR_hL-FABP_binding was analyzed into 1 assay endpoint. This assay enddpoint, UTOR_hL-FABP_binding_Kd, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, measures of fluorescence for loss-of-signal activity can be used to understand competitive binding of L-FABP. Furthermore, this assay endpoint can be referred to as the primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is fatty acid binding protein.",binding,percent_activity,0,"1,8-ANS",loss,protein,transporter,transporter,fatty acid binding protein,0,0,1,0,0
1354,2809,1068,BSK_BT_Bcell_Proliferation,1,1,"Data from the assay component BSK_BT_Bcell_Proliferation  was analyzed at the endpoint, BSK_BT_Bcell_Proliferation, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand cellular changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell cycle' intended target family, where the subfamily is 'proliferation'.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,577,0
1355,2811,1069,BSK_BT_PBMCCytotoxicity,1,1,"Data from the assay component BSK_BT_PBMCCytotoxicity  was analyzed at the endpoint, BSK_BT_PBMCCytotoxicity, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand cellular changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell cycle' intended target family, where the subfamily is 'cytotoxicity'.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,cytotoxicity,0,1,1,577,0
1356,2813,1070,BSK_BT_sIgG,1,1,"Data from the assay component BSK_BT_sIgG was analyzed at the endpoint, BSK_BT_sIgG, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'immunoglobulin' intended target family, where the subfamily is 'IgG'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,immunoglobulin,IgG,0,0,1,577,0
1357,2815,1071,BSK_BT_xIL17A,1,1,"Data from the assay component BSK_BT_xIL17A was analyzed at the endpoint, BSK_BT_xIL17A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0
1358,2817,1072,BSK_BT_xIL17F,1,1,"Data from the assay component BSK_BT_xIL17F was analyzed at the endpoint, BSK_BT_xIL17F, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0
1359,2819,1073,BSK_BT_xIL2,1,1,"Data from the assay component BSK_BT_xIL2 was analyzed at the endpoint, BSK_BT_xIL2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0
1360,2821,1074,BSK_BT_xIL6,1,1,"Data from the assay component BSK_BT_xIL6 was analyzed at the endpoint, BSK_BT_xIL6, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0
1361,2823,1075,BSK_BT_xTNFa,1,1,"Data from the assay component BSK_BT_xTNFa was analyzed at the endpoint, BSK_BT_xTNFa, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,577,0
1362,2825,1081,BSK_MyoF_ACTA1,1,1,"Data from the assay component BSK_MyoF_ACTA1 was analyzed at the endpoint, BSK_MyoF_ACTA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'actin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,actin,0,0,1,577,0
1363,2827,1082,BSK_MyoF_bFGF,1,1,"Data from the assay component BSK_MyoF_bFGF was analyzed at the endpoint, BSK_MyoF_bFGF, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'growth factor' intended target family, where the subfamily is 'basic fibroblast growth factor '.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,growth factor,basic fibroblast growth factor ,0,0,1,577,0
1364,2829,1083,BSK_MyoF_VCAM1,1,1,"Data from the assay component BSK_MyoF_VCAM1 was analyzed at the endpoint, BSK_MyoF_VCAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,577,0
1365,2831,1084,BSK_MyoF_CollagenI,1,1,"Data from the assay component BSK_MyoF_CollagenI was analyzed at the endpoint, BSK_MyoF_CollagenI, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,577,0
1366,2833,1085,BSK_MyoF_CollagenIII,1,1,"Data from the assay component BSK_MyoF_CollagenIII was analyzed at the endpoint, BSK_MyoF_CollagenIII, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,577,0
1367,2835,1086,BSK_MyoF_CollagenIV,1,1,"Data from the assay component BSK_MyoF_CollagenIV was analyzed at the endpoint, BSK_MyoF_CollagenIV, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,577,0
1368,2837,1087,BSK_MyoF_IL8,1,1,"Data from the assay component BSK_MyoF_IL8 was analyzed at the endpoint, BSK_MyoF_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0
1369,2839,1088,BSK_MyoF_Decorin,1,1,"Data from the assay component BSK_MyoF_Decorin was analyzed at the endpoint, BSK_MyoF_Decorin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'decorin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,decorin,0,0,1,577,0
1370,2841,1089,BSK_MyoF_MMP1,1,1,"Data from the assay component BSK_MyoF_MMP1 was analyzed at the endpoint, BSK_MyoF_MMP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,577,0
1371,2843,1090,BSK_MyoF_PAI1,1,1,"Data from the assay component BSK_MyoF_PAI1 was analyzed at the endpoint, BSK_MyoF_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,577,0
1372,2845,1091,BSK_MyoF_SRB,1,1,"Data from the assay component BSK_MyoF_SRB was analyzed at the endpoint, BSK_MyoF_SRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,577,0
1373,2847,1092,BSK_MyoF_TIMP1,1,1,"Data from the assay component BSK_MyoF_TIMP1 was analyzed at the endpoint, BSK_MyoF_TIMP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,577,0
1374,2849,2719,BSK_BF4T_MCP1,1,1,"Data from the assay component BSK_BF4T_MCP1 was analyzed at the endpoint, BSK_BF4T_MCP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,164,0
1375,2851,2720,BSK_BF4T_Eotaxin3,1,1,"Data from the assay component BSK_BF4T_Eotaxin3 was analyzed at the endpoint, BSK_BF4T_Eotaxin3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,164,0
1376,2853,2721,BSK_BF4T_VCAM1,1,1,"Data from the assay component BSK_BF4T_VCAM1 was analyzed at the endpoint, BSK_BF4T_VCAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,164,0
1377,2855,2722,BSK_BF4T_ICAM1,1,1,"Data from the assay component BSK_BF4T_ICAM1 was analyzed at the endpoint, BSK_BF4T_ICAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,164,0
1378,2857,2723,BSK_BF4T_CD90,1,1,"Data from the assay component BSK_BF4T_CD90 was analyzed at the endpoint, BSK_BF4T_CD90, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0
1379,2859,2724,BSK_BF4T_IL8,1,1,"Data from the assay component BSK_BF4T_IL8 was analyzed at the endpoint, BSK_BF4T_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0
1380,2861,2725,BSK_BF4T_IL1a,1,1,"Data from the assay component BSK_BF4T_IL1a was analyzed at the endpoint, BSK_BF4T_IL1a, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0
1381,2863,2726,BSK_BF4T_Keratin818,1,1,"Data from the assay component BSK_BF4T_Keratin818 was analyzed at the endpoint, BSK_BF4T_Keratin818, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'keratin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,keratin,0,0,1,164,0
1382,2865,2727,BSK_BF4T_MMP1,1,1,"Data from the assay component BSK_BF4T_MMP1 was analyzed at the endpoint, BSK_BF4T_MMP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,164,0
1383,2867,2728,BSK_BF4T_MMP3,1,1,"Data from the assay component BSK_BF4T_MMP3 was analyzed at the endpoint, BSK_BF4T_MMP3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,164,0
1384,2869,2729,BSK_BF4T_MMP9,1,1,"Data from the assay component BSK_BF4T_MMP9 was analyzed at the endpoint, BSK_BF4T_MMP9, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,164,0
1385,2871,2730,BSK_BF4T_PAI1,1,1,"Data from the assay component BSK_BF4T_PAI1 was analyzed at the endpoint, BSK_BF4T_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,164,0
1386,2873,2731,BSK_BF4T_SRB,1,1,"Data from the assay component BSK_BF4T_SRB  was analyzed at the endpoint, BSK_BF4T_SRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,164,0
1387,2875,2732,BSK_BF4T_tPA,1,1,"Data from the assay component BSK_BF4T_tPA was analyzed at the endpoint, BSK_BF4T_tPA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'serine protease'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,164,0
1388,2877,2733,BSK_BF4T_uPA,1,1,"Data from the assay component BSK_BF4TA was analyzed at the endpoint, BSK_BF4TA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'serine protease'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,164,0
1389,2879,2734,BSK_BE3C_ICAM1,1,1,"Data from the assay component BSK_BE3C_ICAM1 was analyzed at the endpoint, BSK_BE3C_ICAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,238,0
1390,2881,2735,BSK_BE3C_ITAC,1,1,"Data from the assay component BSK_BE3C_ITAC was analyzed at the endpoint, BSK_BE3C_ITAC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0
1391,2883,2736,BSK_BE3C_IL8,1,1,"Data from the assay component BSK_BE3C_IL8 was analyzed at the endpoint, BSK_BE3C_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,238,0
1392,2885,2737,BSK_BE3C_EGFR,1,1,"Data from the assay component BSK_BE3C_EGFR was analyzed at the endpoint, BSK_BE3C_EGFR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'kinase' intended target family, where the subfamily is 'receptor tyrosine kinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,238,0
1393,2887,2738,BSK_BE3C_Keratin818,1,1,"Data from the assay component BSK_BE3C_Keratin818 was analyzed at the endpoint, BSK_BE3C_Keratin818, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'keratin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,keratin,0,0,1,238,0
1394,2889,2739,BSK_BE3C_MMP9,1,1,"Data from the assay component BSK_BE3C_MMP9 was analyzed at the endpoint, BSK_BE3C_MMP9, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,238,0
1395,2891,2740,BSK_CASM3C_PAI1,1,1,"Data from the assay component BSK_CASM3C_PAI1 was analyzed at the endpoint, BSK_CASM3C_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,238,0
1396,2893,2741,BSK_hDFCGF_MCP1,1,1,"Data from the assay component BSK_hDFCGF_MCP1 was analyzed at the endpoint, BSK_hDFCGF_MCP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0
1397,2895,2742,BSK_hDFCGF_ICAM1,1,1,"Data from the assay component BSK_hDFCGF_ICAM1 was analyzed at the endpoint, BSK_hDFCGF_ICAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,238,0
1398,2897,2743,BSK_hDFCGF_CollagenI,1,1,"Data from the assay component BSK_hDFCGF_CollagenI was analyzed at the endpoint, BSK_hDFCGF_CollagenI, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,238,0
1399,2899,2744,BSK_hDFCGF_ITAC,1,1,"Data from the assay component BSK_hDFCGF_ITAC was analyzed at the endpoint, BSK_hDFCGF_ITAC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0
1400,2901,2745,BSK_hDFCGF_TIMP2,1,1,"Data from the assay component BSK_hDFCGF_TIMP2 was analyzed at the endpoint, BSK_hDFCGF_TIMP2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,238,0
1401,2903,2746,BSK_KF3CT_IL8,1,1,"Data from the assay component BSK_KF3CT_IL8 was analyzed at the endpoint, BSK_KF3CT_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,238,0
1402,2905,2747,BSK_KF3CT_MIG,1,1,"Data from the assay component BSK_KF3CT_MIG was analyzed at the endpoint, BSK_KF3CT_MIG, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0
1403,2907,2748,BSK_KF3CT_PAI1,1,1,"Data from the assay component BSK_KF3CT_PAI1 was analyzed at the endpoint, BSK_KF3CT_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,238,0
1404,2909,2749,BSK_IMphg_MCP1,1,1,"Data from the assay component BSK_IMphg_MCP1 was analyzed at the endpoint, BSK_IMphg_MCP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,164,0
1405,2911,2750,BSK_IMphg_MIP1a,1,1,"Data from the assay component BSK_IMphg_MIP1a was analyzed at the endpoint, BSK_IMphg_MIP1a, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0
1406,2913,2751,BSK_IMphg_VCAM1,1,1,"Data from the assay component BSK_IMphg_VCAM1 was analyzed at the endpoint, BSK_IMphg_VCAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,164,0
1407,2915,2752,BSK_IMphg_CD40,1,1,"Data from the assay component BSK_IMphg_CD40 was analyzed at the endpoint, BSK_IMphg_CD40, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0
1408,2917,2753,BSK_IMphg_ESelectin,1,1,"Data from the assay component BSK_IMphg_ESelectin was analyzed at the endpoint, BSK_IMphg_ESelectin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'selectins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,164,0
1409,2919,2754,BSK_IMphg_CD69,1,1,"Data from the assay component BSK_IMphg_CD69 was analyzed at the endpoint, BSK_IMphg_CD69, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0
1410,2921,2755,BSK_IMphg_IL8,1,1,"Data from the assay component BSK_IMphg_IL8 was analyzed at the endpoint, BSK_IMphg_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0
1411,2923,2756,BSK_IMphg_IL1a,1,1,"Data from the assay component BSK_IMphg_IL1a was analyzed at the endpoint, BSK_IMphg_IL1a, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0
1412,2925,2757,BSK_IMphg_MCSF,1,1,"Data from the assay component BSK_IMphg_MCSF was analyzed at the endpoint, BSK_IMphg_MCSF, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'colony stimulating factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,164,0
1413,2927,2758,BSK_IMphg_IL10,1,1,"Data from the assay component BSK_IMphg_IL10 was analyzed at the endpoint, BSK_IMphg_IL10, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0
1414,2929,2759,BSK_IMphg_SRB,1,1,"Data from the assay component BSK_IMphg_SRB  was analyzed at the endpoint, BSK_IMphg_SRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,164,0
1415,2931,2760,BSK_IMphg_SRB.Mphg,1,1,"Data from the assay component BSK_IMphg_SRB.Mphg  was analyzed at the endpoint, BSK_IMphg_SRB.Mphg, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,164,0
1416,2933,2761,BSK_LPS_Thrombomodulin,1,1,"Data from the assay component BSK_LPS_Thrombodulin was analyzed at the endpoint, BSK_LPS_Thrombomodulin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'gpcr' intended target family, where the subfamily is 'rhodopsin-like receptor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,238,0
1417,2935,2762,BSK_LPS_CD69,1,1,"Data from the assay component BSK_LPS_CD69 was analyzed at the endpoint, BSK_LPS_CD69, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,238,0
1418,2938,2763,IUF_NPC2a_radial_glia_migration_72hr,1,1,"Data from the IUF_NPC2a_radial_glia_migration_72hr component was analyzed at the endpoint IUF_NPC2a_radial_glia_migration_72hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of migration reporter, gain or loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,SRC kinase inhibitor PP2,bidirectional,cellular,cellular,neurodevelopment,neural progenitor cell migration,1,0,1,124,2240
1419,2940,2764,IUF_NPC2a_radial_glia_migration_120hr,1,1,"Data from the IUF_NPC2a_radial_glia_migration_120hr component was analyzed at the endpoint IUF_NPC2a_ radial_glia_migration_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of migration reporter, gain or loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,NA,bidirectional,cellular,cellular,neurodevelopment,neural progenitor cell migration,1,0,1,124,2163
1420,2942,2765,IUF_NPC2b_neuronal_migration_120hr,1,1,"Data from the IUF_NPC2b_neuronal_migration_120hr component was analyzed at the endpoint IUF_NPC2b_neuronal_migration_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of migration reporter, gain or loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,NA,bidirectional,cellular,cellular,neurodevelopment,neural progenitor cell migration,1,0,1,124,2066
1421,2944,2766,IUF_NPC2c_oligodendrocyte_migration_120hr,1,1,"Data from the IUF_NPC2c_oligodendrocyte_migration_120hr component was analyzed at the endpoint IUF_NPC2c_oligodendrocyte_migration_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of migration reporter, gain or loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,NA,bidirectional,cellular,cellular,neurodevelopment,neural progenitor cell migration,1,0,1,124,2018
1422,2946,2767,IUF_NPC3_neuronal_differentiation_120hr,1,1,"Data from the IUF_NPC3_neuronal_differentiation_120hr component was analyzed at the endpoint IUF_NPC3_neuronal_differentiation_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of differentiation reporter, gain or loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,EGF,bidirectional,cellular,cellular,neurodevelopment,neural progenitor differentiation,1,0,1,124,2069
1423,2948,2768,IUF_NPC4_neurite_length_120hr,1,1,"Data from the IUF_NPC4_neurite_length_120hr component was analyzed at the endpoint IUF_NPC4_neurite_length_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of differentiation reporter, gain or loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,NA,bidirectional,cellular,cellular,neurodevelopment,neural progenitor differentiation,1,0,1,124,2039
1424,2950,2769,IUF_NPC4_neurite_area_120hr,1,1,"Data from the IUF_NPC4_neurite_area_120hr component was analyzed at the endpoint IUF_NPC4_neurite_area_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of differentiation reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,NA,loss,cellular,cellular,neurodevelopment,neural progenitor differentiation,1,0,1,124,2038
1425,2952,2770,IUF_NPC5_oligodendrocyte_differentiation_120hr,1,1,"Data from the IUF_NPC5_oligodendrocyte_differentiation_120hr component was analyzed at the endpoint IUF_NPC5_oligodendrocyte_differentiation_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of differentiation reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,BMP7,loss,cellular,cellular,neurodevelopment,neural progenitor differentiation,1,0,1,124,2009
1426,2954,2771,IUF_NPC2-5_cytotoxicity_72hr,1,1,"Data from the IUF_NPC2-5_cytotoxicity_72hr component was analyzed at the endpoint IUF_NPC2-5_cytotoxicity_72hr in the positive analysis fitting direction relative to the dynamic range and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to understand cytotoxicity effects.",cytotoxicity,percent_activity,0,lysed cells,loss,cellular,enzyme activity,cell cycle,cytotoxicity,1,0,1,124,6700
1427,2956,2772,IUF_NPC2-5_cytotoxicity_120hr,1,1,"Data from the IUF_NPC2-5_cytotoxicity_120hr component was analyzed at the endpoint IUF_NPC2-5_cytotoxicity_120hr in the positive analysis fitting direction relative to the dynamic range and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to understand cytotoxicity effects.",cytotoxicity,percent_activity,0,lysed cells,loss,cellular,enzyme activity,cell cycle,cytotoxicity,1,0,1,123,6503
1428,2958,2773,IUF_NPC2-5_cell_number_120hr,1,1,"Data from the IUF_NPC2-5_cell_number_120hr component was analyzed at the endpoint IUF_NPC2-5_cell_number_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand viability effects.",viability,percent_activity,0,EGF,bidirectional,cellular,cell count,cell cycle,viability,1,1,1,124,2164
1429,2960,2774,IUF-NPC2-5_viability_120hr,1,1,"Data from the IUF_NPC2-5_viability_120hr component was analyzed at the endpoint IUF-NPC2-5_viability_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand viability effects.",viability,percent_activity,0,lysed cells,bidirectional,cellular,mitochondria,cell cycle,viability,1,1,1,124,6692
1430,3019,2805,VALA_TUBHUV_Agonist_CellCount,1,1,"Data from the assay component VALA_TUBHUV_Agonist_CellCount was analyzed at the endpoint, VALA_TUBHUV_Agonist_CellCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cell count.",viability,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,1,1,47,277
1431,3020,2806,VALA_TUBHUV_Agonist_TubuleLength,1,1,"Data from the assay component VALA_TUBHUV_Agonist_TubuleLength was analyzed at the endpoint, VALA_TUBHUV_Agonist_TubuleLength, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is tubulogenesis.",developmental,percent_activity,0,suramin,gain,cellular,morphology,neurodevelopment,tubulogenesis,0,0,1,47,344
1432,3021,2807,VALA_TUBHUV_Antagonist_CellCount,1,1,"Data from the assay component VALA_TUBHUV_Antagonist_CellCount was analyzed at the endpoint, VALA_TUBHUV_Antagonist_CellCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cell count.",viability,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,1,1,47,330
1433,3022,2808,VALA_TUBHUV_Antagonist_TubuleLength,1,1,"Data from the assay component VALA_TUBHUV_Antagonist_TubuleLength was analyzed at the endpoint, VALA_TUBHUV_Antagonist_TubuleLength, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is tubulogenesis.",developmental,percent_activity,0,suramin,loss,cellular,morphology,neurodevelopment,tubulogenesis,0,0,1,47,336
1434,3023,2809,VALA_TUBIPS_Agonist_CellCount,1,1,"Data from the assay component VALA_TUBIPS_Agonist_CellCount was analyzed at the endpoint, VALA_TUBIPS_Agonist_CellCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cell count.",viability,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,1,1,47,342
1435,3024,2810,VALA_TUBIPS_Agonist_TubuleLength,1,1,"Data from the assay component VALA_TUBIPS_Agonist_TubuleLength was analyzed at the endpoint, VALA_TUBIPS_Agonist_TubuleLength, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is tubulogenesis.",developmental,percent_activity,0,suramin,gain,cellular,morphology,neurodevelopment,tubulogenesis,0,0,1,47,321
1436,3025,2811,VALA_TUBIPS_Antagonist_CellCount,1,1,"Data from the assay component VALA_TUBIPS_Antagonist_CellCount was analyzed at the endpoint, VALA_TUBIPS_Antagonist_CellCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cell count.",viability,log2_fold_induction,0,NA,loss,cellular,nucleus,cell cycle,cell count,0,1,1,47,339
1437,3026,2812,VALA_TUBIPS_Antagonist_TubuleLength,1,1,"Data from the assay component VALA_TUBIPS_Antagonist_TubuleLength was analyzed at the endpoint, VALA_TUBIPS_Antagonist_TubuleLength, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is tubulogenesis.",developmental,percent_activity,0,suramin,loss,cellular,morphology,neurodevelopment,tubulogenesis,0,0,1,47,371
1438,3027,2813,VALA_MIGHUV1_ScratchOnly_CellCount,1,1,"Data from the assay component VALA_MIGHUV1_ScratchOnly_CellCount was analyzed at the endpoint, VALA_MIGHUV1_ScratchOnly_CellCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cell count.",viability,log2_fold_induction,0,BIO-acetoxime,loss,cellular,nucleus,cell cycle,cell count,0,1,1,47,372
1439,3028,2814,VALA_MIGHUV1_ScratchOnly_WoundArea,1,1,"Data from the assay component VALA_MIGHUV1_ScratchOnly_WoundArea was analyzed at the endpoint, VALA_MIGHUV1_ScratchOnly_WoundArea, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is migration.",developmental,percent_activity,0,cytochalasin D,gain,cellular,migration,neurodevelopment,migration,0,0,1,47,380
1440,3029,2815,VALA_MIGHUV2_CellCount,1,1,"Data from the assay component VALA_MIGHUV2_CellCount was analyzed at the endpoint, VALA_MIGHUV2_CellCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cell count.",viability,log2_fold_induction,0,BIO-acetoxime,loss,cellular,nucleus,cell cycle,cell count,0,1,1,47,324
1441,3030,2816,VALA_MIGHUV2_Bcatenin,1,1,"Data from the assay component VALA_MIGHUV2_BCatenin was analyzed at the endpoint, VALA_MIGHUV2_BCatenin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is migration.",developmental,percent_activity,0,cytochalasin D,gain,cellular,migration,neurodevelopment,migration,0,0,1,47,314
1442,3031,2817,VALA_MIGHUV2_WoundArea,1,1,"Data from the assay component VALA_MIGHUV2_WoundArea was analyzed at the endpoint, VALA_MIGHUV2_WoundArea, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is migration.",developmental,percent_activity,0,cytochalasin D,gain,cellular,migration,neurodevelopment,migration,0,0,1,47,348
1443,3032,2818,CCTE_GLTED_hIYD,1,1,"Data from the assay component CCTE_GLTED_hIYD was analyzed at the assay endpoint CCTE_GLTED_hIYD in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand iodotyrosine deiodinase activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'dehalogenase' intended target family, where the subfamily is 'iodotyrosine deiodinase'.",enzymatic activity,percent_activity,0,3-Nitro-L-tyrosine (0.05 M NaOH for model inhibitor (MNT)),loss,protein,enzyme,dehalogenase,iodotyrosine deiodinase,0,0,1,167,318
1444,3067,2836,CCTE_Mundy_HCI_iCellGluta_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. This assay endpoint is considered less reliable by experts on the assay due to low occurrence of branch points in the iCell GlutaNeurons. Use data with caution.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,140,974
1445,3068,2837,CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,140,974
1446,3069,2838,CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,140,974
1447,3070,2839,CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,cytotoxicity,0,0,1,140,974
1448,3072,2841,CCTE_Deisenroth_5AR_NBTE_autofluor,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_autofluor was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Deisenroth_5AR NBTE_autofluor, was analyzed with bidirectional fitting relative to median test wells for the baseline of activity. Using a type of background reporter, gain-of-signal activity can be used to understand autofluorescence. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves an artifact detection function.",background control,log2_fold_induction,0,Tracer Fluorogenic Probe,gain,chemical,physical feature,background measurement,artifact fluorescence,0,0,1,0,0
1449,3074,2842,CCTE_Deisenroth_5AR_NBTE_donor,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_donor was analyzed into 1 assay endpoint. This assay endpoint,  CCTE_Deisenroth_5AR NBTE_donor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in the donor luminescence as related to 5alpha-reductase catalytic function. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves an artifact detection function.",enzymatic activity,log2_fold_induction,0,"Dutasteride, Finasteride",bidirectional,protein,protein-specified,background measurement,artifact luminescence,0,0,1,229,1512
1450,3076,2843,CCTE_Deisenroth_5AR_NBTE_acceptor,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_acceptor was analyzed into 1 assay endpoint. This assay endpoint,  CCTE_Deisenroth_5AR NBTE_acceptor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in the acceptor fluorescence as related to 5alpha-reductase catalytic function. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves an artifact detection function.",enzymatic activity,log2_fold_induction,0,"Dutasteride, Finasteride",bidirectional,protein,protein-specified,background measurement,artifact fluorescence,0,0,1,229,1512
1451,3078,2844,CCTE_Deisenroth_5AR_NBTE_ratio,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_ratio was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Deisenroth_5AR NBTE_ratio, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in 5alpha-reductase catalytic function. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is 5-alpha reductase.",enzymatic activity,fold_induction,0,"Dutasteride, Finasteride",bidirectional,protein,enzyme,misc protein,5-alpha reductase,0,0,1,229,1512
1452,3086,2848,TAMU_PeakParms_SingleDonor1434_Asystole,1,1,"Data from the assay component TAMU_PeakParms_SingleDonor1434_Asystole was analyzed into 1 assay endpoint. This assay endpoint, TAMU_PeakParms_SingleDonor1434_Asystole, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, loss-of-signal activity can be used to understand changes in the cardiac function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cardiomyocyte function intended target family, where the subfamily is cessation of beating.",cardiac function,percent_activity,0,NA,loss,extracellular,action potential ,cardiomyocyte function,cessation of beating,0,0,1,95,397
1453,3087,2849,IUF_NPC1_cytotoxicity_72hr,1,1,"Data from the IUF_NPC1_cytotoxicity_72hr component was analyzed at the endpoint IUF_NPC1_cytotoxicity_72hr in the positive analysis fitting direction relative to the dynamic range and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to understand cytotoxicity effects.",cytotoxicity,percent_activity,0,lysed cells,loss,cellular,enzyme activity,cell cycle,cytotoxicity,1,0,1,116,8931
1454,3088,2850,CCTE_GLTED_hTBG,1,1,"Data from the assay component CCTE_GLTED_hTBG was analyzed at the assay endpoint CCTE_GLTED_hTBG in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand a chemical's ability to displace T4 from thyroxine-binding globulin. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'transporter' intended target family, where  the subfamily is 'hormone carrier protein'.",binding,percent_activity,0,"3,5,3,5-tetraiodothyronine (T4)",loss,protein,transporter,transporter,hormone carrier protein,0,0,1,17,70
1455,3089,2851,CCTE_GLTED_hTTR,1,1,"Data from the assay component CCTE_GLTED_hTTR was analyzed at the assay endpoint CCTE_GLTED_hTTR in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, loss-of-signal activity can be used to understand a chemical's ability to displace T4 from transthyretin. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'transporter' intended target family, where  the subfamily is 'hormone carrier protein'.",binding,percent_activity,0,"3,5,3,5-tetraiodothyronine (T4)",loss,protein,transporter,transporter,hormone carrier protein,0,0,1,90,352
1456,3090,2852,CCTE_GLTED_hTPO,1,1,"Data from the assay component CCTE_GLTED_hTPO was analyzed at the assay endpoint CCTE_GLTED_hTPO in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter (the Amplex UltraRed assay), loss-of-signal activity can be used to understand decreased peroxidase activity in the presence of excess hydrogen peroxidase. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'oxidoreductase' intended target family, where the subfamily is 'peroxidase'.",binding,percent_activity,0,Methimizole,loss,protein,enzyme,oxidoreductase,peroxidase,0,0,1,20,48
1457,3091,2853,CCTE_GLTED_xDIO3,1,1,"Data from the assay component CCTE_GLTED_xDIO3 was analyzed at the assay endpoint CCTE_GLTED_xDIO3 in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand deiodinase Type 3 activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'deiodinase' intended target family, where the subfamily is 'deiodinase Type 3'.",enzymatic activity,percent_activity,0,xanthohumol,loss,protein,enzyme,deiodinase,deiodinase Type 3,0,0,1,21,36
1458,3092,2854,CCTE_GLTED_xIYD,1,1,"Data from the assay component CCTE_GLTED_xIYD was analyzed at the assay endpoint CCTE_GLTED_xIYD in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of enzyme reporter, loss-of-signal activity can be used to understand iodotyrosine deiodinase activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'dehalogenase' intended target family, where the subfamily is 'iodotyrosine deiodinase'.",enzymatic activity,percent_activity,0,3-Nitro-L-tyrosine (MNT),loss,protein,enzyme,dehalogenase,iodotyrosine deiodinase,0,0,1,16,54
1459,3094,2855,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17,1,1,"Data from the assay component CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17 was analyzed into 2 assay endpoint. This assay endpoint, CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in gene expression. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves as a measure of endoderm differentiation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transcription factor intended target family, where the subfamily is SRY-related HMG-box.",gene expression,percent_activity,0,SB431542,bidirectional,protein,transcription factor,transcription factor,SRY-related HMG-box,0,0,1,68,576
1460,3095,2856,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox2,1,1,"Data from the assay component CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox2 was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in gene expression. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as a measure of pluripotency or ectoderm differentiation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transcription factor intended target family, where the subfamily is SRY-related HMG-box.",gene expression,percent_activity,0,NA,gain,protein,transcription factor,transcription factor,SRY-related HMG-box,0,0,1,68,576
1461,3096,2857,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Bra,1,1,"Data from the assay component CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Bra was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Bra, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in gene expression. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves as a measure of mesoderm differentiation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transcription factor intended target family, where the subfamily is T-box protein.",gene expression,percent_activity,0,NA,gain,protein,transcription factor,transcription factor,T-box protein,0,0,1,68,576
1462,3098,2858,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_CellCount,1,1,"Data from the assay component CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_CellCount was analyzed into 2 assay endpoint. This assay endpoint, CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_CellCount, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline activity. Using nuclei counting, gain or loss-of-signal activity can be used to understand changes in cell viability. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves as a measure of cytotoxicity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,percent_activity,0,NA,bidirectional,cellular,cellular,cell cycle,cytotoxicity,0,1,1,68,576
1463,3099,2860,ATG_frGR_EcoTox2,1,1,"The assay endpoint ATG_frGR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene for glucocorticoid receptor. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,20,54
1464,3101,2861,ATG_rtGR_EcoTox2,1,1,"The assay endpoint ATG_rtGR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene for glucocorticoid receptor. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,20,54
1465,3103,2862,ATG_jmGR_EcoTox2,1,1,"The assay endpoint ATG_jmGR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene for glucocorticoid receptor. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,20,54
1466,3105,2863,ATG_zfGR_EcoTox2,1,1,"The assay endpoint ATG_zfGR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene for glucocorticoid receptor. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,20,54
1467,3107,2864,ATG_hPPARa_EcoTox2,1,1,"The assay endpoint ATG_hPPARa_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARa. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1468,3109,2865,ATG_frPPARa_EcoTox2,1,1,"The assay endpoint ATG_frPPARa_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARa. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1469,3111,2866,ATG_rtPPARa_EcoTox2,1,1,"The assay endpoint ATG_frPPARa_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARa. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1470,3113,2867,ATG_jmPPARa_EcoTox2,1,1,"The assay endpoint ATG_jmPPARa_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARa. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1471,3115,2868,ATG_zfPPARa_EcoTox2,1,1,"The assay endpoint ATG_zfPPARa_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARa. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1472,3117,2869,ATG_hPPARg_EcoTox2,1,1,"The assay endpoint ATG_hPPARg_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rosiglitazone,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1473,3119,2870,ATG_frPPARg_EcoTox2,1,1,"The assay endpoint ATG_frPPARg_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1474,3121,2871,ATG_rtPPARg_EcoTox2,1,1,"The assay endpoint ATG_rtPPARg_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1475,3123,2872,ATG_jmPPARg_EcoTox2,1,1,"The assay endpoint ATG_jmPPARg_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,NA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,20,54
1476,3125,2873,ATG_zfPPARg_EcoTox2,1,1,"The assay endpoint ATG_zfPPARg_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Triphenyl phosphate,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,-1,-1
1477,3127,2874,ATG_hRXRb_EcoTox2,1,1,"The assay endpoint ATG_hRXRb_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRb. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Bexarotene,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,-1,-1
1478,3129,2875,ATG_frRXRb_EcoTox2,1,1,"The assay endpoint ATG_frRXRb_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRb. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Bexarotene,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,-1,-1
1479,3131,2876,ATG_rtRXRb_EcoTox2,1,1,"The assay endpoint ATG_rtRXRb_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRb. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Bexarotene,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,-1,-1
1480,3133,2877,ATG_jmRXRb_EcoTox2,1,1,"The assay endpoint ATG_jmRXRb_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRb. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Bexarotene,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,-1,-1
1481,3135,2878,ATG_zfRXRb_EcoTox2,1,1,"The assay endpoint ATG_zfRXRb_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRb. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Bexarotene,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,-1,-1
1482,3137,2879,ATG_hERa_EcoTox2,1,1,"The assay endpoint ATG_hERa_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,-1,-1
1483,3139,2880,ATG_zfER1_EcoTox2,1,1,"The assay endpoint ATG_zfER1_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,-1,-1
1484,3141,2881,ATG_frER1_EcoTox2,1,1,"The assay endpoint ATG_frER1_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,-1,-1
1485,3143,2882,ATG_hAR_EcoTox2,1,1,"The assay endpoint ATG_hAR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,11-keto Testosterone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,-1,-1
1486,3145,2883,ATG_zfAR_EcoTox2,1,1,"The assay endpoint ATG_zfAR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,11-keto Testosterone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,-1,-1
1487,3147,2884,ATG_M_61_EcoTox2,1,1,"The assay endpoint ATG_M_61_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,-1,-1
1488,3149,2885,ATG_M_06_EcoTox2,1,1,"The assay endpoint ATG_M_06_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,-1,-1
1489,3151,2886,ATG_M_32_EcoTox2,1,1,"The assay endpoint ATG_M_32_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,-1,-1
1490,3153,2887,ATG_M_19_EcoTox2,1,1,"The assay endpoint ATG_M_19_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,NA,gain,protein,transcription factor,background measurement,internal marker,0,0,1,-1,-1
1491,3155,2859,ATG_hGR_EcoTox2,1,1,"The assay endpoint ATG_hGR_EcoTox2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene for glucocorticoid receptor. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,-1,-1
1492,3161,2891,CCTE_Deisenroth_H295R-HTRF_384WELL_ESTRADIOL,1,1,"This assay endpoint, CCTE_Deisenroth_H295R-HTRF_384WELL_ESTRADIOL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using Homogenous Time Resolved Fluorescence technology was used to understand synthesis of estradiol in the H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,fold_induction,0,forskolin for gain; prochloraz for loss,bidirectional,molecular messenger,estradiol,steroid hormone,estrogens,0,0,1,-1,-1
1493,3162,2892,CCTE_Deisenroth_H295R-HTRF_384WELL_TESTOSTERONE,1,1,"This assay endpoint, CCTE_Deisenroth_H295R-HTRF_384WELL_TESTOSTERONE, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using Homogenous Time Resolved Fluorescence technology was used to understand synthesis of testosterone in the H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,fold_induction,0,forskolin for gain; prochloraz for loss,bidirectional,molecular messenger,testosterone,steroid hormone,androgens,0,0,1,-1,-1
1494,3163,2893,CCTE_Deisenroth_H295R-HTRF_384WELL_CTOX,1,1,"This assay endpoint, CCTE_Deisenroth_H295R-HTRF_384WELL_CTOX, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity using CellTiter-Glo 2.0 technology was used to understand viability in the H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity",viability,fold_induction,0,NA,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,-1,-1
1495,3164,2894,CCTE_Mundy_HCI_iCellGABA_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGABA_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGABA_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. This assay component is considered less reliable by experts on the assay due to low occurrence of branch points in the iCell GABANeurons. Use data with caution.",developmental,percent_activity,0,Rac 1 inhibitor (30uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,-1,-1
1496,3165,2895,CCTE_Mundy_HCI_iCellGABA_NOG_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGABA_NOG_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGABA_NOG_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (30uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,-1,-1
1497,3166,2896,CCTE_Mundy_HCI_iCellGABA_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGABA_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_iCellGABA_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (30uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,-1,-1
1498,3167,2897,CCTE_Mundy_HCI_iCellGABA_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGABA_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGABA_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (30uM),loss,cellular,cellular,neurodevelopment,cytotoxicity,0,0,1,-1,-1
